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Abstract 
The enzyme transketolase (TK) (EC2.2.1.1) catalyses a reversible asymmetric carbon-
carbon bond forming reaction, where a two carbon ketose donor is transferred to an 
aldose acceptor.  The use of hydroxypyruvate (HPA), a non-phosphorylated ketol 
donor with subsequent loss of carbon dioxide renders the reaction irreversible 
generating the dihydroxyketone product.  Several years ago the TK gene from the 
plasmid of E. coli (BJ502/pKD112A) was incorporated into a high copy plasmid leading 
to the overexpression of the protein in E. coli, a suitable host for industrial processes.  
The TK condensation of HPA with glycoladehyde and propanal, in analogous but 
separate experiments, has been described in the literature.  The on-going development 
of the enzyme TK as a practical biocatalyst performed on a small scale recently led to 
the discovery of the first biomimetic TK reaction.   
 
The aims of the PhD project were principally two-fold; to explore both biomimetic and 
biocatalytic routes to α,α’-dihydroxyketones.  Firstly, investigation of the new one pot 
synthesis of racemic dihydroxyketones; in terms of substrate scope of the reaction, 
including aromatic, aliphatic hydrophobic aldehydes as substrates.  Donors other than 
hydroxypyruvate (HPA) were also investigated to assess the general synthetic utility of 
the reaction.  Reaction optimisation studies and preliminary mechanistic studies were 
performed.  In addition, investigations into the development of an asymmetric 
organocatalytic reaction were pursued.  Secondly, libraries of TK mutants were also 
screened against a range of non-natural substrates.  A colorimetric assay for screening 
active mutants in a 96 well plate format was used to identify sucessfully a number of 
active mutants with enhanced substrate specificity towards novel cyclic and aromatic 
acceptor molecules, as well as being used for determining initial rate velocities.  A 
chiral assay as a means to determine the absolute stereochemistry, using chiral 
derivatising agents (CDAs) was established which was used with HPLC for successful 
characterisation of the dihydroxyketone motifs. 
 
Chapter 1 of this thesis is an introduction to the important role of thiamine dependent 
enzymes in synthesis, in particular transketolase: the structure, mechanism and its 
usage in industry is covered.  Chemical synthetic routes to ketodiol motifs are also 
mentioned.  Chapter 2 presents the use of a novel chiral assay to determine absolute 
stereochemistries achieved in biocatalytic or biomimetic reactions. Chapter 3 describes 
studies of stereoselectivities with active point single TK mutants on cyclic aldehydes.  
Chapter 4 covers the use of aromatic acceptor substrates with transketolase.  Chapter 
5 describes investigation into novel asymmetric biomimetic routes to ketodiol synthesis 
and finally Chapter 6 concludes the studies and encourages further research. 
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Abbreviations 
 
Ǻ  Angstrom 
AcOH  Acetic acid 
Ar  Aromatic 
Arg  Arginine 
Asp  Aspartic Acid 
BAL  Benzaldehyde lyase  
Boc  tert-Butyloxycarbamate 
BOP-Cl Bis (2-oxo-3-oxazolidinyl) phosphinic chloride 
BFD  Benzoylformate decarboxylase  
BKD  1,3-Dihydroxy-1-phenyl-propan-2-one 
BzCl  Benzoyl chloride 
br  Broad 
cat.  Catalyst 
CDCl3  Deuterated chloroform 
CHCl3  Chloroform 
CH2Cl2  Dichloromethane 
d  Doublet 
dd  Doublet of doublets 
δ  Chemical Shift in ppm 
δLow  Low field protons 
δhigh  High field protons 
∆δH  Chemical shift difference 
DCC  Dicyclohexylcarbodiimide 
DHE  α,β-Dihydroxyethyl- 
DHE–ThDP α,β-Dihydroxyethyl- thiamine diaphosphate intermediate 
DMAP  Dimethylaminopyridine 
DMF  Dimethylformamide 
DMPU  1,3-Dimethyl-2-oxo-hexahydropyrimidine 
DMSO  Dimethylsufoxide 
ee  Enantiomeric excess 
eq  Equivalence 
E. coli  Escherichia coli 
EtOAc  Ethyl Acetate 
E4P  Erythrose-4-phosphate 
FAB  Fast atom bombardment 
F6P  Fructose-6-phosphate 
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GC  Gas chromatography 
Glu  Glutamic acid 
Gly-gly  gly-glycine 
h  Hour(s) 
His  Histidine 
HPA  β-Hydroxypyruvic acid 
HPLC  High performance liquid chromatography 
IDH  Iditol dehydrogenase 
IR  Infra-red 
LB  Luria-Bertani 
m  Multiplet (NMR) 
mg  Milligram 
Mg2+  Magnesium 
min  Minute(s) 
mmol  Millimoles 
MOPS  3-(N-morpholino)propanesulfonic acid 
MTPA  α-Methoxy-α-trifluoromethylphenylacetic acid 
MTPA-Cl α-Methoxy-α-trifluoromethylphenylacetic acid chloride 
NaCNBH3 Sodium cyanoborohydride 
NaOH  Sodium hydroxide 
NADH  Reduced nicotinamide adenine dinucleotide 
NMM  N-methylmorpholine 
NMR  Nuclear magnetic resonance 
NEt3  Triethylamine 
OD  Optical density 
PDC  Pyruvate decarboxylase  
PEP  Phosphophenol pyruvate 
pKa  Acid dissociation constant 
PKD  1,3-Dihydroxy-pentan-2-one 
POX  Pyruvate oxidase 
PDH  Pyruvate dehydrogenase 
PTSA  p-Toluenesulphonic Acid or pTsOH  
q  quartet 
QN  Quinine 
QD  Quinidine 
R  Unspecified carbon substituent 
(R)  Rectus (clockwise direction) chirality 
Rf  Retention factor 
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rt  Room temperature 
s  Strong Intensity (IR) 
s  Singlet (NMR) 
(S)  Sinister (counter-clockwise direction) chirality 
SAMP  (S)-1-amino-2-methoxy-methylpyrrolidine  
Ser  Serine 
t  Triplet (NMR) 
TBS  tert-butyldimethylsilyl (protecting group) 
TBSOTf tert-butyldimethylsilyl trifluoromethanesulfonate  
ThDP  Thiamine diphosphate 
TLC  Thin layer chromatography 
TFA  Trifluoroacetic acid 
TK  Transketolase 
Tris  Tris(hydroxymethyl)methylamine 
t-BuLi  tert-Butyllithium 
THF  Tetrahydrofuran 
UV  Ultraviolet 
Vrel  Relative Velocities 
KM Michaelis Constant – concentration at which rate of enzyme reaction is 
half Vmax 
Vmax Maximum rate 
WT-TK  Wild type transketolase 
Xu5P  Xylulose-5-phosphate 
λmax  Wavelength at maximum absorbance (UV) 
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1.1 Enzymes used as biocatalysts in synthesis 
 
Enzymes are highly suited to the on-going ‘Green Chemistry’ initiative first proposed by 
P.T Anastas of ‘designing new products and processes that reduce or eliminate the use 
and generation of hazardous substances’.1 Enzymes by their nature are biodegradable, 
renewable sources and utilize water as the reaction solvent.  Reactions catalyzed by 
enzymes are the most mild, effective and selective ‘green’ processes available to date.  
The advantages of using biocatalysts include; high regio- and stereoselectivity, 
substrate versatility, and the production of fewer by-products that can be considered 
detrimental to the environment. Enzyme catalysed formation of C-C bonds is important 
in synthetic organic chemistry, providing efficient access to stereospecific motifs, which 
may require a number of synthetic steps to produce using chemical transformations.  
 
In light of the demand for enantiomerically pure compounds for pharmaceutical 
purposes, the benefits of using enzymes are obvious.  One example reported by Frost 
et al.2 is the novel synthesis of shikimic acid an essential precursor to the production of 
tamiflu.  The success of this shikimic pathway is dependent on the directed evolution of 
2-keto-3-deoxy-6-phosphogalactonate aldolase 1 (KDPGal) to generate 3-deoxy-D-
arabino-heptulosonate 7-phosphate 4, from pyruvate 3, and a non-natural substrate D-
erythrose-4-phosphate 2. The KDPGal variant was overexpressed in E. coli and 
incubated with pyruvate 3, and 2, 3-dehydroquinate synthase 5, and 3-dehydroquinate 
dehydratase 6 which catalyzed the formation of enantiomerically pure 3-dehydroxy-
shikimate 7 in 90% yield (Scheme 1).  
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Scheme 1: The pathway for microbacterial production of 3-dehydroxyshikimate by using 
recombinant E.coli KDPGal 
 
 In carbohydrate chemistry in particular, the usage of a plethora of protecting groups is 
typically required for chemical preparation due to the multiple hydroxyl groups. A 
variety of enzymes such as lyases and aldolases have been used to synthesize 
complex sugars and other biologically important natural compounds.3 One such 
example is the synthesis of aza sugars which are known as potential enzyme inhibitors 
and therapeutic agents.  Ketoses containing an azido group can be generated by an 
enzymatic aldol condensation between dihydroxyacetone phosphate 8 as a donor 
molecule with an azido containing acceptor aldehyde 9.3c Then treatment with acid 
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phosphatase and an isomerase to generate 6-azido-6-deoxyaldopyranose 10, which 
upon reductive amination afforded the 7-membered azasugar 11 (Scheme 2). 
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Scheme 2: Chemoenzymatic pathway for the production of a 7 membered azasugar 
 
1.1.0 Thiamine-dependent enzymes 
 
Thiamine-dependant enzymes have been used on an industrial since the early 1920’s 
as catalysts, in a baker’s yeast whole cell biotransformation of (R)-phenylacetyl 
carbinol, a precursor to (-)-ephedrine.  However it was not until 1937 that the structure 
of thiamin diphosphate (ThDP) was first determined.4  In most ThDP (Fig. 1) dependent 
enzymes the haloenzyme catalyses a carbon-carbon bond cleavage of a donor 
substrate forming a reactive intermediate which condenses with an acceptor molecule 
generating a new product with the regeneration of ThDP.  The nature of the acceptor 
molecule determines if the enzyme is more specific in the reaction or more permissive.  
From an industrial stand point, enzymes that tolerate a large spectrum of substrates 
are of greater interest.  Discussed below are several ThDP dependent enzymes, their 
substrate specificity and their industrial synthetic potential, with examples.  
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Figure 1: Structure of ThDP, amPyr = aminopyrimidine ring, Thiaz = thiazolium ring, 
 Diphos = Diphosphate 
 
1.1.1 Benzoylformate decarboxylase 
 
Benzoylformate decarboxylase (BFD) (E.C. 4.1.1.7) involved in the mandelate 
biosynthetic pathway5 is a ThDP dependant enzyme purified and characterized from 
Pseudomonas putida,6 or from Acinetobacter calcoaceticus.7  BFD has been shown to 
exhibit various catalytic activities; a non oxidative decarboxylation of benzoyl formate 
13 to form benzaldehyde 14 and catalyses the enantioselective acyloin formation of 
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(S)-2-hydroxypropiophenone 15, (92% ee) from Pseudomonas putida BFD within a 
broad pH range (5-8) and temperature (20-40 ºC) range (Scheme 3).8  Further (S)-15 
analogues have also been formed upon the ligation of acetaldehyde with different, 
aromatic, heteroaromatic, olefinic and cyclic aliphatic aldehydes, with high ees in the 
range of 87-99%.9,10 
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Scheme 3: The catalytic mechanism of BFD generating benzaldehyde and 15 
 
The carboligase activity of BFD from Pseudomonas putita has also been reported for 
the general C-C bond mediated synthesis of enantiomerically pure benzoin and 
substituted benzoin derivatives from aromatic aldehydes. The carboligation 
experiments were performed with benzaldehyde as the sole substrate and generated 
(R)-benzoin 16 in an optimized 70% yield and >99% ee (Scheme 4).   
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Scheme 4: The generation of (R)-benzoin products 16 
 
The cross coupling of various aromatic aldehydes with acetaldehyde as acceptor, to 
generate (S)-2-hydroxy ketones using WT-BFD was achieved without the need for 2-
ketoacids as substrate donor molecules (c.f pyruvate decarboxylase (PDC)), and 
resulted in good to high conversions to (S)-2-hydroxypropanone derivatives on a 
preparative scale.11 The highest ees were obtained using aromatic substrates 
containing substituents on the meta or para position on the aryl ring (Scheme 5). 
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Scheme 5: Cross coupling of an aromatic aldehyde with acetaldehyde to generate 17 
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Ortho- substituted aromatic substrates were poorly accepted by WT-BFD, with the 
exception of 2-fluorobenzylaldehydes. This was attributed to steric and electronic 
effects.12  The limitations with ortho-substituted aromatic aldehydes were circumvented 
by site directed mutagenesis via directed evolution.13  A BFD mutant L476Q, not 
directly involved in the binding of the acyl donor had an increased substrate specificity 
profile, and improved organic solvent toluene in aqueous media was observed. The 
same approach was applied to interchange BFD and PDC carboligation activity. The 
BFD variant A460I was used to decarboxylate pyruvate in the presence of long chain 
aliphatic substrates, giving (R)-acyloin products 18 in 34-85% ee (Scheme 6). 12 
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Scheme 6: Self condensation reaction with BFD 
 
1.1.2 Benzaldehyde lyase (BAL) 
 
Benzaldehyde Lyase (BAL) (EC 4.1.2.38) from Pseudomonas fluorescens was first 
reported by Gonzales et al.14  The purified enzyme cleaved acyloin and benzyloin 
linkages using a bivalent ion and ThDP as a cofactor.  It was first reported that BAL 
catalysed the carboligation of two aldehydes to afford the products (R)-16 and (R)-15.15 
Since then, the carboligation activity of BAL with a broad range of substrates has been 
explored (Scheme 7). 
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Scheme 7: General carboligation with BAL 
 
The mechanism of BAL is in accordance with other ThDP-dependent enzymes 
(Scheme 8).  The first step involves the attack of the thiazolium ylid on the carbonyl 
carbon of the (R)-16 to form adduct A.  The nitrogen on the thiazolium ring acts as an 
electron sink which enables an electron rearrangement leading to the enamine-
carbanion intermediate with the release of one benzaldehyde molecule 14.  The 
enamine intermediate can be generated upon attack of the ThDP ylid with a free 
benzaldehyde molecule. In the absence of an acceptor aldehyde the enamine 
intermediate is protonated and a benzaldehyde molecule is released with the 
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regeneration of ThDP (route B).  In the presence of an acceptor molecule the 
carboligation reaction can occur, generating (R)-15 as product and regenerating of the 
ThDP ylid (route C). 
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Scheme 8: Catalytic cycle of BAL using ThDP 
 
In contrast to BFD, BAL can accept ortho- substituted aromatics.15  Several synthetic 
benzoin derivatives were synthesized by BAL mediated self-condensation reaction in 
96-99% ee,16 heterocyclic aldehydes had slightly lower ees; 92% ee for 2-
furfuraldehyde and 91% ee for thiophene-2-carboxyaldehyde. Pyridine-3/4-
carboxyaldehydes and sterically demanding aryl aldehydes, gave poor yielding benzoin 
condensation products.18 Unlike BFD, BAL has a wider substrate group tolerance for 
longer chain aliphatic aldehydes (e.g propanal and butyraldehyde) as an acyloin 
acceptor.  The structural differences between BAL and BFD and the reason for the 
general R-specificity of BAL upon formation and cleavage of the 2-hydroxyketone is 
due to the wider overall shape of the binding site and the absence of an ‘S-pocket’ 
structural element in BAL, responsible for directing stereoselectivity.17,18   In another 
study, BAL has been used to form enantiopure 2,3-dioxygenated aryl propanones 19, 
highly valuable chiral synthons used for the synthesis of cytoxazone, a novel cytokine 
modulator 20, lignans 21, and aryl isoserines 22.  This involved the carboligation of 
aromatic aldehydes with methoxy and dimethoxyaldehydes generating (R)-2-hydroxy-
3-methoxy-1-arylpropane-1-one derivatives in high yields in 89 - 98% ee (Scheme 9). 
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Scheme 9: Synthesis of enantiopure 19 that can be used as chiral synthons 
 
1.1.3 Pyruvate decarboxylase (PDC) 
 
Pyruvate decarboxylase PDC [(E.C.4.1.1.1)] is an important enzyme in the glycolytic 
pathway and ethanol fermentation. PDC has been an important biocatalyst in 
carboligation reactions such as (R)-15, a key intermediate for ephedrine 23 and 
pseudophedrine 24 production (Scheme 10).19   
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Scheme 10: The production of ephedrine 23 and pseudoephedrine 24 from 15 
 
The PDCs used in biocatalysis are isolated from Neurospora crassa, Zymomonas 
mobolis, Candida utilis, and Rhizopus javanicus.20  The mechanism for the formation of 
(R)-15 involves the decarboxylation of pyruvic acid to form the reactive enamine for 
carboligation with the acceptor molecule benzaldehyde. 
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Scheme 11: General reaction mechanism for (R)-15 synthesis 
 
Various aldehydes have been explored to produce S-acetyl aromatic carbinols using   
S. cerevisiae.  It was found that substrates containing ortho- substituents failed, whilst   
-CH3, -CF3, and -Cl substiuents at the para- position generated higher yields than the 
meta- counterparts.  Mono and disubstituted halogenated benzaldehyde derivatives 
were also investigated for the syntheses of novel (R)-15 analogs using purified PDC 
from yeast.21 The substrates containing the highest relative initial rates were                 
2-fluorobenzaldehyde and 2,3-diflurobenzaldehyde with high ees (>99%) but moderate 
yields (60% and 40% respectively).21 
 
Further to this report Crout et al. used recombinant PDC from Z. mobilis to catalyse 
(R)-aromatic acyloin formations in high optical purity from o, m, p-halogenated aromatic 
aldehydes as acceptor molecules, with either pyruvate or acetaldehyde.  Heterocyclic 
aldehydes, including furfural aldehydes and thiophene-3-aldehyde, were poor 
substrates but gave products in relatively high 80-90% ees.  The acyloin reaction was 
also carried out with aliphatic aldehydes.  Only propanal gave the acyloin product with 
pyruvate generating 2-hydroxypentan-3-one 25 and 3-hydroxypentan-2-one 26 in equal 
amounts with no self condensation producted isolated (Scheme 12). 22 
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Scheme 12: Carboligation of propanal and pyruvate 3 
 
Other ketoacids were explored, such as 3-hydroxypyruvate (HPA), but they failed to 
generate acyloin product. The keto acid can selectively be decarboxylated by Z. mobilis 
PDC to generate glycolaldehyde, however no acyloin product was afforded with either 
aromatic or aliphatic aldehydes. 
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1.2 Transketolase and the transketolase reaction  
 
Transketolase (TK) [E.C.2.2.1.1] is an important and versatile enzyme in the non-
oxidative branch in the pentose phosphate pathway in animals and the Calvin Cycle of 
photosynthesis.23  In vivo the enzyme reversibly transfers a two carbon ketol unit to the 
carbon terminus of aldosugars; erythrose-4-phosphate (E4P) and ribose-5-phosphate 
(R5P) which affords fructose-6-phosphate (F6P) and sedoheptulose-7-phosphate  
(S7P) respectively (Scheme 13).  In the Calvin Cycle, TK catalyses the reverse 
reaction. 
Xylulose
5-phosphate  (Xu5P)Ribose5-phosphate  (R5P)
Glyceraldehyde
3-phosphate  (G3P) Sedoheptulose7-phosphate  (S7P)
OHH
OHH
OHH
H2C OPO32-
C OHH
O
OHH
OHH
H2C OPO32-
H
HHO
OHH
OHH
OHH
H2C
O
OPO32-
C OH
OHH
OPO32-H
H
H
H
TK
OH
H O
OHH
OHH
OH
CH2OPO32-
C OHH
O
OHH
OHH
H2C OPO32-
H
HHO
OHH
OHH
O
C OH
OHH
OPO32-H
H
H
H
TK
H O
CH2 OPO32-
Erythrose 
5-phosphate  (R5P)
Xylulose
5-phosphate  (Xu5P) Glyceraldehyde3-phosphate  (G3P)
Fructose
6-phosphate  (F6P)
+
+
+
+
 
Scheme 13: Transfer of a ketol unit to an aldose sugar phosphate molecule 
 
 
The TK enzyme has been shown to be dependant on cofactor thiamine pyrophosphate 
(ThDP) and a bivalent metal ion (Ca2+, Mg2+, Co2+, Mn2+, Ni2+) for enzymatic activity, but 
the activity is independent of the nature of the bivalent metal ion used.24  From 
mechanistic studies, catalysis is initiated by the deprotonotation of carbon-2 of the 
thiazolium ring of ThDP (Fig. 2). 
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Figure 2: The chemical structure of ThDP 
 
The reactive ThDP ylid attacks the carbonyl group of a donor Xu5P substrate.  The C2-
C3 bond cleavage of the ketose sugar yields glyceraldehye-3-phosphate (GAP) and an 
enzyme bound α,β-dihydroxethyl-ThDP (DHE-ThDP) resonance stabilised carbanion 
intermediate.  The DHE-ThDP carbanion then attacks the aldehyde of the aldose sugar 
ribulose-5-phosphate (R5P) forming sedoheptulose-7-phosphate ((S7P)-ThDP) adduct.  
ThDP is finally eliminated by cleavage of the thiazolium ring yielding the S7P product 
(Scheme 14). 25    
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Scheme 14: The ThDP mechanism of TK 
 
1.2.1  X-ray crystal structure of saccharomyces cerevisiae transketolase 
 
TK is a member of a group of transferases, composed of two identical subunits, each 
with a molecular mass of 74.2 kDa.26 X-ray crystallographic studies on Saccharomyces 
cerevisiae TK indicated that each monomer of the dimeric TK enzyme consists of three 
domains: N-, or PP- domain (residues 3-322); the middle section, or Pyr-domain (323-
538), and the C-domain (539-680).27  The first two domains are involved in the catalytic 
profile of the enzyme and coenzyme binding, while the role of the C-domain is relatively 
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unclear.  At the interface lie the cofactors ThDP and a bivalent metal ion (calcium) in a 
deep cleft between the subunits (Fig. 3). 
 
Figure 3: X-ray crystal structure of Saccharomyces cerevisae TK with ThDP, Ca2+and E4P 
(1NGS.pdb) from www.rcsb.org/pdb 
 
The thiazolium ring is bound to both subunits, held together by hydrophobic 
interactions from nearby aromatic residues, Typ 442/445 and Tyr-446.  Only the C2 
atom of the thiazolium ring of ThDP is exposed and bound covalently to the donor 
substrate in solution.  The ThDP diphosphate group hydrogen bonds with His residues 
(69 and 263) and a Gly residue (158) and an electrostatic interaction with the calcium 
ion is also present  
 
1.2.2  Substrate binding in thiamin diphosphate-dependant transketolase 
 
A TK crystal structure with bound acceptor substrate molecule, erythrose-4-phosphate 
(E4P) present in the active site was first studied by Schneider and coworkers.28  E4P 
was generated from the enzymatic cleavage of donor substrate fructose-6-phosphate 
(F6P).  The X-ray crystal structure identified amino acid residues at the active site 
primarily involved in substrate binding.  E4P is projected from the surface of the protein 
into the enzyme cleft; with the phosphate group hydrogen bonding with conserved 
residues Arg359, Ser386, Arg528, and His469 at the entrance of the cleft assessible to 
solvents.  The side chains Arg528, His469 and Ser386 are within hydrogen bond 
distances to the substrate’s phosphate group.28 Another polar interaction occurs 
between the hydroxyl group of E4P and the Asp477 residue, and the aldehydic oxygen 
atom can interact with two His residues which are conserved in known transketolases 
sequenced thus far (Fig.4). 
PP-Domain 
Pyr-Domain 
C-Domain 
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Figure 4: Selected amino acid residues and the hydrogen bonding distances  
(1NGS.pdb) from www.rcsb.org/pdb 
 
 
Analyses of the quarternary complex of TK revealed that the substrates bind in a 
narrow channel. The substrate extends until it is in contact with the C2 carbon atom of 
ThDP which is located at the end of the interior protein channel.  It is not possible for 
both the donor and acceptor molecule to enter and covalently bind in the active site 
simultaneously, hence a Bi Bi Ping Pong mechanism was proven.29  The aldehydic 
carbon cannot interact with the C2 carbon of the thiazolium ring which is at a distance 
of 4.16 Ǻ.  There is however, a small enough pocket for an α,β-dihydroxyethyl (DHE) 
group to generate a DHE-ThDP-carbanion intermediate, reducing the distance to 3.2 Ǻ 
between the acceptor substrate and this reactive intermediate to covalently bond     
(Fig. 5). This is made possible with a few side chain rotations but no necessary side 
chain rearrangement of the amino acid residue is required.   
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Figure 5: Schematic interaction of ThDP with E4P 
 
 28 
Despite the successes of Schneider’s preliminary X-ray crystal studies on substrate 
binding, important key features of the catalytic cycle remained elusive.  Most 
importantly, what is the driving force for the C2-C3 cleavage of the substrate donor 
molecule upon formation of the DHE-ThDP carbanion intermediate?  Recent studies by 
Schneider attempt to address the issue with a non-phosphorylated donor substrate, 
hydroxypyruvic acid and its isolated DHE–ThDP carbanion crystal structure30 in the 
active site of TK.  However the study does not take into account the natural TK sugar 
phosphates which behave differently in the active site.  Recently in the literature, 
Tittman’s group have reported the first crystal structure of the ketose-cofactor adducts 
trapped in the active site of E. coli TK, shedding more light on the mechanism of TK. 31 
 
The X-ray crystal structure revealed xylulose-5-phosphate (Xu5P) is covalently bonded 
to C2 carbon of the thiazolium ring (ThDP), as determined by the (i) tetrahedral shape 
of Xu5P C2’ carbon that is sp3 hybridised.  (ii) The distance between the C2’ carbon of 
the sugar and C2 carbon of ThDP is 1.5 Å, suggesting the carbonyl addition of the 
sugar to the ThDP’s C2 had indeed taken place.  The structure itself reveals key 
features of the Xu5P-ThDP intermediate: the C2’-C2 bond was not coplanar to the 
thiazolium ring, there is an out-of-plane distortional angle of (25-30º) implying 
conformational strain on the intermediate. The glyceraldehyde-3-phosphate (G3P) 
generated relieves the bond tension with the formation of a planar unrestrained DHE-
ThDP enamine intermediate an important driving force for the elimination of product 
(Fig. 6).   
 
Figure 6 Crystal structure of Xu5P-ThDP adduct with an out-of-plane distortional angle (25-30º) 
(2R8O.pdb) from www.rcsb.org/pdb 
 
Similar findings have also been reported in ThDP-dependant enzymes involving 
pyruvate as the substrate, such as pyruvate oxidase32 (POX) and pyruvate 
dehydrogenase33 (PDH).  These form a pyruvate-ThDP adduct with varying degrees of 
out-of-plane distortions from 5 -7º (POX) to 11º (PDH).  The cleaved C2’-C3’ bond of 
the Xu5P is perpendicular to  the positively charged thiazolium ring of ThDP to act as 
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an optimal electron sink for the electron pair of the DHE-ThDP intermediate upon 
elimination of G3P.  The facile conjugation with the electron pair of thiazolium pi-
electrons makes the cleavage possible, effectively maximising the overlap to give a 
more stable conformation.  This has been predicted and considered from theoretical 
based ThDP-based enzymes34,35 and has experimentally been shown to operate in 
enzymes catalyzing decarboxylation reactions.32, 33 
 
1.2.3 Site directed mutagenesis on selected amino acid residues with catalytic 
activity 
 
Non-phosphorylated donor substrates such as fructose and ribose sugars can be used 
in the TK reaction.  However previous research conducted had shown poor substrate 
affinity indicative from the large KM values compared with its phosphorylated 
counterparts.36  The importance of hydrogen bonding and tight ionic interactions with 
the phosphate moiety and the amino acid residues at the entrance of the cleft to the 
active site is believed to contribute to the enzyme’s catalytic activity.  This was further 
demonstrated by selective mutations at the phosphate binding site: the polar amino 
acid residues were substituted with a non polar alanine residue, which resulted in high 
KM (µM) values for mutants R359A, R528A, and H469A (Table 1).  It is important to 
note the larger KM value for ribose-5-phosphate (R5P) in comparison to its counterpart 
xylulose-5-phosphate (Xu5P).  The rational basis for the large difference in KM values 
can be attributed to the closeness of the C2 carbon of the thiazolium ring and the 
carbonyl centre from the acceptor molecule.  Xylulose binds deeper into the channel 
weakening the important interaction between the phosphate group and arginine 
residues.  The mutant H469A is enclosed in the interior of the substrate channel which 
can effectively hydrogen bond to the phosphate group of xylulose.  This was 
rationalised by noting the effect this residue on the KM value for the xylulose substrate 
compared to KM values of mutants R359A and R528A (Fig. 7). 
 
Enzyme Activity Xu5P (KM) µM R5P (KM) µM 
Wild type 100 73 146 
D477A 1.7 595 1750 
H469A 77 829 5970 
R359A 31 163 5650 
R528A 17 318 7000 
 
Table 1: The kinetic data of several TK mutants with Xu5P and R5P as acceptor substrates 
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Figure 7: (A) WT amino acid residues hydrogen bond to E4P (B) Mutant amino acid residues 
hydrogen bonding to E4P (mutagenesis performed by pyMOL) 
 
1.2.4 Amino acid residue Asp477 responsible for enantioselectivity 
 
Previous work conducted by Whitesides37 and Kochetov36 noted that sugar phosphates 
with D-threo configurations at the C3 and C4 carbon atoms can act as efficient donors 
in the TK reaction.  The high stereoselectivity of the enzyme can be recognised from 
C3 and C4 hydroxyl groups forming hydrogen bonds to the side chains of Asp477, 
His30, and His263.  The C3 and C4 carbon atoms correspond to the C1 and C2 carbon 
atoms of the aldose acceptor molecule.  On a structural hypothesis, the removal of the 
hydroxyl group, or the inversion of the stereocenter disrupts the hydrogen bonding and 
lowers the substrate affinity of the acceptor molecule.38   
 
Schneider investigated the stereospecificity of wild type and mutant TK D477A.38  A 
series of acceptor aldehydes were screened with/without the hydroxyl group present at 
the C2 carbon position and kinetic Kcat/KM values were compared.  The Kcat/KM results 
indicated that α-hydroxyaldehydes with specific D-configurations (e.g. ribose-5-
phosphate) are required for high catalytic activity compared with α-deoxyaldehydes.  
This strongly suggested that the hydroxyl group at C2 in the acceptor substrate was 
highly important for catalytic activity.  Further evidence was provided with the screening 
of TK mutant D477A with various acceptor molecules, which revealed a considerable 
decrease in catalytic activity, when Asp was replaced with the non-polar residue, Ala.  
The studies conducted by Schneider’s group provided a strong case for determining 
that Asp477 was involved in acceptor substrate specificity, but it failed to address the 
issue of the stereoselectivity of the ketodiol products generated.  The kinetic 
parameters alone provided evidence that Asp477 was involved in the increase in 
product yield; however increased kinetic activity does not also lead to high selectivites 
in the products formed. 
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1.2.5 Protocols for the transketolase reaction 
 
It is known that the transketolase-catalysed interconversion of carbohydrates is a 
reversible reaction.  To drive the equilibrium to completion, Srere et al.39 demonstrated 
that β-hydroxypyruvic acid (HPA) could be used as a substrate for TK.  The 
decarboxylation of HPA and the subsequent removal of CO2 from the reaction mixture 
render it an irreversible condensation reaction (Scheme 15).  The Lithium HPA salt    
(Li-27) has since been used as a substrate in many experimental TK reactions instead 
of ketose sugars.   
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Scheme 15: Irreversible Condensation reaction of Li-27 
 
The pH of the reaction will exceed 7.5, the optimum pH for TK,40 due to the 
consumption of one proton per molecule of product formed.  This pH can be easily 
maintained by using buffer or adding acid slowly over the course of the reaction.    
 
Current biological studies involve the isolation of transketolase and this can be isolated 
from three main sources: 
 
• Baker’s yeast, Saccharomyces cerevisiae, commercially available (Fluka) at 
moderate cost.  Stable for several months in its lyophilized powered form, and 
at pH 7.5 in gly-gly buffer solution. 
• Spinach leaves, which can be used immediately after isolation.  The activity of 
the enzyme can be greatly improved if purified to homogeneity; however activity 
is lost after a few days. 41 
 
Unfortunately neither of these sources yields considerable quantities of the enzyme, 
however catalytic findings have been demonstrated on a small scale.42  The drawbacks 
have been surmounted by introducing the TK gene into a high copy plasmid leading to 
a over-expression of the protein in E. coli.43 
 
1.2.6 Transketolase: A biocatalyst for asymmetric carbon-carbon bond synthesis 
and applications in organic syntheses using yeast, spinach and E.coli TK. 
 
In the oxidative pentose phosphate pathway, it is known that ribose 5-phosphate (α-
hydroxyaldehyde) is a donor molecule in the TK-catalysed reaction.  In the early 1990s, 
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research focused on a wide variety of non-phosphorylated α-hydroxyaldehydes as 
substrate acceptor molecules; for yeast, spinach and E.coli TK.  
 
Whitesides et al. conducted experiments using α-hydroxyaldehydes, HPA and 
commercially available yeast TK whilst maintaining the pH of the reaction mixture at pH 
7.5 by controlled slow addition of an HPA solution (ca pH 4.0).42  When using α-
hydroxyaldehydes and HPA, the hydroxyketone group was transferred with the 
formation of a (3S,4R) chiral triol 29, in decent yields (30-60%).  Most significant of 
these findings was the kinetic resolution of racemic α-hydroxyaldehydes 28 with TK.  
The recognition of chirality in the aldehydic moiety afforded (2S)-28 with ees >95%, 
although the isolated yields were modest (9-23%) (Scheme 16).  Effenberger et al. later 
significantly improved the yields of these optically pure (2S)-aldehydes (50-78%) by 
using different R (e.g PhCH2OCH2, CH3OCH2, SHCH2, FCH2) side chains.44   
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Scheme 16: The yeast TK biotransformation reaction using Li-27 and 28 
 
On inspection of the chiral triols isolated; the relative rates for the formation of 29b-29d 
suggested that the branching of the aldehyde leads to lower reaction rates, aldehydes 
29h-29i containing an extra hydroxyl group revealed a slight preference for the 
dihydroxyl aldehydes compared to the mono hydroxyl aldehydes. However 
comparisons in yields proposed by Effenberger et al. ranging from 72-80% suggested 
otherwise.  Both research groups, used CH3CH2- (29c, 29n), and MeOCH2- (29e, 29k) 
aldehydic groups with varying product yields, but this could be attributed to the different 
reaction conditions used in the biocatalysis.  Effenberger et al. uses stoichiometric 
amounts of substrates whilst maintaining the temperature at 30 ºC, in comparison to 
Whitesides’ variable substrate concentrations (Table 2). 
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Table 2: Reported results of α-hydroxyaldehydes as acceptor molecules with yeast TK.  Whitesides 
et al.(pink), biotransformation conditions; Li-27 (10 mM), aldehyde (50-130 mM), pH maintained by 
addition of Li-27, 10-30U TK added.  Effenberger et al. (blue), biotransformation conditions: 25-50 
mM scale, equimolar reagents, Tris.HCl buffer (0.5 M, pH 7.6) incubated at 30 ºC, unspecified 
amount of enzyme used. 42, 44 
 
The stereochemistries of 29f-29i were determined from the optical rotations of known 
carbohydrates, however no attempts were made to accurately determine the ees of the 
carbohydrates isolated.42 The stereochemistries of the compounds were not discussed 
but were inferred to possess high ees from the determination of the known absolute 
stereochemistry of 29c. The ees of compounds 29j-29m were determined by gas 
chromatography on a β-cyclodextrine phase; however the absolute stereochemistry 
was presumed to possess the (2R,3S)-configuration.   
 
The Dumuynck began preliminary investigations on the tolerance of a greater variety of 
substrate acceptor molecules, more specifically non-α-hydroxyaldehydes (Scheme 
17).45 This investigation reported initial relative velocities of the substrates expressed 
as a percentage compared to the initial velocity of glycolaldehyde, a highly reactive 
acceptor.  The initial velocities were monitored by the consumption of hydroxypyruvate 
by using an enzymatic assay.46  Some general conclusions were made on the nature of 
the aldehyde acceptor molecule; the presence of a hydroxyl group or an oxygen atom 
R 29 Vrel Yields % (2S)-28 (ee%) 
H a 100 60 n/a 
CH3 b 20 44 >95 
CH3CH2 c 33 45 95 
CH3(CH2)2 d 22 39 77 
MeOCH2 e 27 38 94 
H2C=CH f 56 30 - 
H2C=CHCH2 g 28 45 95 
(S)-H2C=CHCHOH h 49 60 - 
(R)-H2C=CHCHOH i 50 63 - 
PhCH2OCH2 j - 79 98 
MeOCH2 k - 72 99 
SHCH2 l - 80 99 
EtSCH2 m - 74 99 
CH3CH2 n - 50 99 
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at an α-carbon or/and β-carbon 30c-30d enhanced relative rates. Steric hindrance near 
the aldehyde group reduced the reactivity 30f. An α,β-Unsaturated aldehyde 30e is 
accepted as TK substrate, benzaldehyde 30g is a poor substrate but the presence of 
hydroxy-groups on C2
 
 30h leads to higher activities. Hetereocyclic aldehydes 30i-30k 
were better substrates than benzaldehyde but overall low initial velocities were 
observed (Table 3).45     
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Scheme 17: The yeast TK reaction using a non-α-hydroxyaldehyde with Li-27 
 
R 30 Vrel 
HOCH2- a 1 
CH3- b 0.25 
CH3OCH2- c 0.32 
(R,S) CH3CHOHCH2 d 0.29 
(CH3)2CH=CH e 0.11 
(R,S) CH3CH(OBz)-CH27- f 0.14 
Phenyl- g <0.1 
2-hydroxyphenyl- h 0.28 
2-Furanyl- i 0.11 
2-Thiophenyl- j 0.32 
2-Pyridyl k 0.13 
 
Table 3: Vrels of non-α-hydroxyaldehydes using yeast TK.  Demuynck et al. biotransformation 
conditions; TK (1 U ml-1), gly-gly buffer 0.1 M at pH 7.5, aldehyde (60-200 mM), and Li-27 (7.5 mM). 
 
Isolated yields were not reported in this publication.  The assay used to determine the 
Vrels depended heavily on the depletion of Li-27.  No controls were mentioned in their 
studies to ensure the degradation of Li-27 was not influenced by the decarboxylation of 
the α-keto acid47 or the possible aldol condensation of substrates in aqueous solution.48  
In conclusion, the Vrels calculated may not be an adequate description for the initial 
relative velocities and substrate affinities of accepter aldehydes used. 
 
Dumuynck’s group later addressed these issues by investigating the stability of Li-27 in 
various buffers as well as the biocatalytic potential of spinach TK.49 The stability of     
Li-27 was monitored over a period of time with four different buffered solutions; gly-gly, 
triethanolamine, HEPES and Tris.  All buffers showed 20-80% depletion of Li-27 in 24 
hours but Tris was found to be the most Li-27 stable and was then selected for 
biocatalysis.  The results obtained from the biotransformation of spinach TK confirmed 
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previous results from yeast TK, that the presence of an α-hydroxyl group in the 
aldehyde leads to higher reaction rates.  The replacement of the hydroxyl group with a 
methylthiol 30p, or methoxy- group 30n revealed a decrease in the Vrels of reactions 
(Table 4). 
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R 30 Vrel Yield % ee% 
H- l 0.12 30 70 
OH- m 1 70 64 
CH3O- n 0.32 45 60 
ClCH2- o 0.23 - - 
CH3S- p 0.35 46 64 
CH3SCH2- q 0.24 20 76 
 
Table 4: The Spinach TK reaction with various acceptor aldehydes. Demuynck et al. 
biotransformation conditions; Spinach TK (250 U), Tris buffer 0.1 M at pH 7.5, Li-27 (100 mM), 
aldehyde (100 mM) 
 
The ees of 30l-30q were determined by preparing the trifluoracetate derivatives of 
these sugars and analysis by GC and the (S)-configuration of the new stereogenic 
carbon center was inferred from previous studies on ketose sugars with L-erythrulose.50 
and 4-deoxy-L-erythrulose.46 
 
TK from E. coli has several added benefits over spinach and yeast TK, such as the 
greater acceptance of the donor molecule Li-27 with a conversion rate which is 30 
times and 6 times higher than the rates for spinach and yeast TK respectively.51 TK 
from E. coli was determined to be relatively non-specific for the aldehyde acceptor, 
similar to that for the aldehyde specificity profile reported for yeast.  In general, the 
condensation of α-hydroxyaldehydes 28 with Li-27 using E.coli TK was similar to that of 
yeast TK and was specific for aldehyde acceptor molecules bearing the α-hydroxyl 
group in the D (i.e. 2R)-configuration (Scheme 18).   
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Scheme 18 TK-catalysed reaction with Li-27 and (R)-α-hydroxyaldehyde 
 
An experiment measuring Li-27 depletion at different time intervals when using 
enantiomers of glyceraldehyde demonstrated that D-glyceraldehyde reacts at 
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approximately the same rate as the achiral substrate glycolaldehyde, however, no 
reaction with L-glycolaldehyde was observed (Fig. 8).52   
 
Figure 8 Depletion of HPA towards D-, L- and DL-glyceraldehyde. Reprinted from ‘‘Transketolase 
from Escherichia coli: A practical procedure for using the biocatalyst for asymmetric carbon-
carbon bond synthesis’’ with permission from Elsevier 52 
 
Previous investigations50 had concluded that yeast TK enzyme has a kinetic preference 
for α-hydroxyaldehydes having a 2R-configuration as evidenced by the relative rates of 
D-glyceraldehyde (78%) and L-glyceraldehyde (<0.01) relative to that of glycolaldehyde 
(Table 5). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5: The relative rates of various substrates for the TK reaction 
 
Preliminary relative rates studies by Turner et al. also monitored the depletion of Li-27 
in bioconversions using non α-hydroxyaldehyde acceptor molecules, with cell free      
E. coli TK lysates.51   
 
 
 
Substrates Vrel 
D-glyceraldehyde 3-phosphate 44 
D-erythrose 4-phosphate 33 
D-arabinose 5-phosphate 24 
D-glucose 6-phosphate 9 
D-glyceraldehyde 78 
L-glyceraldehyde <0.01 
DL-glyceraldehyde 56 
D-erythrose 56 
D-glucose 4 
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This demonstrated low activity for simple aliphatic aldehydes, 30r-30t, however it was 
still possible to obtain product on a preparative scale. The cyclic acceptor molecules 
revealed to have the poorest activity, presumably due to the unfavourable electrostatic 
and steric interactions in the enzyme’s binding site (Table 6). 
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Table 6: E.coli TK with various acceptor molecules. Turner et al. 51 biotransformation reaction; Li-27 
(7.5 mM), gly-gly buffer (70 mM at pH 7.6), aldehyde (100 mM) TK (3U) in 1 ml. 
 
Isolated yields were omitted from this publication, with no further discussion on 
stereochemistries of the generated analogues 30.  The substrate specificity profile of    
E.coli TK appears to show a similar trend to that reported for yeast TK.  
Characterisation of the substrate specificity profile will be discussed later. 
 
1.2.7 Transketolase in synthesis 
 
The use of TK has been employed in complex syntheses of biologically important 
molecules, for instance TK from baker’s yeast was utilised for the stereospecific 
synthesis of the naturally occurring beetle pheromone (+)-exo-brevicomin 31 (Scheme 
19).37 
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Scheme 19: Retrosynthesis of (+)-exo-Brevicomin 
 
The process involved the transfer of the ketol unit to a 2-hydroxy butyraldehyde 
acceptor substrate molecule.  A vicinal diol possessing the D-threo isomer of the 
product (45% yield) with ees >95% was generated.  Then a short sequence of 
reactions involving conversion the protected ketose to an aldose, a Wittig extension of 
the aldehyde, and subsequent hydrogenation and ketal hydrolysis afforded the title 
compound.  
 
Transketolase has also recently been used to synthesize ulosonic acids, 3-deoxy-D-
manno-2-oculosonic acid (KDO) and 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid 
(KDN).  These are integral components of lipopolysaccharides of Gram-negative 
bacteria.  The new synthetic analogues (e.g 32) generated may be useful in developing 
new antibacterial agents.53  Currently in the literature most enzymatic approaches to 
these compounds involve aldol condensations with pyruvate or phosphophenol-
pyruvate (PEP) with aldoses.54 A versatile method was investigated using an (S)-α-
hydroxyaldehyde containing a terminal nitrile 33. The D-threo isomer 34 was isolated in 
a 73% yield.55  Subsequent enzymatic reduction proceeded using iditol dehydrogenase 
(IDH) with formate dehydrogenase (FDH) and sodium formate to regenerate NADH in 
situ.  The hydroxyl groups of the compound were then protected as benzyl ethers 35.  
Hydrolysis of the nitrile group 36, final ozonolysis of the methylene esters and 
deprotection by hydrogenation completes the formation of ulonic acid analogue 32 
(Scheme 20). 
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Scheme 20: Retrosynthesis and synthesis of an ulosonic acid analogue 
 
Many types of imino sugars have been reported in recent years containing a different 
spectrum of activity against a range of glycosidases, such as with the synthesis of 
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fagomine using yeast TK (such as 1,1-dideoxyiminoalditols).56a  Most recently the E. 
coli TK-mediated coupling of racemic 3-O-benzylglyceraldehyde with Li-27, has been 
carried out on a multigram scale to provide triol 37 as an important precursor of a novel 
N-hydroxypyrrolidine.  The synthesis proceeded via the protected oxime 38 (83%), 
which converts to the aldehyde 39 (66%), and is cyclised to the 1,2-oxazine 40.  The 
oxazine undergoes a rearrangement followed by a reduction to yield the protected N-
hydroxypyrrolidine 41 (37% over two steps).  Finally the deprotection with HF 
generated the active product 42 in quantitative yield (Scheme 21).56b  
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Scheme 21: Synthesis of novel N-hydroxypyrrolidine 
 
1.3 Synthesis of acyclic α,α’-dihydroxyketones 
 
The biocatalytic transketolase reaction is well documented for the formation of α,α’-
dihydroxyketones. However there is a lack of methodologies for the chemical synthesis 
of α,α’-dihydroxyketones in the literature and until recently no one-pot chemical 
synthesis of these was availablle.  Multistep chemical strategies to α,α’-
dihydroxyketones  are reviewed below.     
 
1.3.1 Addition of 2-lithio-1,4-dioxane to aldehydes/ketones followed by peracid 
oxidation  
 
Research conducted by Fetizon et al.57 formulated a five-step synthetic approach. This 
involved the synthesis of dihydro-1,4-dioxin-2-yl lithium 44, prepared by the lithiation of 
dihydro-1,4-dioxin 43 with t-butyllithium, and reaction with aldehydes or ketones, to 
give the intermediate adduct 45 in moderate yields ranging from 52 to 64%.  
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Methanolic peracid epoxidation and subsequent reduction and acid hydrolysis yielded 
the α,α’-dihydroxyketone 46 (Scheme 22). 
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Scheme 22: Multi-step synthesis of ketodiol 46 
 
The difficulties in this strategy are that it relies on the synthesis of 45, synthesised from 
a high cost starting material 43, as a prerequisite for the eventual α,α’-dihydroxyketone 
reaction.  Whilst affording a racemate, it is noteworthy for its production of α,α’-
dihydroxyketones in the final synthetic step with yields ranging from  moderate to 
excellent yields (65 to 95%).   
 
1.3. 2-Chloroalkyl p-tolyl sulfoxides as hydroxycarbonyl anion equivalents 
 
The difficulties associated with creating a stable hydroxyketol anion equivalent stems 
from the subsequent β-elimination of hydroxide or alkoxide upon generation of the 
anion via umpolung approaches (using diathianes or hydrazones).  In 1991 Satoh et al 
described a strategy involving the conversion of carbonyl compounds to α-hydroxy 
acids, esters, and amides and α,α’-dihydroxy ketones.  As in the transketolase reaction 
involving the donation of a two-carbon nucleophilic moiety, Satoh used a donor 
substrate of 1-chloroalkyl p-tolyl sulfoxide58 as the hydroxycarbonyl anion equivalent. 
The carbon bearing the sulfinyl group and a chlorine atom requires one oxidation state 
higher than its present state to be used as a hydroxyl anion equivalent. Thus, the three 
step conversion of 47 to α,α’-dihydroxyketones 50 proceeds via an oxidation with OsO4 
of the vinyl chloride intermediate 49 (Scheme 23). 
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Scheme 23: Chloroalkyl p-tolyl sulfoxides used in the synthesis of ketodiol 50 
 
The oxidation reaction with various ketones via vinyl chloride intermediate 49 was 
performed cleanly, to afford products 50a (67%), 50b (68%), 50c (79%) (Table 7). 
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Table 7: Examples of the synthesis of ketodiols using chloroalkyl p-tolyl sulfoxides 
 
1.3.3 The ruthenium-catalysed oxidation of allenes 
 
A recently developed oxidation method known for the cis-dihydroxylation of alkenes 
dubbed as the ‘flash dihydroxylation’ due to its efficiency and short reaction times59 was 
used to catalyse the oxidation of β-allenic esters 51 and 53.  The ruthenium-catalysed 
oxidation60 of β-allenic esters afforded α,α’-dihydroxyketones 52 in 24-72% yields with 
good levels of chiral transfer of one particular chiral allene 54 in 88% de (Scheme 24). 
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Scheme 24: Ruthenium catalysed oxidation of allenes to ketodiols 52 and 53 
 
Most significant, is the application of this method to the synthesis of corticosteroids 
exemplified by the conversion of allenic steroid61 55 into dihydroxyketone 56 (16% 
yield) and ketone side product 57 (49% yield), demonstrating the application of 
ruthenium catalysed flash oxidation of allenes to target molecules possessing biological 
activity (Scheme 25).  Further improvements of the method by using non-aqueous 
a
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conditions and lower temperatures were reported to be currently under development to 
increase its efficiency.  
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Scheme 25 The synthesis of corticosteroids 
 
1.3.4 A double hydroxylation of enol silyl ethers 
 
In 1975, Hassner initially reported the oxidation of enol silyl ether with peracid as a 
reliable method for the preparation of α-hydroxyketones.62a Thereafter, research 
conducted by Horiguchi et al,62b reported that if the enol silyl ester 58 possessed 
certain structural features, the reaction affordeed hydroxyl siloxy ketone 59 and could 
be converted to the corresponding dihydroxyketone.  Significantly there was no trace of 
the ‘normal oxidation’ product 60 found (Scheme 26).  
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Scheme 26 Preparation of α-silyoxy and α-hydroxy ketones 
 
Mechanistic studies have shown an interesting pathway differing from the normal 
reaction (path 2) proceeding via the migration of the silyl group from the enol oxygen 
61 to the epoxide oxygen 64.  Product 63 was isolated by using only one molar 
equivalent of the oxidant determined through reaction path 1 involving the 
rearrangement of intermediate epoxide to the allylic alcohol (loss of hydrogen).  
Subsequent oxidation afforded the desired dihydroxyketone 65 (Scheme 27). 
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Scheme 27: Mechanistic pathway for the generation of α-silyoxy and α-hydroxy ketones 65 
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The ‘non-Hassner’ reaction pathway is preferred by the silyl enol ether of methyl alkyl 
ketones and steric hindrance at the site of the initial oxidation favours the pathway.  
Taking into account these contributing factors, yields ranging from 72-79% for the 
double hydroxylation of enol silyl ethers have been achieved. 62b 
 
1.3.5 The SAMP/RAMP-Hydrazone Methodology 
 
There are two closely related syntheses of the dihydroxyacetone equivalent, 2,2-
dimethyl-1,3-dioxan-5-one. The first approach was developed by Hoppe et al.63  
Starting from commercially available 2-amino-2-(hydroxymethyl)propane-1,3-diol 
hydrochloride salt (Tris.HCl) 66, the diol was protected in acid-catalysed conditions by 
the formation of the acetal 67 in the presence of 2,2-dimethoxypropane.  Subsequent 
oxidation with the treatment of sodium periodate generated a formaldehyde by-product 
and 2,2-dimethyl-1,3-dioxan-5-imine which was subjected to hydrolysis in situ, affording 
2,2-dimethyl-1,3-dioxan-5-one 68 in 68% yield over two steps.  The other approach to 
dioxanone 68 is a four-step procedure, starting from nitromethane.64 A base-catalysed 
nitroaldol reaction in the presence of paraformaldehyde gave 2-(hydroxymethyl)-2-
nitropropane-1,3-diol 69. Then sub-sequent Lewis-Acid catalysed acetal formation was 
followed by a hydrogenation.  The β-aminoalcohol was obtained, and subjected to 
sodium periodate cleavage, with a significantly lower 17% yield (Scheme 28). 
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Scheme 28: Two approaches for the synthesis of 2, 2-dimethyl-1, 3-dioxan-5-one.  DMP=2,2-
dimethoxypropane, PTSA = p-toluenesulfonic acid. 
 
The dioxanone provides a useful tool in asymmetric synthesis, when coupled with the 
chiral auxiliary (S)-1-amino-2-methoxy-methylpyrrolidine (SAMP) or its enantiomer 
RAMP, to give the SAMP hydrazone 70.65 Treatment with tert-butyl lithium to form the 
lithium azaenolate at low temperatures, and then subsequent reaction with 
electrophiles such as Michael acceptors, alkyl halides, and aziridines have been used 
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to afford α-alkylated hydrazones 71 with high diastereoselectivities (≥ 96% de) 
(Scheme 29). 
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Scheme 29: The asymmetric synthesis of 4-substituted 2,2-dimethyl-1,3-dioxane-5-ones 
 
Cleavage of the chiral auxiliary can be carried out oxidatively with ozone,66 or under 
biphasic conditions (solutions of aqueous copper (II) chloride67 or oxalic acid68 with 
hexane or ether).  Ozonolysis does not affect the acetal protecting group, and the chiral 
auxiliary can be recycled by reduction of the nitrosamine cleavage product.  However 
substrates containing other unsaturated carbon bonds are more likely to form large 
amounts of byproducts.  Oxalic acid cleavage is more amenable as no carcinogenic 
nitrosamine by-product is formed as in the case in ozonolysis and a simple extraction is 
used to recover the chiral auxiliary from the aqueous phase after basification.  Copper 
(II) chloride cleavage is advantageous as the substrate substituents containing acid-
labile or unsaturated carbon groups are not affected in this hydrolytic procedure 
(Scheme 30).70 
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Scheme 30: Clevage of chiral auxiliary and acetal protecting group to afford ketodiol product 
 
The monoalkylation concept was further extended to α,α’-bisalkylations.69  The 
monoalkylated hydrazone products can be further reacted following the monoalkylation 
procedure again.  1,3-Trans substituted products were exclusively isolated in 58-83% 
yield and ees >96% (Scheme 31).   
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Scheme 31: Formation of Disubstituted 2,2-Dimethyl-1,3-dioxane-5-ones. 
 
Most recently, the Ender’s group has extended the highly stereoselective alkylation 
technique towards the asymmetric synthesis of α,α’-quaternary 2-keto-1,3-diols 76.70  
This was achieved by sequential alkylations of the SAMP-hydrazone and the yields 
over three consecutive alkylations ranged from 70% (R1 = Et) to 77% (R1 = n-Hex) 74.  
However attachment of the secondary α’-quaternary carbon center in the substrate 
molecule without the presence of complexing agent afforded low yields.  Introducing 
one equivalent of 1,3-dimethyl-2-oxo-hexahydropyrimidine (DMPU) to the reaction 
mixture increased the nucleophilicity of the azaenolate.  This was evident from the 
moderate to very good yields 75 (53-90%), and high diastereoselectivies (91-97%).70 
The removal of the chiral auxiliary was not straight forward as there was too much 
steric demand to generate the Criegee intermediates by ozonolysis (≈25%).  An 
alternative acid-catalysed cleavage protocol of both the acetal and the chiral auxiliary 
was performed, providing moderate to excellent yields (36-97%) of ketodiol products 
formed 76 (Scheme 32). 
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Scheme 32: Symmetric synthesis of α,α’-quaternary 2-keto-1,3-diols 
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1.3.6 Aims of Research 
 
The aim of this research was principally two-fold; (i) pursue the potential of a library of 
E.coli TK mutants through directed evolution processes to accept a variety of 
substrates, (ii) organocatalytic approaches to enantiopure ketodiols.  Both comparative 
methods allow the synthesis of valuable intermediates for contemporary industrial 
production of enantiomerically pure pharmaceuticals, agrochemicals or fine chemicals. 
 
In vivo the enzyme transketolase (TK) reversibly transfers a two carbon ketol unit from 
a ketose donor to an aldose phosphate acceptor.  The use of hydroxypyruvate (HPA) 
Li-27 as a ketol donor yields an irreversible reaction with the evolution of carbon 
dioxide generating the desired ketodiol product. The condensation of HPA with 
glycolaldehyde and propanal as acceptor substrates has well been described in the 
literature.90-92  The nature of the aldehydic acceptor tolerance of TK to generate chiral 
synthons for use in synthetic applications is further investigated.  Furthermore a chiral 
assay for successful characterization of these structural ketodiol motifs is also 
explored. 
 
The development of the enzyme TK as a practical biocatalyst for enzyme-catalysed 
asymmetric carbon-carbon bond synthesis on a small scale has since led to the 
discovery of the first biomimetic TK reaction at UCL. Optimisation studies and 
preliminary mechanistic studies will be performed and an eventual organocatalytic 
approach to enantiopure dihydydroxyketones will also be pursued.   
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2.1 Determination of the absolute stereochemistry of chiral carbinol carbons  
 
Determining the absolute stereochemistry of natural compounds and synthetic 
compounds is an essential task for organic chemists. The infamous history of 
thalidomide,71 an effective sedative against morning sickness 78, and a potent 
teratogen 77 that may cause severe birth defects if the drug is taken during pregnancy 
serves as a crucial model for identifying compounds of correct configuration and ee      
(Fig. 9). 
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Figure 9: The two enantiomers of thalidomide 
 
Such useful methods for identifying substances of unknown structural ‘scaffolds’ 
include (i) comparisons of optical rotations via polarimetric methods to those of known 
literature values (ii) X-ray Crystallography and various exciton chirality methods72 (iii) 
and NMR spectroscopy via the use of lanthanide shift reagents and chiral derivatising 
agents73 of which the Mosher’s method using 2-methoxy-2-(trifluoromethyl)phenylacetic 
acid (MTPA) 80 or chloride (MTPA-Cl) 81 to form the Mosher’s ester 82 is most 
prevalently used (Scheme 33).74 
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Scheme 33: The synthesis of (R)- and (S)- Mosher’s ester from the stereogenic carbinol centre 
 
2.2 Determining the absolute stereochemistry of chiral carbinols using Mosher’s 
ester analysis 
 
The Mosher’s Method is a reliable method for determining the absolute configuration of 
stereogenic carbon centers with secondary alcohols 79 (i.e R1R2CCHOH, wherein R1 ≠ 
R2), primary amines (R1R2CCHNH2, or R1R2CCHNHR3 wherein R1 ≠ R2 ≠ R3 ) and 
amino acids.  The determination of the carbinol carbons involves the coupling of the 
hydroxyl group in two separate but analogous experiments of each enantiomer of the 
Mosher’s acid. (i.e 2R and 2S) to afford the corresponding MTPA esters (Scheme 33).  
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Each of the diastereoisomers possesses different physical and most notably 
spectroscopic properties; differential in chemical shifts of resonances in 1H NMR 
spectra, or the 19F atom in the CF3 group in the MTPA moiety.75   
 
Mosher proposed that predicting the absolute configuration of the secondary alcohol 
depended upon the configuration of the ester carbonyl, the methine proton of the 
stereogenic carbon, and the trifluoromethyl (CF3) groups of the MTPA moiety lie on the 
same plane (0º dihedral angle) 82.  Although this is not the only conformation 
populated by rapid interconverting rotamers, another stable conformation calculated by 
perturbative configuration interaction using localized orbitals (PCILO)76 predicted the 
close proximity of the methoxy group (0º dihedral) to the ester carbonyl.  However, in 
light of empirical evidence such as X-ray studies and IR adsorption76 (in CCl4) on (R)-
MTPA esters of various cyclohexanols i.e 4-trans-tert-butylcyclohexanol77 validates that 
Mosher’s original proposal is preferred.  Mosher and coworker state that these 
conformations ‘are intended to represent a model which successfully correlates known 
results…they may in fact measure the effective average of many conformations’ (Fig. 
10). 75 
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Figure 10: Common conformational representations of the MTPA-esters.   
The diamagnetic shielding effect is indicated by the arrow. 
 
When the aryl group of the MTPA esters is in the Mosher’s hypothesized conformation, 
it is known to impose a diamagnetic shielding effect on the proton environments 
residing above or below the plane of aryl ring (Fig. 10).  Thus, the protons with spatial 
proximity of the aryl ring will exhibit an upfield chemical shift in the 1H NMR spectrum.  
On inspection of the two conformations exhibited by both diastereoisomers key 
characteristic features are revealed.  Protons residing on the R2 substructure of (S)-82 
are more shielded and upfield relative to that of (R)-82, conversely protons residing on 
R1 substructure of the (R)-82 are more shielded (upfield) relative to that of the (S)-82 , 
and this is the basic concept of the Mosher’s method.   
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The 1H chemical shift differences are calculated (∆δ = δS-MTPA – δR-MTPA)78 and the 
protons residing in R1 will be positive (∆δ >0) while protons of the R2 environment will 
be negative (∆δ <0).  Thus, by assigning the values of the chemical shift differences 
(∆δ) one can deduce the (sub)structures of R1/R2  indicating the correct absolute 
stereochemistry of the secondary alcohol of the carbinol center.  In addition to the 
absolute configuration of the Mosher’s esters, the derivatives can deduce the 
enantiomeric excess (ee % = major isomer – minor isomer) of the sample of interest, 
by measuring the relative intensities of 1H or 19F NMR spectroscopy signals with similar 
environments in each diastereoisomer.79 However, further justification by 
complementary measurement by gas or liquid choromatographic analysis is also 
normally provided. 
 
2.2.1 19F Chemical Shifts of α-Methoxy- α-trifluoromethylphenylacetate (MTPA) 
Derivatives75 
 
At the time of Mosher’s publication, NMR machines normally available were 60-100 
MHz instruments and the complete assignment of protons of complex organic 
molecules was not feasible.  Instead, Mosher and coworkers developed modifications 
of this model, providing a rationale to correlate the absolute configuration and 19F NMR 
chemical shifts of MTPA-esters.  This method had an inherent advantage over proton 
chemical shift differences (∆δ) of the same compound; generally the 19F NMR chemical 
shift differences for the α-CF3 of diastereomeric derivatives are greater and are 
unobstructed in this spectral region.  Studies had also shown that the presence of TFA 
had a significant effect on α-CF3 resonances, and on the chemical shift differences 
between diastereomeric MTPA esters.79 
 
In light of these findings, configuration correlation models (Fig. 11) has been proposed 
for rationalizing the nonequivalent α-CF3 chemical shift differences.  The diamagnetic 
deshielding of the α-CF3 of the MTPA substituent by the carbonyl ester is believed to be 
responsible for the observed phenomena.  The magnitude of nonequivalence of each 
19F diastereomer is up to 0.73 ppm, and the model predicts the α-CF3 environment to 
be deshielded (downfield) or more shielded (upfield).  The deshielding of α-CF3 group is 
dependant upon the electronic or steric bulkiness of R1 or R2 carbon substituents and 
its effect to force the α-CF3 group out of coplanarity (θ ≠ 0º). 
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Figure 11: Configuration-correlation models where (R)-MTPA diastereomer is downfield relative 
to alternate diastereomer 
 
If we assume the model was based solely on sterics; then phenyl is larger than the 
methoxy group and R2 bulkier than R1 then under these conditions the sterics are 
minimized and the α-CF3 is coplanar with the carbonyl of the diastereomer 83.  
Conversely if the bulkier R2 substituent is juxtaposing the equally bulky phenyl group, 
an imposing steric interaction incurs resulting into the displacement of α-CF3 out of 
coplanarity with the carbonyl of the MTPA ester 84 in a less deshielded (upfield) 
environment.  Predicting the absolute stereochemistry based on the 19F NMR 
nonequivalence of MTPA diastereomers follows this configuration-correlation model.  
Hence if the diastereomer was prepared from (R)-(+)-MTPA with a downfield α-CF3 
signal (δ< 0) in comparison to the other α-CF3 resonance of the alternate diastereomer, 
it will adopt the configuration shown in 84 where R1 is smaller than R2.  If (S)-(-)-MTPA 
was used to prepare a diastereomer, then the diastereomer 85 with the relatively 
downfield α-CF3 signal will adopt conformation 86 an enantiomer of 84.  The absolute 
stereochemistry of the molecule with subsequent assignment of the Cahn-Ingold-
Prelog nomenclature rules then follows (Fig. 12). 
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Figure 12: Configuration-correlation models where S-MTPA diastereomer is downfield relative to 
alternate diastereomer 
 
The main setback towards this modified Mosher’s approach stems from organic 
compounds with increased complexity. The 19F NMR method relies upon the 
substituents of β- and the β’- carbons responsible for eliciting a chemical shift 
difference of the CF3 (19F) group.  However other substituents (on the γ, δ, ε position), 
θ = 0°  
θ = 0°  θ ≠ 0°  
θ ≠ 0°  
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may have a greater steric interaction with the phenyl group of the MTPA moiety 
entirely.80  In such cases a simple comparison between the bulkiness of β-substitutents 
can be considered futile i.e Borneol 87 (Fig. 13). 
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Figure 13: Conformational representation of the interaction between γ, δ substiuents and the aryl 
group of MTPA, an example of borneol an exception to this model 
 
2.2 Modified Mosher’s method on the absolute stereochemistry of β-chiral 
primary alcohols. 
 
Currently in the literature there are few examples for determining the absolute 
configurations of β-chiral primary alcohols due to the irregularities of ∆δ (chemical shift 
differences).81  However, attempts to determine the absolute stereochemistry of natural 
products possessing a branched methyl group at C2 (β) relative to primary alcohols 
were first described by Minale et al.82 A modified Mosher’s method was used to 
elucidate the absolute stereochemistry of steroids containing a chiral methyl group at 
C25 with a primary hydroxyl group at C26 88 (Fig. 14). Once the samples were 
derivatised to the MTPA diastereomers, a unique splitting pattern was observed with 
the oxymethylene protons. The 1H NMR spectra of (R)-(+)-MTPA esters, gave a 
smaller chemical shift difference (∆δ = δLow – δHigh, ca. 0.04 ppm) for the methylene 
protons of the 25S isomer, than those of the 25R isomer (∆δ ≈ 0.14). However, the 
relationship was reversed when (S)-(-)-MTPA esters were used. 
HO OH
HO
OH
R O
O
25
26
R =HA HB CF3
Ph OMe
88
 
Figure 14: Investigating the stereochemistry steroid 88 
 
Kobayashi’s83 group further substantiated Minale’s proposal with a series of known 
primary alcohol stereochemistries with a methyl group at the C2 (β) position.  Thus, the 
absolute configurations were determined by calculating the chemical shift difference of 
the lower field protons (δLow) and higher field (δHigh) oxymethylene protons.   It was 
observed that the (S)-MTPA esters of compounds 89-92 possessing the 2S-
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configuration had the largest chemical shift difference (∆δ ca. 0.20-0.14) compared to 
those of the (R)-MTPA esters (∆δ ca. 0.00-0.05).  A typical splitting pattern is shown in 
(Fig. 15, spectra A and B) and these results corresponded well to Minale’s proposal of 
predicting the chiral C2 centre.  
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Figure 16: Chemical shift differences ∆δ of oxymethylene protons of MTPA  
               esters of primary alcohols with a Methyl group at C2-position. 
 
For compounds 93-95 containing a level of unsaturation, such as a carbonyl, a 
conjugate ester, or a phenyl group the chemical shift difference (∆δ) was small.  This is 
due to the deshielding effect of the aryl ring of the MTPA ester and the unsaturated 
moiety.  Compounds 96-97 containing consecutive stereocenters at C2 and C3 varied 
on chemical shift differences (∆δ), due to the restricted rotation around the C2-C3 
bond.  The study suggested that the level of unsaturation increased in the molecule the 
splitting pattern of the oxymethylene protons were less resolved with chemical shift 
A B 
Figure 15: ABX splitting pattern of diastereotopic protons.  Reprinted from ‘‘Application of Modified 
Mosher's Method for Primary Alcohols with a Methyl Group at C2 Position’’, with permission from Chemical 
and Pharmaceutical Bulletin.83 
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differences (<0.05 ppm), so it may be difficult to predict the absolute stereochemistry at 
the C2 position.  Likewise, molecules containing a consecutive chiral center at C3 
could not be used with this model.  
 
Simultaneously, another research group has conducted experiments assigning 
naturally occurring 2,3- epoxy-2-methylbutanoate esters.84  In this case, the esters 
were reduced to form a diol with C2 (β) position branched with a methyl and a hydroxyl 
substituent compound 98 (Fig. 17).   
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Figure 17: Retrosynthesis of bioactive natural product from 2-methyl-1, 2-butanediol 
 
The primary alcohol of 98 was MTPA-derivatised to form the Mosher’s ester and the 1H 
NMR spectra indicated an AB system of diastereotopic oxymethylene protons with a 
distinct chemical difference between the pairs of diastereomers.  The (2R,2’R) and 
(2S,2’S) configurations gave rise to the 1H NMR spectrum A (Fig.18) with small 
chemical shift differences, in comparison with the (2R,2’S) and (2S,2’R) configurations 
spectrum B (Fig. 18).  No explanation is given in the paper, however it may be due to 
the anistropic effect from the aryl ring of the MTPA substituent that may have an 
electrostatic or steric interaction with the hydroxyl group residing on the same face.  A 
large chemical shift difference in the oxymethylene protons was observed compared to 
the smaller chemical shift differences when the aryl and hydroxyl substituents were on 
opposite faces (Fig 18).  
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Figure 18: The 1H NMR AB-spectra of diastereotopic oxymethylene protons, the arrows represent 
the anistropic interaction of the aryl ring and the hydroxyl group. Reprinted from ‘’Stereochemical 
assignment of naturally occurring 2,3-epoxy-2-methylbutanoate esters’’, with permission from 
John Wiley and Sons.84 
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2.3 Application of a modified Mosher’s method for the determination of chiral 1,3-
dihydroxyketones 
 
α,α’-Dihydroxyketone functionalities are present in several biologically important 
compounds and can further be used as synthons for further structural elaborations to a 
range of compounds involving ketosugars. The enzyme transketolase (TK) has been 
shown to successfully generate the dihydroketone product 30s in vitro via the 
condensation of hydroxypyruvate (HPA, Li-27) with propanal as previously described 
(Scheme 34).42,46, 51,52, 85 
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Scheme 34: TK-catalysed reaction with propanal and HPA 
 
Chiral assays for the determination of the absolute stereochemistry of these structural 
motifs have been one of the focuses when using TKs.  Currently Ender’s chiral auxiliary 
methodology59 generating α,α’-dihydroxyketones in high enantioselectivities with 
subsequent HPLC/GC analysis for comparative purposes has been used to confirm 
absolute stereochemistries.  This six step procedure tolerates a broad range of 
electrophilic acceptors (Scheme 35); however the reaction fails to accommodate 
derivatives when R = Ar and is a time consuming method for determining the absolute 
stereochemistry. 
OH OH
HO NH2.HCl
O O
NN
OMe
R
OH
OH
O
R
OAc
OAc
O
HPLC
1) PSTA, DMP, 2,2-DMP
2) NaIO4, KHPO4
3) SAMP, toluene, ∆
4) t-BuLi, RI
5) 6N HCl
6) Ac2O, pyridine, DMAP
30s
 
Scheme 35: Ender’s chiral auxiliary methodology 
 
A reliable and convenient method via a Mosher’s ester would be a useful and effective 
tool for determining the carbinol stereocenter of the α,α’-dihydroxyketone motif.  
Currently in the literature the modified Mosher’s method has been applied to 1,3-diols 
via synthesis of the mono-MTPA and di-MTPA esters,86 however the irregularities of 
chemical shift difference (∆δ) of acyclic anti-1,3-diols made this method not useful in 
most cases.  The potential of a modified mosher’s method prompted us to examine it 
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as a method for determining the enantiomeric purities and absolute stereochemistry of 
stereochemically defined α,α’-dihydroxyketones (Fig.16). 
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Figure 16: TK- catalysed reactions forming α,α’-dihydroxy ketones 30 
 
The absolute stereochemistry and optical purity of (3S)-1,3-dihydroxypentan-2-one has 
previously been established (Figure 16).87  Preliminary investigations involved the 
coupling of the MTPA moiety, to the primary hydroxyl group of 30s, generated after 
biotransformation with WT-TK.  The diastereotopic protons Ha and Hb in 30s are 
observed as doublets at 4.59 ppm and 4.70 ppm, with a large geminal coupling 
constant of 19.0 Hz.  Attachment of the MTPA moiety to a hydroxyl group deshields the 
CH2 protons by about 0.5 ppm.83 
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Figure 17: Formation of MTPA ester 
 
The esterification of 30s with (R)- or (S)- MTPA was performed under standard 
procedures using the MTPA-Cl/triethylamine or MTPA/DCC coupling method.  After 
removal of starting materials and urea side products the MTPA esters were analysed 
by 1H NMR spectroscopy in CDCl3.  The 1H NMR spectra of the (R)- and the (S)- MTPA 
esters (R)-82s and (S)-82s differ only in the chemical shifts of the diastereotopic 
protons Ha and Hb; in the (S)-MTPA ester the major isomer (2S,3S) resonated at δH 
4.93 ppm and 5.17 ppm with a 0.24 chemical shift difference (∆δH2S,3S) and the minor 
isomer resonated at δH 5.05 ppm (∆δH2S,3R is 0).  For the (R)-MTPA ester the major 
isomer (2R,3S’) resonates at δH 5.05 ppm (∆δH2S,3R is 0), and the minor isomer at δH 
4.93 and 5.17 ppm (∆δH2R,3R is 0.24) (Fig. 18).  The average of the two ee values 
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calculated from the integration of HaHb gave comparable results (55%) to the literature 
value of 58% ee determined by GC methods.86 
 
   
 
Figure 18: (A) S-MTPA ester (S)-82s and (B) R-MTPA ester (R)-82s 
 
Other dihydroxyketones with reported absolute configurations were then investigated to 
validate the method further.  Firstly commercially available L-erythrulose was prepared 
from glycoaldehyde 30r and Li-27 using TK.  The corresponding (R)- and (S)-MTPA 
esters were prepared using MTPA acid chlorides, obtaining product yields of 51% and 
63% respectively.  There are three hydroxyl groups present in L-erythrulose and only 
approximately 1.0 eq (S)-MTPA-Cl was used in the esterification process to avoid 
multiple esterification.  The only isolatable compound observed was with the MTPA 
substituent attached to the primary α-ketoalcohol.  The 1H NMR spectra revealed Ha 
and Hb in the (S)-MTPA ester (2S,3S) were observed at δH 5.05 and 5.23 ppm (∆δH2S,3S 
is 0.18) and no minor isomer (2R,3S) was detected.  For the (R)-MTPA ester (2R,3S) 
the diastereotopic protons were at ∆δH 5.11 and 5.19 ppm (∆δH2S,3S is 0.18) and 
negligible signals for the minor isomer were observed.  The average integrations of the 
signals for Ha and Hb indicated L-erythrulose was formed in >95% ee.  This confirms 
the original observation that ∆δH2S,3S’ > ∆δH2S,3R’. 
 
2-Methoxyethanal was prepared from acid deprotection of commercially available 
methoxyacetaldehyde dimethyl acetal,42 and was then used directly as an aldehyde 
acceptor with wild type E. coli TK to further validate the Mosher’s ester method. 
Previous studies involving spinach TK using 2-methoxyethanal as the aldehyde 
acceptor have been reported, with a 60% ee observed (S-major isomer).49 Compound 
30n was obtained in 30% yield from the biotransformation using WT-TK, and coupling 
to MTPA-Cl gave compounds (R)-82n and (S)-82n with Ha and Hb for the major 
isomers at 5.13 and 5.17 ppm (2R,3S) and 5.02 and 5.29 ppm (2S,3S) respectively.  
Again, this demonstrated ∆δH2S,3S (0.27) > ∆δH2S,3R (0.04), with the average integrations 
of the Ha and Hb protons of both MTPA esters giving an ee of 57%, comparable to WT-
spinach TK.49  The stereoselectivity of E. coli WT-TK was comparable to that of 
∆δH
2S,3S
 
∆δH
2R,3R
 
A B 
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spinach TK with 2-methoxyethanal.  This data indicated that the Mosher’s method is 
applicable to aliphatic α,α’-ketodiols and ee measurements can be determined within 
5% of the values given by GC or HPLC methods, as well as determining the absolute 
stereochemistries.   
 
Although the proton coupling system differs to that of Kobayashi et al. on chiral primary 
alcohols with methyl groups at the C2 position (ABX),83 the chemical shift differences of 
the diastereotopic protons are in agreement with his preliminary findings, where 
∆δH
2R,3R
 and ∆δH2S,3S > ∆δH2S,3R and ∆δH2R,3S.  However the reverse is true for Torres-
Valencia et al on chiral primary alcohols with a methyl and a hydroxyl group at the C2 
position (AB).84  This can accounted for by the diamagnetic effect of the aryl ring of the 
MTPA substituent on the hydroxyl group affecting the chemical shift differences of the 
vicinal diastereotopic protons (Fig. 19). The differences in the chemical shift patterns of 
α,α’-dihydroxyketones and its analogues compared with previous work conducted on 
chiral primary alcohols, is that there is a ketone on C2.  
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Figure 19: A conformational model proposed for the analysis of the diastereomeric MTPA ester 
 
The conformational restriction of the C2-C3 bond may confer a larger observed 
chemical shift difference of the diastereotopic protons.  The diamagnetic effect of the 
aryl group of the MTPA substituent can affect the protons residing above or below the 
plane of the aryl ring; it is also possible that the spatial position of the hydroxyl group at 
the stereogenic centre C3 may impose an added electronic effect on the diasteretopic 
proton closest to the hydroxyl group on rapid rotation.  As a result there is a greater 
chemical inequivalency between the diastereotopic protons which is observed from the 
large chemical shift differences of the spectral data. 
 
The anistropic shielding effect can ‘reach’ a considerable distance within a molecule, 
even the most remote protons can be differentially deshielded in two diastereomers.75  
However, of all examples investigated there are no other significant proton chemical 
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shifts that are uniquely identifiable in the (R)-MTPA and (S)-MTPA esters, other than 
the diastereotopic protons to which the MTPA substituent is attached.   
 
The 19F NMR chemical shifts of α-methoxy- α-trifluoromethylphenylacetate derivatives 
of both diastereomers of the molecules studied have the same chemical resonances at 
δ -72.2.  The α-CF3 chemical shifts in both MTPA esters were identical and can be 
accounted for by the insignificant electronic or small steric bulkiness of the R1 or R2 
carbon substituents to displace the α-CF3 group out of coplanarity (θ ≠ 0º) with the 
carbonyl of the MTPA  ester to a less deshielded (upfield) environment (Fig. 20). 
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Figure 20: Configuration correlation models of MTPA esters where R is small R1 ≈ R2 
 
This method was then used on a range of analogues of aliphatic α,α’-dihydroxyketones 
with lipophilic R group substituents and is described in later chapters.  It was also 
tentatively applied to aromatic substrates as described in Chapter 4. Overall this 
method has the potential for applications with a range of ketodiols. 
 
Summary 
 
The Mosher’s method is a useful tool for identifying the absolute stereochemistry of 
stereogenic carbon centres with secondary alcohols, or primary amines.  Recently a 
modified Mosher’s method was applied to determine the absolute stereochemistry of 
commercially available β-chiral primary alcohols. We have utilized the modified 
Mosher’s method to determine the reliability of this method to confirm the absolute 
stereochemistry of readily available chiral 1,3-dihydroxyketones such as L-erythrulose.  
The attachment of an (S)- or (R)-MTPA ester to the primary alcohol of a 1,3-
dihydroxyketone reveal a large chemical shift difference ∆δ with the diastereotopic 
protons Ha and Hb.  This led to the general agreement with Kobayashi’s preliminary 
finding where ∆δH2R,3R and ∆δH2S,3S > ∆δH2S,3R and ∆δH2R,3S.  The Mosher’s method can 
be used as a tool to determine the absolute stereochemistry and the ees of 1,3-
dihydroxyketone analogues.  
 
θ = 0°  θ = 0°  
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Chapter 3.0 
Aliphatic aldehydes used in the TK 
reaction 
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3.1 UCL developments prior to thesis research 
 
Research conducted by Lilly et al. involved excision of a fragment of DNA encoding for 
the TK gene from the plasmid of E.coli (BJ502/pKD112A) back into a high copy 
plasmid, and overexpression of the protein in E.coli. The new transformants 
JM107/pQR183 and JM107/pQR183 gave TK with approximately four fold greater 
activity when grown on glycerol than BJ502/pKD113A.51 E.coli TK accepts HPA better 
than yeast or spinach TK, with 6 times and 30 times higher specific enzyme activity, 
respectively.46,50,88  Initial rate velocities when using simple aldehydes showed low 
specificity for aldehyde substrates other than glycolaldehyde and α-(R)-
hydroxyaldehydes.51 
 
To achieve industrial viability, an important requirement is for greater specific enzyme 
activity on a broader range of non-phosphorylated substrates.  Therefore variants of TK 
are desired, with improved enzyme activity and one method of achieving this is using 
directed evolution.  In the literature there have been a number of X ray crystallographic 
studies of yeast,26-28 and E.coli TK,89 with/without its naturally occurring substrate in the 
enzyme binding site and this provided data for designing a directed evolutionary 
strategy. One systematic approach used for the directed evolution of TK was site-
targeted saturation mutagenesis of amino acid residues chosen firstly on structural 
grounds, selecting 10 amino acid residues which lie within 4 Ǻ of the bound substrates 
in the TK active site.  The second approach was the selection of amino acids for 
mutation on phylogenetic grounds: 9 amino acid residues within 10 Ǻ of the binding site 
of ThDP cofactor that have varied during the course of bacterial and yeast TK evolution 
(Fig. 21).90  Single point mutations were applied using the Quikchange kit (Stratagene, 
Netherlands) with the plasmid (pQR711) transformed into electrocompetent XL10 
(Strategene) E.coli cells.90-91   
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Figure 21: Location of structurally defined and phylogenetic sites relative to the ThDP cofactor in 
the E.coli TK active site. 
 
3.1.1 Directed evolution of TK substrate specificity towards the non-
phosphorylated substrate, glycolaldehyde 
 
The structural and phylogenetic libraries were subjected to TK biocatalytic conditions 
with Li-27 and glycolaldehyde to generate L-erythrulose 30r (Scheme 36).90 High 
throughput HPLC screening of the reaction products from these libraries was used 
initially for the determination of specific TK activities (Table 8).  The highest performing 
TK mutants using glycolaldehyde as a substrate in activity were A29E, H461S, R520V, 
and R520Stop relative to the specific activity of WT-TK. 
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Scheme 36: Biotransformation of glycolaldehyde with Li-27 as substrate using mutant E.coli TK 
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Enzyme [30r]/TK 
(µmol mg-1min-1) 
[30r]/TK 
Rel. WT 
Rate 
(mM min-1) 
[TK] 
(g ml-1) 
WT 0.65 1 0.29 0.44 
A29E 1.95 3.0 0.66 0.34 
H461S 3.14 4.8 0.60 0.19 
R520V 2.3 3.6 2.16 0.92 
R520Stop 2.3 3.6 0.054 0.023 
 
Table 8: The performance of selected TK mutants 
 
X-ray crystallographic data is currently not available for these mutants, however the 
altered activites can be rationalised. Residue H461 and R520 mutations both interact 
with the phosphate moiety of naturally occurring TK substrates. Mutant H461S 
removes a positively charged histidine which usually interacts with a phosphate group. 
The effect of the R520V mutation reduces the amino acid chain length permitting 
greater accessibility to the TK binding site.  The increased TK specificity for R520Stop 
is suprising as the mutation caused a deletion of residues from the C-terminal domain 
(540-680) and 20 residues from the Pyr (pyridinium binding) domain.  The function of 
the C-terminal domain is still relatively unclear as it does not participate in cofactor 
binding or recruitment of substrates into active site.   
  
A thorough kinetic analysis for the TK mutant A29E was explored as it was the highest 
performing phylogenetic variant located in contact with the terminal phosphate of 
ThDP.  As a result A29E, was considered most likely to directly affect the catalytic 
activity of TK.  The precise interactions made between glycolaldehyde, HPA and the 
amino acid residues, are not yet known.  However, presumably the A29E mutant could 
inadvertently affect the pKa of the ThDP cofactor, potentially through electrostatic 
interactions; it may also anchor the orientation of the cofactor permitting the reactive 
enamine intermediate (DHE) to sufficiently couple with glycolaldehyde (Fig. 22). 
 
Figure 22: The interaction with A29 (A) and the postulated interaction with A29E (B) crude 
mutagenesis performed using pyMol (1NGS.pdb, from www.rcsb.org/pdb) 
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3.1.2 Directed evolution of TK substrate specificity towards an aliphatic aldehyde 
propanal 
 
WT spinach TK can tolerate a range of non-hydroxylated aliphatic aldehydes with 
activities ranging from 5 to 35% in comparison to glycolaldehyde.49 E.coli TK has been 
shown to accept propanal at approximately 20% of the level with glycolaldehyde whilst 
cyclic aldehydes 30u and 30v (page 37) have shown lesser activities <5%.51 To 
achieve industrial viability for larger scale processes, the substrate specificity and 
enzyme activity has to be improved for biocatalytic usage.  Thus a simple aliphatic 
aldehyde, propanal was investigated as a bench mark for further investigation (Scheme 
34). The libraries of TK variants responsible for enhancing TK activity of α-
hydroxylaldehydes were screened against non-hydroxylated acceptor substrate 
propanal, to identify novel E.coli TK variants which have improved substrate activity for 
the generation of the ketodiol product, 1,3,-dihydroxypentan-2-one (30s).  The 
screening involved a high throughput colorimetric assay as discussed below. 
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Scheme 34: TK-catalysed reaction with propanal and Li-27 
 
 
3.1.3 The colorimetric assay for screening transketolase activity92 
 
Research at UCL focused on the preparation of ketodiols by screening libraries of TK 
mutants.  In particular mutants were generated with the aim of increasing the rate of 
reaction with a range of aldehyde substrates compared to those used by the wild type 
enzyme.  The use of a rapid, sensitive and a readily available assay is crucial for the 
facile identification of active mutants.  In the literature, TK activity has been monitored 
using a spectrophotometric method involving the use of an NADH dependant enzyme 
measuring residual Li-27,93 and an HPLC assay for erythulose production and Li-27 
depletion.94 A fluorogenic assay which measures the production of the fluorescent 
umbelliferone catalysed by TK95 has been reported and most recently a coupled assay 
using xylulokinase (XK) to monitor TK activity, based on the in vitro synthesis of 
xylulose-5-phosphate, a natural substrate for TK.96  However these methods suffer 
from poor sensitivities restricted substrate structure or low throughput. 
 
A more generalised method for detecting TK variant activity was identified for use with 
non-hydroxylated aldehydes.  A recent pyruvate decarboxylase (PDC) assay for the 
detection of aromatic acyloins 83 used 2,3,5-triphenyltetrazolium chloride 84 
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(tetrazolium red). Tetrazolium red is colourless and oxidises a phenylacetylcarbinol 2-
hydroxyketone 86 motif to the diketone whilst the tetrazolium red is reduced to the 
corresponding formazane 85 which has an intense red coloration λmax ≈ 485 nm 
(Scheme 37).97   
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Scheme 37: The oxidation of 83 to the diketone 86 generating red coloration 
 
A ketol moiety exists in the starting material Li-27 as well as the ketodiol product and it 
was considered whether this colorimetric assay could be modified for use with TK and 
non-α-hydroxylated aldehyde acceptors.  A model system used Li-27 and E. coli TK 
(XL10/pQR711), and initial experiments used 1,3-dihydroxy-pentan-2-one 30s at 
concentrations typical of those to be used in TK assays (gly-gly buffer at pH 7.0).  A 
calibration assay for the reduction of formazene using concentrations of 30s 
established a protocol that avoided optical density (OD) saturation. It was determined 
that the bioconversion was detectable even at concentrations as low as 2.5 mM.  An 
alternative substrate 1, 3-dihydroxypropiophenone was used in the assay and results 
were comparable (Scheme 38). 
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Scheme 38: The oxidation of the ketodiol to the diketone 87 or ketone-aldehyde 88 
 Forming the reduced formazane red 
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Once the sensitivity of the assay was established, it was necessary to investigate the 
effects of the tetrazolium red after a TK reaction with aldehyde, cofactors and other 
components of the lysate which may mask the assay. Control experiments readily 
established that ThDP, Mg2+ and TK lysate gave no coloration in the well plate.  Some 
reaction occurred between the Li-27 and the tetrazolium red due to the presence of the 
hydroxyketone moiety present in Li-27.  A quarternary amine ionic exchange resin was 
successful in removing unreacted Li-27 secondary amine resins were avoided in case 
a chemical coupling of Li-27 and propanal were observed.98  Overall the assay was 
found to be suitable to detect bioconversions >8% and enable TK variants to be 
identified that couple Li-27 to aldehyde acceptors. 
 
Previous studies involving the substrate activity of TK variants towards the non-
phosphorylated substrate glycolaldehyde, revealed catalytic activity among a set of 
mutants at phylogenetic and conserved residues lying within 10 Ǻ of the ThDP 
cofactor.  Several residues interacted with the phosphate group of ThDP and the 
natural phosphorylated substrates. Further studies revealed a distinct cluster of 
residues found to improve the substrate activity towards propanal and glycolaldehyde.  
High throughput screening by the colorimetric assay when using propanal and TLC 
analysis identified 8 libraries containing variants with enhanced relative activities for the 
formation of 30s compared to WT-TK, D469T, D469Y, R520V, A29E, D259A, H26A, 
R358I, and H61S. The greatest improvements in TK specificity towards propanal were 
in libraries D469 (4.9-fold) and R520 (4.7-fold).  The results also revealed the specific 
activities of the TK variants towards the formation of 30r and 30s which can be 
expressed as a ratio (Table 9).  In this case D469T and D469Y had an 8.5-fold and 64-
fold improvement compared to WT-TK (Scheme 39). 
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Scheme 39: Biotransformations using E.coli TK to generate 30r and 30s 
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Enzyme [30s]/TK 
(µmol mg-1min-1) 
[30s]/TK 
Rel. WT 
[30s]/[30r] 
 
[30r]/TK 
(µmol mg-1min-1) 
WT 0.029 1 0.045 0.65 
D469T 0.14 4.9 0.38 0.37 
D469Y 0.127 4.4 2.9 0.04 
R520V 0.14 4.7 0.059 2.3 
A29E 0.10 3.4 0.050 1.95 
D259A 0.066 2.3 0.044 1.5 
H26A 0.066 2.3 0.25 0.26 
R358I 0.055 1.9 0.037 1.37 
H461S 0.040 1.4 0.013 3.1 
 
Table 9: The specific substrate activities of the formation of 30s and 30r 
 
The mutated residues containing the highest activities were clustered together in 
groups.  Residues D469, H100, and H26 are clustered around the binding site, which 
interacts with the C2 hydroxyl group of erythrulose-4-phosphate (E4P).  However in 
propanal the hydroxyl group at the C2 position is replaced by a methyl group removing 
any potential of hydrogen bonding.  Residues R520, R358, and H461 are located at the 
entrance of the enzyme cleft interacting with the phosphate group of E4P.  Mutations at 
these points will most likely improve catalytic activity by removal of the charge at the 
entrance of the enzyme cleft, thereby increasing accessibility to the binding site.  The 
phylogenetic residues identified, A29 and D259, belong in the active site of second 
shell, the methyl group of A29 interacts with the terminal phosphate group of ThDP, 
and the mutation to A29E may increase catalytic turnover but not the substrate 
specificity (Fig. 23). 
 
Figure 23: Clustered enzyme mutants responsible for catalysis in the active site of TK using 
pyMOL (1NGS.pdb, from www.rcsb.org/pdb) 
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Mutant D469T was selected for further kinetic experiments using purified enzyme, 
since it showed high activity and gave a significant increase in specificity towards 
propanal.  The kinetics of purified WT and D469T were determined at a 50mM Li-27 
concentration over a range of propanal concentrations, and revealed an 8.9-fold 
increase in Vm, but a decreased KM of 2.5-fold for propanal compared to WT-TK (Table 
10). This suggests the methyl group on propanal has created specific interactions with 
the mutated residue that has replaced Asp, which interacts with an α-hydroxyated 
aldehyde (e.g glycolaldehyde).  This was evident by no improvement in activity with 
D469T towards glycolaldehyde.  It was concluded that the variants in the D469 library 
were most likely to have specific interactions with non-α-hydroxyated aldehydes, 
favouring side chains with non-polar groups. 
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3.1.4 Investigating cyclic aldehydes with evolved TK enzymes 
 
It is of great interest to explore a broad substrate repertoire beyond that currently used 
with TK. This would lead to the formation of complex α,α’-dihydroxyketones for 
conversion into other synthons for further structural elaborations including ketosugars 
and 2-amino-1,3-diols.85,99 However, to achieve industrial viability, an important 
requirement is greater specific enzyme activities and high stereoselectivities on a broad 
substrate range beyond the current biocatalytic conversion of α-hydroxyaldehydes and 
aliphatic aldehyde propanal.    
 
In the literature, there have been few studies using cyclic aliphatic aldehydes as an 
acceptor molecule with TK.  However cyclic aldehydes have been shown to be very 
poor acceptor substrate molecules. For E.coli WT-TK, Turner et al. noted the poor 
relative velocity of cyclohexanecarboxaldehyde C6 (0.04) in comparison with 
glycolaldehyde.51 A systematic study was now carried out with the aim of 
understanding the tolerance of TK mutants towards cyclic aldehydes, from 
Enzyme Vm (mM min-1) KM (mM) 
WT 0.037  140 
D469T 0.33 55 
Table 10: Kinetic parameters for WT and D469T-TK 
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cyclopropanecarboxaldehyde 89 to cyclohexanecarboxaldehyde 91, and then an 
increase in complexity with 3,4-dimethylcyclohex-3-ene-1-carboxaldehyde 92 and 
finally an aromatic acceptor substrate 93 (Scheme 40). 
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Scheme 40: The objectives 
 
Such compounds including aromatic analogues, can be further modified with 
transaminase enzymes (EC 2.6.1.57) for the direct synthesis of aminodiol antibiotic 
motifs such as those in the chloramphenicol and thiamphenicol antibiotics (Scheme 
41). 
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Scheme 41: Potential routes to biologically active compounds 
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3.2 Active mutant Identification with cyclic sustrates 
 
The reaction plates of E.coli TK mutant library D469 (Fig. 24) obtained by saturation 
mutagenesis were incubated with Li-27, cofactor stock solution (ThDP and magnesium 
chloride) and cyclopentanecarboxyaldehyde 90 for two days prior to the treatment with 
the tetrazolium-based colorimetric assay.  In analogous, but separate experiments the 
reaction plates of D469 E.coli TK were incubated with cyclopropanecarboxyaldehyde 
89 and cyclohexanecarboxyaldehyde 91 as acceptor molecules.  
 
 
Figure 24: Enzyme active site to E.coli TK highlighting position of D469 
 
Each of the 96 well plates was subjected to an MP-Carbonate scavenger resin 
(Biotage) and was left standing for 3 hours to remove unreacted HPA. The colorimetric 
assay involved the oxidation of the ketodiol product formed from the biocatalysis, while 
the colorless tetrazolium salt was reduced resulting in an intense red coloration.  The 
optical densities (OD485nm) from the D469 libraries displayed good activities with no 
inactive mutants generated (Fig. 26).  The variants selected were based on the 
consistent high performing wells towards 89, 90, and 91 aldehydes (Fig. 25).  The wells 
B6, B7, D5, E3, F12, G6, and H4 were investigated further on a preparative scale. 
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Figure 25: ODs of selected D469 E.coli TK with substrates 89, 90, 91 
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Figure 26: Colorimetric plates screened against the cyclic aldehydes
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3.3 Obtaining E. coli TK cell-free lysates 
 
Some of the D469 wells described above showing good conversions to products 
contained mutants that had previously been sequenced (Hibbert et al.)90 including the 
mutants identified with improved activity towards propanal; D469T and D469E.  
Biocatalytic reactions using the D469T and D469E were explored further at a 50 mM 
concentration, obtaining preparative quantities to determine the stereochemistry of the 
ketodiol product generated.  Colonies were therefore picked from wells of the master 
plate and were streaked onto Luria-Bertani (LB) agar plates.  The individual colonies 
were selected and grown in LB for 12 hours and then the 50 ml innocolum was 
transferred to further LB broth, and was incubated for 8 hours.  Some culture was left 
aside for glycerol stocks. The supernatant was discarded and approximately 0.1 g of 
cell pellet was afforded from 50 ml of innoculum.  The cell pellet was resuspended in 
sodium phosphate buffer (10 ml for 1 g), the suspension was sonicated on ice and the 
crude lysate centrifuged, then the clarified lysate was pipetted into Eppendorf flasks 
and was stored at -20ºC.  The TK protein concentration in lysates was determined 
using SDS-PAGE (fraction of the total protein which is TK) and the Bradford assay 
(total protein concentration) performed by Phattaraporn Morris (Fig. 27, Table 11). 
 
 
 
Figure 27: Top view of a 7.5% SDS-page gel of TK variants, WT-TK, and purified TK.  The enzyme 
was purified using a XK 16/20 chromatographic column. The dark band represents the denatured 
TK protein monomer at 75kDa. The samples are as follows: (1) Protein standard marker; (2) WT; (3) 
D469L; (4) H4; (5) H26Y; (6) D469T; (7) Purified TK; (8) D469E; (9) D469S; (10) G6  
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Enzyme TK [mg ml -1] 
WT 0.24 
D468L 0.20 
H4 0.32 
H26Y 0.22 
D469T 0.30 
D469E 0.30 
D469S 0.30 
G6 0.32 
 
Table 11: The calculated TK protein concentration in lysates 
  
3.4 Cyclopropanecarboxaldehyde as an acceptor substrate for the TK reaction 
 
The biomimetic TK reaction with cyclopropanecarboxaldehyde 89 was conducted in a 
THF:H2O (1:1) solution in the presence of Li-27 and N-methylmorpholine (NMM) used 
as a catalyst to afford the ketodiol product 30v in 12% yield.  The isolated racemic 
ketodiol was purified using silica gel chromatography and 30v was used as a standard 
reference in reactions to assess the stereoselectivity of the biotransformations using 
HPLC. 
 
O2C
OH
O
Li+
O
H
OH
O
OH +H2O, rt
NMM CO2
89 30vLi-27
 
Scheme 42: The biomimetic formation of 30v 
 
The ketodiol product was derivatised to the UV active monobenzoate, using 
triethylamine and benzoyl chloride, to generate 94 with 87% yield (Scheme 43). A 10 µl 
benzoylated ketodiol sample was injected in a chiralpak-AD column at varying flow 
rates from 0.8-1.2 ml min-1 and eluting at different isochratic solvent systems using 
hexane (95-99%): isopropanol (5-1%) concentrations.  The sample was detected but 
not separable using the chiralpak-AD column. However, successful separation of the 
racemic products was discovered using a chiralpak-OD column eluting at 
hexane:isopropanol (97:3) and a concentration of 1 ml min-1 with peaks detected at 
33.2 mins and 34.9 mins with equal integrations (Scheme 43). 
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Scheme 43: Benzoylation of 30v and HPLC data of 94 
 
In separate, but comparable biotransformations, the selected TK mutants from the 
D469 library exhibiting high enzyme activity from the colorimetric assay were all used  
at a 50 mM reaction mixture with 89, stated to pH 7.0 and left to stir for 48 hours. The 
ketodiol products 30v were purified via silica gel chromatography.  The TK variants 
D469L, D469K and G6 used in the bioconversions afforded poor yields 1-10% 
comparable to WT-TK. The TK mutant H26Y exhibited no activity against this 
substrate. However TK mutants D469T, D469E and H4 revealed some substrate 
activity with better yields in comparison to other TK variants under investigation.   
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10 
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10 
 
nr 
 
2 
 
Table 12: The percentage yields obtained from acceptor substrate 89 
 
The products from the TK mutant biotransformations were monobenzoylated 94 and 
the ees were determined from the established HPLC procedure compared to WT-TK 
(Fig. 28). 
 
Figure 28: (A) racemate 94; (B) D469T product with added racemate; (C) D469T product 
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R D469E  
ee% 
D469T 
ee% 
D469K 
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D469L 
ee% 
G6 
ee% 
H4 
ee% 
H26Y 
ee% 
WT-TK 
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>99 
 
99 
 
99 
 
99 
 
99 
 
99 
 
nr 
 
72 
 
Table 13: The ees obtained from selected D469 mutants of 30v 
 
The absolute stereochemistry of the product 30v was determined by coupling the 
terminal hydroxyl group of 30v with an (R)-MTPA-Cl generating the (S)-MTPA ester 95 
(Scheme 44).   
Cl
O
CF3
Ph OMe
S-MTPA
  esterOH
OH
O Ha Hb
O
OH
O Ha Hb O
Ph OMe
CF3NEt3, CH2Cl2 87%
9530v
 
Scheme 44: Formation of the (S)-MTPA ester 95 
 
The AB splitting pattern is observed from diastereotopic protons Ha and Hb of the (S)-
MTPA ester 95.  The major isomer (2S,3S) resonated at δH 5.37 ppm and 4.95 ppm 
with a  chemical shift difference ∆δH2S,3S of 0.42 with trace amounts of the minor isomer 
at δH 5.17 ppm and 5.05 ppm (∆δH2S,3R is 0.12). A recent procedure to assign the 
absolute stereochemistry at C3 of α,α'-dihydroyketones (see previous chapter),100 
established that the chemical shift patterns of the diasteretopic protons, derivatised as 
Mosher’s esters, varied such that ∆δH2S,3’S > ∆δH2S,3’R. This indicated that the 
stereochemistry at C3, formed by D469T, had the (3S)-configuration (Fig. 29). 
 
 
Figure 29: 1H NMR region 5.0 to 5.5 ppm of (S)-MTPA ester 95 
 
The D469E TK mutant was selected for biocatalysis with cyclopropanecarboxaldehyde 
89, due to the high yielding (70%) and excellent ees (88%) obtained using propanal as 
substrate.87 The structural differences between propanal and cyclopropane-
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carboxyaldehyde affect the substrate activity of TK.  The non-cyclic aldehyde, can 
freely move between side chains and enter the active site for catalysis.  However the 
cyclopropane structure may have more limited access to the acceptor binding site and 
conformational restrictions which could account for the low yield with high ees are 
obtained. 
 
3.5 Cyclopentanecarboxaldehyde as an acceptor substrate for the TK reaction 
 
The biomimetic reaction with cyclopentanecarboxaldehyde 90 was performed in water 
in the presence of Li-27 and N-methylmorpholine used as a catalyst and adjusted to 
pH 8.0 to afford the ketodiol product 30x in 20% yield.  However, the reaction became 
slower when adjusted to pH 7.0 with less isolated product (5%) after 48 hours (Scheme 
45). 
 
30x
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O
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O
90
OH
O
O
LiO
Li-27
 
Scheme 45: Biomimetic formation of 30x 
 
The ketodiol was then derivatised to the UV active benzoate, using benzoyl chloride 
and triethylamine as before. Only the monobenzolyated product 96 was obtained, 
probably due to steric hindrance preventing the benzoylation at the secondary alcohol 
(Scheme 46). A 10 µl benzoylated ketodiol sample analysed as with 94 using a 
chiralpak-AD column at varying flow rates from 0.8-1.2 ml min-1 and eluting at different 
isochratic solvent system using hexane (95-99%): isopropanol (5-1%) concentrations.  
The sample was detected, but not separable using the chiralpak-AD column. However, 
the racemic mixture was detected and successfully separated using a chiralpak-OD 
column eluting at hexane:isopropanol (97:3) concentration at 1 ml min-1 with peaks 
detected at 32.1 mins and 34.8 mins with equal integrations (Scheme 46). 
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Scheme 46: Benzoylation of 30x and HPLC data of 96  
 
The selected TK mutants (D469E, D469T, D469K, D469L, G6, H4 and H26Y) were 
prepared as before and the biotransformations performed with 90 at pH 7.0 for 48 
hours.  The biotransformation reaction was monitored by TLC analysis and the product 
purified using silica gel chromatography.  TK mutants D469E and D469T when used 
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with 90 have obtained 30x in isolated yields of 40% and 30% respectively.  Poor 
substrate activity was revealed for WT-TK and H26Y, whilst D469L afforded no product 
after 48 hours (Table 14). 
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30 
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Table 14: The percentage yields obtained from acceptor substrate 90 
 
Products from the TK mutant biotransformations were monobenzoylated and the ees 
were determined from the established HPLC procedure described above.  The D469 
TK mutants selected for biotransformations exhibited excellent ees compared to the 
racemic mixture obtained from WT-TK (Fig. 30).  Mutant H26Y afforded the opposite 
isomer than the mutants from the D469 TK library.  
 
 
Figure 30: (A) racemate of 96; (B) D469T product with added racemate 96; (C) D469T product  
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Table 15: The ees obtained from selected D469 mutants of 30x 
 
The absolute stereochemistry of 30x was examined, in separate but comparable 
reactions coupling the terminal hydroxyl group of 30x with (R)-MTPA-Cl and (S)-MTPA-
Cl in presence of triethylamine generating an (S)-MTPA ester 97 and (R)-MTPA ester 
98 respectively (Scheme 47).   
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Scheme 47: Formation of (S)-MTPA and (R)-MTPA ester, 97 and 98 
 
In racemic ketodiol 30x, the (S)- and (R)-MTPA esters exhibited comparable splitting 
patterns (Fig. 31, B).  In the (S)-MTPA ester 97, the major isomer (2S,3S) resonated at 
δH 5.21 ppm and 4.93 ppm with a chemical shift difference ∆δH2S,3S of 0.28 with no 
(2R,3S) isomer present (Fig. 31, A).  In the (R)-MTPA ester 98, the major isomer 
(2S,3R) resonates at δH 5.08 ppm and 5.05 ppm with a chemical shift difference 
∆δH
2S,3S of 0.03 with no (2R,3R) isomer present (Fig. 31,C). The assignment of the 
absolute stereochemistry at C3 of α,α’-dihydroyketones (see previous chapter),100 
established that the chemical shift patterns of the diasteretopic protons, derivatised as 
Mosher’s esters, varied such that ∆δH2R,3’R and ∆δH2S,3’S > ∆δH2S,3’R and ∆δH2R,3’S. This 
indicated that the stereochemistry at C3 in 97, formed by D469T, had the (3S)-
configuration (Fig. 31). 
 
 
Figure 31: (A) SMTPA ester of D469T (B) racemic (S)-, (R)-MTPA esters, (C) (R)-MTPA ester D469T 
 
The modified Mosher’s method also revealed from the 1H NMR integration of Ha and Hb   
of the D469T mutant product the ee was >99% which was comparable to the data via 
HPLC.  Hence the D469 TK mutants assessed were stereoselective for the (S)-
configuration.  
 
The rationale for the generally higher yields (30-40%) for D469T and D469E mutants 
with cyclopentanecarboxaldehyde 30x in comparison to cyclopropane 30v (10%) is 
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presumably due to the ring size. The cyclopentane ring bears a resemblance to the 
natural substrate ribose-5-phosphate RP5 (furanose form) which enters deep in the 
enzyme cleft that lies in close proximity to ThDP and Asp469 for catalysis to occur 
(Fig.32). 
 
 
Figure 32: RP5 furanose form in enzyme active site with ThDP  
 
3.6 Cyclohexanecarboxaldehyde as an acceptor substrate for the TK reaction 
 
Preliminary investigations on the TK biomimetic reaction involved reactions with 
stoichiometric amounts of cyclohexanecarboxaldehyde 91, N-methylmorpholine and Li-
27 in aqueous media at room temperature to afford ketodiol product in 25% yield. The 
reaction has since improved in yield (50%) with cases of stereoselectivity introduced in 
ketodiol product formation (Chapter 5). The racemic ketodiol was purified from the 
reaction mixture using silica gel eluted with 1:1 EtOAc:hexane. The readily generated 
30y was used as a standard reference for product identification on TLC and 
stereoselectivity of the biotransformations using HPLC (Scheme 48). 
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Scheme 48: Biomimetic formation of ketodiol 30y 
 
Initially the hydroxyl groups were acetylated using a pyridine: acetic anhydride (3:1) 
mixture followed by an acid/base work up to afford quantitative yields of 99 (Scheme 
49).  A 20 µl acetylated ketodiol sample was analysed using a chiralpak-AD column at 
a 1ml min-1 flow rate eluting with a hexane:isopropanol (98:2) isochratic solvent system.  
The isomers were detected and separated at 12.0 mins and 13.6 mins with equal 
integrations. However, separation of the isomers was not consistent and the acetylated 
esters were not readily detected with diluted samples. 
 
 
 81 
 
9930y
O
O
O OO
py, AcO2
100%
OH
OH
O
(3:1)
 
Scheme 49: Acetylation of ketodiol 30y 
 
The ketodiol, was then derivatised as the monobenzoate for better detection under UV.  
The benzoyated product was purified and analysed by HPLC using a chirapak-OD 
column. The mono- benzoylated product 100 exhibited clear separations of the 
isomers; using an isochratic solvent system; hexane: isopropanol (97:3) concentration, 
at a flow rate of 1.0 ml min-1 (Scheme 50). 
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Scheme 50: Benzoylation of ketodiol 30y 
     
 
The TK mutants selected were used with 91 as previously described for 89 and 90 and 
the product 30y was isolated in each case by silica chromatography.  The D469 TK 
mutants all revealed some substrate acitivity with D469E exhibiting the highest 
conversion yields.  Poor substrate activity was revealed for WT-TK and mutants 
D469K, and D469T, whilst D469L and H26Y afforded no product after 48 hours (Table 
16). 
OH
O
O
LiO
Li-27
+ CO2+R
O
H R
OH
O
OH
Mg2+, ThDP
E.coli TK
91 30y
 
R D469E  
% 
D469T 
% 
D469K 
% 
D469L 
% 
G6 
% 
H4 
% 
H26Y 
% 
D469WT 
% 
 
 
 
10 
 
3 
 
3 
 
nr 
 
4 
 
4 
 
nr 
 
1 
 
Table 16: The percentage yields of ketodiol product 30y 
 
The products from the TK mutant biotransformations, were monobenzoylated and the 
ees were determined from the established HPLC procedure previously mentioned (Fig. 
33).  Excellent ees were observed compared to the racemic mixture formed with WT-
TK (Table 17). 
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Figure 33: (A) racemate 30y; (B) D469T product with added racemate 30y; (C) D469T product 
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Table 17: The ees obtained from selected D469 mutants of 30y 
 
The absolute stereochemistry of the biosynthesised product 30y from D469E was 
determined by coupling the terminal hydroxyl group of 30y with an (R)-MTPA-Cl 
generating an S-MTPA ester (Scheme 51).   
Cl
O
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Scheme 51 Formation of the (S)-MTPA ester 101 
 
As previously, the major isomer (2S,3S) resonated at δH 5.19 ppm and 4.90 ppm with a  
chemical shift difference ∆δH2S,3S of 0.29 with trace amounts of minor isomer.  This 
indicated stereochemistry at C3, formed by D469T, was the (3S)-configuration (Fig. 
34). 
 
Figure 34: 1H NMR of Ha Hb from 101 
 
24 26 24 24 26 26 
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The rationale behind the low yields exhibited using cyclohexanecarboxaldehyde as a 
substrate is presumably due to the large cyclohexane ring which does not readily enter 
the narrow enzyme cleft to reach the enzyme active site.  The generally high ees 
revealed by the TK mutants in comparison to WT-TK is presumably due to the 
restricted conformations and orientations of the cyclohexane ring in the TK mutant 
active sites. 
 
3.7 Initial relative rates of D469T 
 
Due to the high stereoselectivity of D469T with the cyclic aldehydes, the initial relative 
rates were determined and relative velocities were compared to the comparable data 
for propanal (Table 18).  The D469T-TK mutant has previously been shown to have an 
8.5-fold specificity towards propanal over that of glycolaldehyde when compared to 
WT-TK.  However D469T with cyclic aldehydes gave lower specific substrate activities 
in relation to propanal. Furthermore, as the ring size increased the substrate specific 
activity decreased. This may be a result of restricted oreientation exhibited by the cyclic 
rings which increases with ring size.  The D469T TK mutant was shown to have an 0.4 
fold relative activity towards cyclopentanecarboxaldehyde 90 as substrate with a higher 
yield obtained in comparison to lower yielding cyclopropane-carboxaldehyde 89 
exhibiting a 0.6 fold relative activity.  The differences in substrate activity are possibly 
due to product inhibition. 
Aldehyde Mutant Initial rate 
[mM h-1] 
TK (mg ml-1) Spec. activity 
(mmol mg-1min-1) 
Initial rel. 
rate 
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4.47 
 
0.3 
 
0.25 
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O
H
 
 
D469T 
 
3.46 
 
0.3 
 
0.19 
 
0.3 
Table 18: The kinetic kinetic data obtained for D469T on various acceptor substrates  
                 obtained by the colorimetric assay  
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3.8 Synthesis of 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde and the formation 
of the ketodiol product 
 
The use of novel substrates, including bulky, and hydrophobic moieties with diverse 
functional groups for further chemical modification would enhance the synthetic 
applications of TK.  This rationale led to the use of a Diels-Alder cyclic adduct 3,4-
dimethyl-3-cyclohexen-1-carboxaldehyde, that differs slightly from previous cyclic 
aliphatic aldehydes investigated due to the presence of an unsaturated bond and two 
methyl groups on the cyclohexene ring. This aldehyde was selected as a 
representative cycloaddition precursor. 
 
The aldehyde 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde 104 was synthesized 
from a Diels-Alder reaction in a Lewis acid ionic liquid containing choline chloride and 
zinc chloride (1:2).  The added benefits of this reaction are; the ionic liquid is not 
moisture sensitive and the reaction has a short reaction time at an ambient 
temperature.101  The ionic liquid was formed by heating the choline chloride and Zinc 
Chloride
 
to approximately 150 ºC and was left to stir until a colourless melt was 
obtained which was then cooled to a viscous liquid. The addition of water was essential 
to reduce the viscosity of the ionic liquid, so the reaction can be stirred magnetically.  It 
also highlighted that the ionic liquid has not declined in catalytic efficacy with traces of 
water present. 
 
 Acrolein 102 and 2,3-dimethylbutadiene 103 were then added to the magnetically 
stirred ionic liquid at 26 ºC for 2 h.  The reaction mixture was left to stand, then product 
decanted off and the ionic liquid washed with hexane which was evaporated. This 
afforded aldehyde 104 in an 85% yield (Scheme 52).102  The recyclability of the viscous 
ionic liquid was also explored by the addition of water (≈ 0.5 ml) and the reactions were 
repeated generating comparable yields of 104 (82%).   
 
 
 
Scheme 52: Formation of aldehyde 104 via ionic liquid 
 
 
O
+ H
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H
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The biomimetic TK reaction was performed using a THF:H2O (1:1) reaction mixture 
adjusted to pH 7.0, and stoichiometric amounts of aldehyde 104, N-methylmorpholine 
(NMM) and Li-27 to prepare ketodiol product 105(a-d) as a four diastereomeric mixture 
in 10% yield.  The yield marginally increased to 15% when the THF:H2O reaction 
mixture was not adjusted to pH 7.0 during the course of the reaction (Scheme 53). 
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Scheme 53: Biomimetic reaction of aldehyde 104 
 
The ketodiol mixture was derivatised, to form the UV detectable benzoates, using 
benzoyl chloride and triethylamine again, only the mono-benzoylated product 106 at 
the primary alcohol position was obtained (Scheme 54).   
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Scheme 54: Benzoylation of ketodiol 105 
 
A 10 µl benzoylated ketodiol sample was analysed using a chiralpak-AD column at 
varying flow rates from 0.8-1.2 ml min-1 and eluting at different isochratic solvent 
system using hexane (90-99%): isopropanol (10-1%) concentrations.  The four isomers 
were detected at 28.6 min, 30.8 min, 34.0 min, and 43.1 min with equal integrations 
under isocratic conditions using isopropanol (3%) as the polar stationary phase and 
hexane (97%) as the non-polar mobile phase with a 0.8 ml min-1 flow rate (Fig. 35). 
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Figure 35: HPLC trace of 4 isomers of 106 
 
3.9 The colorimetic screening of library D469 with aldehyde 104 
 
A high-throughput colorimetric screening using tetrazolium red was used to detect 
formation of the product in the bioconversion.  Lydia Crago (UCL Biochemical 
Engineering) performed the colorimetric assay, screening the D469 library with 
acceptor substrate 104 (Fig. 36).  
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Figure 36: Colorimetric assay on D469 library with aldehyde 104 
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The investigation led to 5 mutants (wells B6, B7, D5, F1 and F12) that were identified 
with good activities against 104.  These mutants were sequenced and further examined 
for accurate expression levels of the protein (Table 19).103 
 
Well 
Number 
Mutant Relative Activitya,b 
(D469T = 1) 
TK expressed  
(% total protein) 
WT D469 0 31 
F12 D469T 1 33 
B6 D469K 0.82 35 
B7 D469S 0.81 32 
F1 D469T 0.79 19 
D5 D469L 0.76 25 
 
Table 19: The relative activities and total expressed protein of D469 TK mutants 
 
Two strains of D469T were identified from wells F12 and F1, however the greater 
overall expression, cell growth and activity in well F12 was selected for further work.  A 
TLC plate was taken to visualise the ketodiol product formation using D469T TK in 
comparison to the poor substrate accepting WT-TK enzyme (Fig. 37). The TLC 
analysis was also used to confirm product conversion with the mutant demonstrating 
activity against 104. 
 
Figure 37: Comparison of WT-TK and D469T-TK mutant by TLC 
 
3.10 Aldehyde acceptor 104 as acceptor substrate for the TK reaction 
 
In separate, but analogous biotransformations, D469T and D469L were used in 50 
mM reaction mixtures with aldehyde 104, at pH 7.0 and 48 hours, affording 10% 
yields of 105 in both cases (Scheme 55).  
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Scheme 55: The biotransformation of 104 and Li-27 to generate ketodiol 105 
D469T WT
 88 
The products from the TK mutant biotransformations, were monobenzoylated and 
the absolute stereochemistry was determined from the established HPLC procedure 
previously mentioned. The D469T and D469L TK mutants selected were highly 
diastereoselective in nature, for the same major diastereomer with traces of the 
remaining 3 isomers formed (Fig. 38, peak 3). Preparative-scale biotransformation 
using mutants D469T91 and D469L proved to have the most interesting 
enantiostereo-selectives and were further explored, however since D469T was 
more active than D469L, the determination of absolute stereochemistry and kinetic 
analyses was carried out with D469T (Fig. 38). 
 
 
Figure 38: HPLC traces of monobenzoylated products 105 
 
The absolute configuration and enantioselectivity of D469T TK was determined via 
preparation of the 1’R-aldehyde (R)-104 and the recently developed  modified 
Mosher’s acid method. To determine the stereochemistry at the C1 position, the 
biotransformation product 105 from the reaction using the D469T was reacted with 
(R)-MTPA-Cl to form the (S)-MTPA ester 107 at the primary alcohol (Scheme 56). 
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Scheme 56: Formation of (S)-MTPA ester 107 
 
Following the modified Mosher’s method the stereochemistry at C1, formed by 
D469T, was assigned the S-configuration (1S) (Fig. 39). 
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Figure 39: 1H NMR spectra of Ha and Hb of 107 
 
The C1’ stereocenter was determined by generating a stereodefined (1’R)-ketodiol 
from a (1R)-aldehyde (R)-104 precursor (Fig. 40). 
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Figure 40: Retrosynthesis of (1’R)-105 
 
Macmillan catalyst, (5S)-2,2,3-trimethyl-5-phenylmethyl-4-imidazolidinone 108, was 
used to generate the (1’R)-aldehyde (1R)-104 and was reacted with 102 and 103 in 
a CH3CN-H2O (95:5,v:v) solvent mixture, to generate (1R)-104 in an 83% yield 
(Scheme 59).112   
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Scheme 57: Diels-Alder formation of (1R)-104 
 
The aldehyde was directly used in the biomimetic reaction in the presence of N-
methylmorpholine, and Li-27 to generate (1’R)-105 (10% yield). The ketodiol     
(1’R)-105 was then monobenzoylated to afford (1’R)-106 (70% yield).  
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Scheme 58: The formation of the benzoylated product 106 
 
The HPLC spectra of (1’R)-106 was compared to the HPLC traces of the D469T-TK 
product (1S)-106 and the biomimetic four isomer product 106 (Fig. 41). 
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Figure 41: Spectra (A) Biomimetic, (B) 2 major peaks and (c) D469T product, 1 major peak 
 
These experiments helped elucidate the absolute stereochemistry of the major 
isomer of the D469T-TK product as (1S,1’R) (Fig. 41). Closer inspection of the 
D469T-TK ketodiol HPLC spectra (Fig. 41) indicated that a 93:7 (anti:syn) product 
was formed.  
 
Additional experiments were conducted using (1R)-104 in the biotransformation with 
D469T-TK. This yielded the same major diastereoisomer 105 (as determined by HPLC 
analysis) was afforded as with racemic 104 in the same yield (10%). The major isomer 
(1S,1'R)-105 was formed in 97% ee  (minor isomer (1R,1'R)-105) and no (1S,1’S) or 
(1R,1’S)-105 isomers were detected (Scheme 59). This confirmed the 
biotransformation using racemic 104 with D469T-TK is highly enantioselective for (1R)-
104. Since the ketodiol product 105 is formed in the same yield regardless of whether 
racemic or optically pure 104 is used, this suggested that the reaction was not inhibited 
by (1S)-104 and that the rationale for the low yield of the reaction is most likely due to 
product inhibition which can be tackled by process engineering techniques in situ.104  
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Scheme 59: Formation of (1S, 1’R)-106 
 
The only current X-ray crystal structure of E.coli TK, in a non covalent complex with 
with acceptor aldose ribose-5-phosphate (R5P) can shed light on the alleged 
stereoselective nature of the mutant enzyme.  The replacement of the aspartate 
residue (D469) involved in the catalytic activity disrupts the important hydrogen 
bonding (2.74 Ǻ) to the C2 hydroxyl group of acceptor substrate (R5P) molecule   
(A, Fig. 42).  The mutation to a threonine residue, containing a neutral side chain, 
may result in a steric clash between neighbouring side chains (B, Fig. 42) and may 
require a side chain rearrangement to accommodate a new side chain.  However 
the mutation may be favorable due to weakened hydrogen bonding (5.69 Ǻ) 
capacity with the D469T residue allowing a larger substrate such as 104 to bind (C, 
Fig. 42).   
 
Figure 42 (A) D469 hydrogen bonding to R5P (B) D469/D469T steric clash to neighbouring side 
chains (C) D469T hydrogen bonding to R5P (a crude pyMOL mutagenesis (1NGS.pdb, taken from 
www.rcsb.org/pdb) 
 
The D469T mutant has previously been shown to have 8.5-fold improved specificity 
towards propanal relative to glycolaldehyde when compared to WT, highlighting that 
the conversion of an acidic residue to threonine may favour conversions with more 
lipophilic substrates.87,91  It is surprising nevertheless, that a single point mutation of 
an enzyme shows high catalytic activity with bulkier substrates in comparison to 
WT, as usually an accumulation of multiple mutations is required.105   
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The colorimetric assay was also used to obtain kinetic data (performed by Lydia 
Crago) using purified His-tagged D469T TK with 104 at a various concentrations     
(0–50 mM) and 50 mM Li-27.91 A Vmax of 0.07 mM min-1, an apparent KM of 69.9 
mM, and a kcat of 17.5 s-1 was observed. This resulted in a 18,000-fold improvement 
in substrate specificity (kcat/Km) for D469T compared to WT-TK. 
 
3.11 Summary  
 
We have identified and demonstrated TK mutants with improved substrate activity 
towards cyclic aliphatic aldehyde substrates with increasing ring size in comparision 
to WT-TK.  The TK mutants, are highly enantioselective with cyclic substrates 89, 
90 and 91 generating (S)-ketodiol products with >99% ees.  Further kinetic 
experiments revealed that the high yielding mutant D469T has poorer substrate 
specificity with the cyclic aldehydes in comparison to propanal as substrate due to 
the increasing lipophilicity and steric bulk of the cyclic aldehydes investigated.  The 
mutant D469T-TK has shown an 18,000-fold increase in reaction rate for cyclic 
aldehyde 92 in comparison to WT-TK.  The biotransformation revealed D469T to be 
highly diastereoselective for the (1S,1’R)-105 isomer, affording a (97:3) anti:syn 
product. Further experiments indicated that the (1S)-104 aldehyde is not 
accountable for enzyme inhibition and suggests that product inhibition is 
presumably responsible for the low yielding ketodiol product generated.  The high 
activity and high stereospecificity demonstrated by D469T highlights the importance 
of exploring the promiscuity of this mutant in the future using an even broader range 
of complex cyclic substrates. 
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Chapter 4.0 
Aromatic aldehydes used in the TK 
reaction 
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4.1 Aromatic aldehydes used as novel substrates in the TK reaction 
 
As previously described in the introduction (Chapter 1), Dumunyck first reported 
relative reaction rates of several aromatic aldehydes used as acceptor molecules with 
Li-27 as the donor substrate in the yeast TK reaction.46 The relative rates were 
determined by monitoring Li-27 depletion by HPLC; with no attempts made to isolate 
the ketodiol products.  The relative velocities calculated revealed that the aromatic 
aldehydes are in general poor substrates with yeast TK reaction in comparison to 
glycoaldehyde.   
 
Turner et al. performed preliminary investigations with several aromatic aldehydes as 
acceptor molecules and Li-27 as the donor substrate for the E. coli TK reaction.  
Furfural showed poor substrate affinity with E.coli TK, assessed via the depletion of    
Li-27 but no apparent product was isolated.51 Enantiomerically pure aromatic               
α-hydroxyaldehydes were synthesized and also used as substrates leading to novel 
optically pure triols 30iv and 30v with moderate to good yields 44% and 54% 
respectively.43 A non α-hydroxyaldehyde, phenylacetaldehyde was also used as an 
acceptor substrate and gave the product 30ii in 33% yield (Table 20).52 
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Table 20: Other aromatic substrates used as substrates 
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Our aim was now to investigate in detail the feasibility of using aromatic aldehydes to 
give ketodiols with potential for conversion to aminodiols. 
 
4.2 The colorimetic screening of library D469 with benzaldehyde 
 
The reaction plate of the E. coli D469 library obtained by saturation mutagenesis was 
incubated with benzaldehyde and Li-27 and then the tetrazolium-red colorimetric assay 
was used to detect the ketodiol product 30Ar1 (Fig. 43).  The colorimetric assay of the 
96-well plate highlighted the overall poor optical densities for the variants in 
comparison to the colorimetric assay with the cyclic aliphatic aldehydes, suggesting 
poor substrate affinity of E. coli TK for benzaldehyde. The screening revealed, however 
that the percentage well containing mutant D469K had the highest optical density.  
Selected mutants were then grown to prepare cell-free lysates for biocatalysis.  TK 
mutants D469E, D469K, D469S, and D469T were chosen for their relatively high 
optical densities on the assay read-out or for exhibiting high enantioselectivities and 
substrate activity with cyclic aliphatic aldehydes.106 Mutant H26Y TK was also selected 
for exhibiting good activity with long chain aliphatics and affording (3R)-ketodiols.87 The 
preparative biotransformations were conducted at a 50 mM scale and monitored by 
TLC analysis.   
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Figure 43: The colorimetric assay screening library D469 for active TK mutants with 
benzylaldehyde 
93
nm
λmax = 485 nm  
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4.3 Benzaldehyde as an acceptor substrate for the TK reaction 
  
Initially racemic 30Ar1 was prepared using the biomimetic reaction in aqueous media 
with stoichiometric amounts of benzaldehyde, N-methylmorpholine and Li-27 (see 
Chapter 5).  The reaction mixture was adjusted to pH 7.0, to reduce the formation of 
the by-product 110 which had been observed when storing 30Ar1 in solution (Scheme 
60). 
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Scheme 60: Formation of 30Ar1 and 110 in water 
 
 
The racemic 30Ar1 isolated had an Rf value of 0.45 in (1:1) ethyl acetate: hexane and 
this was used together with NMR analysis to determine the outcome of the reaction. 
The biotransformations performed exhibited no catalytic activity with WT-TK or the 
mutant H26Y to generate 30Ar1 or 110.  The D469 variants assessed generated 
30Ar1 in low product yields < 5% (Table 21).  
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Increasing the polarity of the eluent to 100% ethyl acetate for D469E, D469T, D469K, 
and G6 revealed the formation of a side product with an Rf of 0.4.  The product isolated 
has a parent ion m/z [M+Na]+ = 249.21, and with further NMR analysis the following 
structure 111 has been proposed (Fig. 44). 
 
R D469E  
(%) 
D469T 
(%) 
D469K 
(%) 
G6 
(%) 
H26Y 
(%) 
WT-TK 
(%) 
 
 
 
30Ar1 (3) 
110 (0) 
 
30Ar1 (3) 
110 (0) 
 
30Ar1 (2) 
110 (0) 
 
30Ar1 (2) 
110 (0) 
 
nr 
 
nr 
Table 21: The yields of the biotransformation product 30Ar1 and 110 using several TK mutants  
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Figure 44: TLC plate showing the biotransformation products of D469T, in 
comparison to the biomimetic products 
 
A mechanism for the ‘double-addition’ product has been proposed involving the 
tautomerisation of Li-27 in situ to form the tartronate semialdehyde 112, a                    
β-ketocarboxylic acid which undergoes decarboxylation in a concerted process.  The 
ease of decarboxylation depends on the stability of the stable 6-membered transition 
state, which lowers the activation energy for decarboxylation to occur at mild 
conditions.107  Decarboxylation of β-ketocarboxylic acids leads initially to the formation 
of the enediol 113 then tautomerises to the corresponding carbonyl to generate 
glycolaldehyde in situ (Scheme 61). 
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Scheme 61: The generation of glycolaldehyde in situ via decarboxylation of a β-ketocarboxylic acid 
 
The acidity of the α-H in 30Ar1 generated in the biotransformation leads to formation of 
the electron rich enediol 114 which attacks the carbonyl of glycolaldehyde, with 
subsequent proton transfer, affording the ‘double addition’ product 111 (Scheme 62). 
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Scheme 62: Mechanism for the generation of the proposed structure of the by-product formed 
 
To determine the absolute stereochemistry of 30Ar1 the Mosher’s derivatisation 
method (Chapter 2) was used.  Compound 30Ar1 produced by mutant D469T was 
coupled to (S)-MTPA-Cl at the terminal hydroxyl group to generate the (R)-MTPA ester 
115 (yield 61%) (Scheme 63). 
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Scheme 63: Formation of (R)-MTPA ester 115 
 
The calculated chemical shift difference of the major isomer (∆δH 0.31) was larger than 
for the minor isomer (∆δH 0.02) of the (R)-MTPA ester 115 (Fig. 45). This indicated the 
stereochemistry at C3, formed by D469T, was assigned as having (3R)-configuration, 
with an approximate 90% ee (Fig. 45). 
 
Figure 45: NMR spectra of (R)-MTPA ester of 115 
 
The HPLC assay to determine the ees of 30Ar1 involved the dibenzoylation of the 
ketodiol products.  The hydroxyl groups of racemic 30Ar1 were benzoylated using a 
benzoyl chloride and 2,4,6-collidine to afford quantitative yields of the dbenzoylates 
(Scheme 64).  The dibenzoylated product 116 isomers were readily separated by chiral 
HPLC, using a chiralpak-AD column, with a hexane:isopropanol (82:18) concentration, 
at a flow rate of 1.0 ml min-1 and gave the retention times of 10.5 min (R-isomer) and 
13.4 min (S-isomer).  Using this assay, the ees of the ketodiols from other D469 TK 
variants were determined with the majority (R)-isomer obtained (Table 22). 
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Scheme 64: Acetylation of 30Ar1 and a spectrum of the separated isomers 116 
Table 22 The percentage ees of ketodiol 30Ar1 upon formation of 116 
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A variety of aromatic aldehydes were screened on a preparative scale and several 
examples are given below: 
 
4.4 Furfural as an acceptor substrate for the TK reaction 
 
The selected mutants used in biocatalytic conversions with benzaldehyde were also 
screened with furfural.  In separate but analogous biotransformations, the TK mutants 
selected were conducted at a 50 mM reaction mixture, at pH 7.0 and for 48 hours.  The 
biotransformation reaction was monitored by TLC analysis and revealed that two 
products were formed in several experiments.  The compounds isolated were ketodiol 
30Ar2 and rearranged ketodiol 117.  The results revealed that WT-TK and H26Y 
mutants had poor activity with furfural exhibiting no product formation after 48 hours 
(Table 23). 
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nr 
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Table 23: Isolated biotransformation yields of 30Ar2 and by-product 117 using several TK mutants 
 
The thermodynamically favoured rearranged product is formed from the deprotonation 
of the acidic α-H of the ketodiol to generate the enediol 118 which tautomerises to form 
the preferred oxo tautomer 117 in conjugation with the furan ring (Scheme 65). 
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Scheme 65: Mechanism of ketodiol 30Ar2 rearranged to 117 
 
To determine whether the rearranged ketodiol product was enzymatically generated, 
117 was derivatised to the Mosher’s ester by coupling the terminal hydroxyl group with 
an (R)-MTPA-Cl generating an (S)-MTPA ester 119 (Scheme 66).  A unique splitting 
pattern was observed from the diastereotopic protons Ha and Hb of the (S)-MTPA ester.  
The two outer mulitiplet signals at δ 3.06 and δ 3.45 ppm represented one isomer while 
the inner multiplet δ 3.30 represents another (Fig. 46). The equal 1H NMR integrations 
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of Ha and Hb revealed the rearranged ketodiol as a racemate.  This suggests 117 was 
formed in situ from 30Ar2 by conversion to the favoured thermodynamic product. 
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Scheme 66: Formation of (S)-MTPA ester 119 
 
 
 
Figure 46: 1H NMR representing HA and HB of 119 
 
The absolute stereochemistry of 30Ar2 resulting from the D469T mutant was 
investigated by coupling to (R)-MTPA-Cl.  However, when the reaction was performed 
in the presence of base triethylamine this resulted in the formation of the 
thermodynamically more stable 119.  A DCC coupling reaction was carried out which 
formed the diMTPA ester under neutral conditions (Scheme 67).  The calculated 
chemical shift difference of the major isomer (∆δH 0.19) was larger than minor isomer 
(∆δH 0.00) of the (S)-MTPA ester.  This suggested the stereochemistry at C3, formed 
using D469T, was the (3S)-configuration, and was generated in approximately 80% ee 
(Fig. 47). 
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Scheme 67: DCC coupling forming (S)-MTPA ester of 30Ar2 
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Figure 47: 1H NMR of Ha and Hb of 120 
 
The ees of the ketodiols obtained from the other mutant TKs are pending identification. 
Nevertheless, ester formation using triethylamine as base was avoided.  Derivatisation 
using benzoic or acetic acid will be carried out using DCC coupling reagent to avoid 
racemisation and analysis of the ees can be achieved using chiral HPLC. 
 
4.5 Phenylacetalydehyde as an acceptor substrate for the TK reaction 
 
The biomimetic reaction with phenylacetaldehyde was conducted using THF:H2O (1:1)  
solution at pH 7.0 in the presence of Li-27 and N-methylmorpholine as a catalyst, to 
afford the ketodiol product 30Ar3 in 5% yield.  The yield increased two-fold, when the 
THF:H2O (1:1) reaction mixture was not adjusted at pH 7.0, but performed at pH 9.0.  
Unlike the other aromatic aldehydes, phenylacetaldehyde is not in conjugation with the 
aromatic ring and is less likely to generate the ‘rearranged product’. The ketodiol 
contains an aromatic chromophore that can be detected by UV absorption.  Initially the 
hydroxyl groups in 30Ar3 were acetylated using a pyridine:acetic anhydride (3:1) 
mixture for 4 hours followed by an acid/base work up to afford quantitative yields of 
121. The acetylated product 121 was detected by normal phase chiral HPLC columns 
available, however various manipulations in the protocol and the use of different 
chiralpak columns (AD, OD, OJ) established that the isomers were inseparable. 
(Scheme 68) 
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Scheme 68: Formation of 30Ar3 and acetylated product 121 (spectra of inseparable isomers) 
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The ketodiol, was therefore derivatised to the mono-, and dibenzoylated products, 122 
and 123 respectively using benzoyl chloride and triethylamine for 12 hours at room 
temperature. The benzoyated products were purified by silca gel chromatography 
before analyzing 122 and 123 using the chirapak-OD column. The dibenzoylated 
product was detected but the isomers appeared inseparable under different 
isopropanol and hexane concentrations and protocols. The mono-benzoylated product 
123 exhibited clear separation of the isomers; using an chiralpak-OD column, with a 
hexane:isopropanol (97:3) concentration, at a flow rate of 0.8 ml min-1 (Scheme 69). 
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Scheme 69: Generation of a Mono-, dibenzoylated products (spectra of separated isomers of 123) 
 
In separate, but analogous biotransformations, the TK mutant reactions were all 
conducted at 50 mM concentrations at pH 7.0 for 48 hours and monitored by TLC. The 
ketodiols were purified using silica gel chromatography (Rf 0.45, Hexane:EtOAc; 4:1). 
WT-TK variant and H26Y gave 30Ar3 in low yields (5%) compared to the D469 TK 
mutant which gave 30Ar3 in 43-50% yields (Table 24). 
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Table 24: Yields of ketodiol 30Ar3 generated 
 
Previous work conducted by Turner et al. gave 30Ar3 in 33% when using unbuffered 
medium at pH 7.0 (pH Stat). In comparison, the corresponding TK reaction in 0.1 M 
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glycylglycine buffer at pH 7.0 gave 30Ar3 in 26% yield.  When they repeated the TK 
reaction in unbuffered media a ‘rearranged ketodiol’ by-product 125 (18% yield) was 
obtained.  However the biotransformations conducted in this work with TK variants 
gave negligible amounts of the ‘rearranged ketodiol’ product.  This can be rationalised 
by the different reaction conditions used in the biotransformation which were not 
specified in detail by Turner and coworkers (Scheme 12).52 
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Scheme 70: Rearrangement mechanism of 30Ar3 
 
The absolute stereochemistry or the enantiopurity of the ketodiol product has not been 
reported in the literature.  Following the HPLC assay, by monobenzoylating the ketodiol 
products from the TK mutant biotransformations, the ees were determined.  Both H26Y 
and WT-TK were low yielding, but high ees were observed.  Most importantly H26Y 
generated the same (S)-isomer as all the other D469 TK mutants in a direct contrast to 
the (R)-ketodiols observed for H26Y with linear aliphatic aldehydes (Table 25).87   
 
 
The absolute stereochemistry of the D469T ketodiol product 30Ar3 was determined by 
coupling the terminal hydroxyl group with an (R)-MTPA-Cl generating an (S)-MTPA 
ester as previously described (Scheme 71).   
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Scheme 71: Formation of the (S)-MTPA ester 126 
 
An interesting splitting pattern was observed for methylene protons Ha and Hb of the 
(S)-MTPA ester 126.  The major isomer (2S,3S) resonates at δH 5.16 ppm and 4.95 
ppm with a 0.21 chemical shift difference (∆δH2S,3S is 0.21) and the minor isomer 
resonates at δH 5.07 ppm and 5.04 ppm (∆δH2S,3R is 0.03). This suggested that the 
stereochemistry at C3, for 30Ar3 formed by D469T had the (3S)-configuration.  An 
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ee% 
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D469K 
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G6 
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Table 25: The percentage ees of ketodiol 30Ar3 generated 
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approximation of the ee was determined from the NMR integration of Ha and Hb giving a 
90% ee, compared to the 96% ee measured via HPLC.  Overall the D469 TK mutants 
assessed were stereoselective for the (S)-configurated product (Fig. 48). 
  
 
Figure 48: 1H NMR spectrum of HA and HB of 126 
 
4.6 2-Phenylpropionaldehyde as an acceptor substrate 
 
The biomimetic reaction was performed using 2-phenylpropionaldehyde as the 
acceptor aldehyde in a THF:H2O (1:1) solvent system to prepare the ketodiol product 
as a four diastereomeric mixture in 20% yield.  The de of the diastereomers was 
determined by 1H NMR spectra, wherein the relative integrations of the separable 
protons were compared.  For instance, the 1H NMR spectrum of ketodiol 30Ar4 (Fig. 
49, Spectrum A), revealed HA at δ 1.28 as a doublet (J 7.1 Hz) for the major isomer, 
while the same proton resonated at δ 1.43 as a doublet (J 7.1 Hz) for the minor isomer 
with relative integrations of 4:1 (de 60%).  In comparison with D469T TK mutant 
affording ketodiol 30Ar4 exhibited separable doublets; with the major doublet at δ 1.28 
ppm, and the minor doublet resonating at δ 1.43 ppm revealed higher relative 
integrations 11:1 (de 83%) (Fig. 49, Spectrum B). 
 
Figure 49: 1H NMR spectra of biomimetic (A) and 1H NMR of D469T (B) 
OH
O
OHHA
H H H 30Ar4
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In separate, but analogous biotransformations, the TK mutants using D469E, D469T, 
D469K, G6, H26Y and WT-TK were all conducted at 50 mM concentrations at pH 7.0 
(pH Stat) for 48 hours and monitored by TLC analysis. The ketodiols were purified 
under silica gel chromatography (Rf of 0.40, Hexane:EtOAc; 1:1). The TK variant H26Y 
when used in the biotransformation afforded no product.  The WT-TK gave rise to 
comparable yields as with the D469 TK mutants which exhibited moderate yields 
(Table 26). 
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Table 26: The yields of the biotransformation product 30Ar4 
 
 
The isomeric mixture of 30Ar4 from the biomimetic reaction was then benzoylated 
using benzoyl chloride and triethylamine.  Only the monobenzolyated product 127 was 
obtained, highlighting the steric hindrance by the aryl ring preventing the benzoylation 
from occurring at the secondary alcohol (Scheme 72). 
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Scheme: 72 Benzoylation of 30Ar4 
 
The monobenzoylated product was detected via HPLC at a wavelength of 214 nm 
using a chiralpak-OD column.  The isomers from the biomimetic reaction were detected 
with two different sets of isomers with equal integration under isocratratic conditions 
using isopropanol (3%) as the polar stationary phase and hexane (97%) as the non 
mobile phase with a 0.8 ml min-1 flow rate (Fig. 50,  A). The HPLC traces corresponded 
to the NMR data where a 1:4 diastereomeric ratio was noted. The ketodiol products 
from D469T-TK mutant were monobenzoylated and subjected to the same HPLC 
procedure.  This revealed that D469T was highly diastereoselective with a preference 
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for the formation of the same major isomer peak 1 with traces of a smaller isomer peak 
3 present (Fig. 50, B). 
 
Figure 50: Spectrum A (127 obtained from D469T) Spectrum B (127 Racemate from biomimetic) 
 
The absolute configuration and diastereoselectivity of D469T was determined via the 
preparation of the R-aldehyde and the developed Mosher’s method.  To determine the 
stereochemistry at the C3 position, 30Ar4 was reacted with (R)-MTPA-Cl to attach the 
Mosher’s ester 128 at the primary alcohol (Scheme 73).  
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Scheme 73: Formation of (S)-MTPA ester 128 
 
The calculated chemical shift difference of the major isomer (∆δH 0.16) was larger than 
the minor isomer (∆δH 0.00) of the (S)-MTPA ester.  This indicated the stereochemistry 
at C3, formed by D469T, had the (3S)-configuration, and an approximate 91% ee at the 
3S position was observed via integration of Ha and Hb protons (Fig. 51). 
 
 
Figure 51: 1H NMR of Ha and Hb of 128 
 
The ketodiol products from the remaining TK mutants D469E, D469K, G6, H26Y and 
WT-TK were benzoylated and the C3 absolute configurations were determined via 
A 
B 
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HPLC.  All contained the (3S) configuration with ee at 3S shown below with the minor 
isomer presumed 3R product (Table 27). 
 
CO2R H
O
OH
OH
O
+
Mg2+, ThDP
E.coli TK R +
30Ar4
OH
O
O
LiO
Li-27
 
Ketodiol D469E 
ee% 
D469T 
ee% 
D469K 
ee% 
G6 
ee% 
H26Y 
ee% 
WT-TK 
ee% 
 
O
OH
OH
 
 
 
90 
 
 
91 
 
 
89 
 
 
88 
 
 
nr 
 
 
76 
 
Table 27: The percentage ees of 30Ar4 
 
The results indicate a continued stereoselective preference for the (3S)-isomer across 
most aryl aldehydes explored with the D469 TK library. This also suggested that the 
interactions with the α–methyl group from the acceptor aldehyde contributed a pivotal 
role in directing the diastereoselectivity of the ketodiol product formed. The TK mutant 
H26Y revealed no activity with 2-phenylpropionaldehyde as the substrate acceptor 
molecule.  In general H26Y appeared to have poor substrate activity with aromatic 
substrates, possibly due to access of the substrate in entering the substrate cleft of the 
TK enzyme.   
 
The C4 stereocentre in the major isomer of 30Ar4 formed using D469 variants was 
determined by generating a stereodefined (4R)-ketodiol from an (R)-aldehyde 131 
precursor (Scheme 74). 
 
OH
O
OH
4
O
H
+
131(4R)-30Ar4
OH
O
O
LiO
Li-27
 
 
Scheme 74: Retrosynthesis of (4R)-30Ar4 
 
Commercially available (R)-carboxylic acid 129 was reduced to the (R)-alcohol 130 
using LiAlH4 in 84% yield. Oxidation to the aldehyde (R)-131 using Swern conditions 
has been reported to generate racemic mixtures.108  Therefore Dess-Martin 
periodinane (1.2 eq.) was used and added in one portion to 130 and the reaction was 
stirred for 3 hours after which TLC analysis indicated the reaction was complete 
(Scheme 75). 
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O
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CH2Cl2THF
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Scheme 75: Formation of (R)-aldehyde 131 
 
 
The aldehyde (R)-131 was directly used in a 1:1 THF:H2O biomimetic reaction in the 
presence of N-methylmorpholine at pH 7.0 generating (4R)-30Ar4 in a 10% yield. The 
ketodiol was then monobenzoylated to generate product (4R)-132 in 80% yield 
(Scheme 76). 
 
(R)-131 (4R)-30Ar4
4
O
H
O
OH
OH
NMM, Li-HPA
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O
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OH
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Scheme 76: Formation of benzoylated (4R)-132 
 
The HPLC trace of (4R)-132 was compared to the HPLC traces biomimetic product of 
the non-chiral aldehyde 127. These experiments helped elucidate the absolute 
stereochemistry of the major isomer of the D469T-TK product as (3S,4R) and the minor 
product (3S,4S) in a 91:9 anti:syn ratio. 
 
O
OH
OH
O
OH
OH
(3S,4R) - Major product (3S,4S) - Minor product
 
Figure 52: HPLC traces of 30Ar4 
 
The results suggested that the TK catalysed reaction of 2-phenylpropional 131 
containing the C2 methyl group is enantioselective for the for the (4R)-configuration. 
The TK mutant biotransformations revealed that they are diastereoselective for the anti 
products generating (3S,4R)-30Ar4 as the major isomer (Table 28). 
 
Ketodiol 
(3S,4R)-30Ar4 
D469E 
anti:syn 
D469T 
anti:syn 
D469K 
anti:syn 
G6 
anti:syn 
H26Y 
anti:syn 
WT-TK 
anti:syn 
 
O
OH
OH
 
 
 
90:10 
 
 
 
91:9 
 
 
89:11 
 
 
88:12 
 
 
nr 
 
 
76:24 
 
Table 28: The diastereoselectivities generated from WT and D469 TK mutants 
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This is in direct contrast to a similar aromatic substrate containing a C2 hydroxyl group 
that was substrate selective for the (R)-configuration as determined by Turner et al. by 
the failed enzyme catalysed coupling reaction of the (S)-aldehyde 131-OH (Fig. 53).43 
. 
O
H
OH
O
H
(S)-131 131-OH
 
Figure 53: Acceptor substrates 
 
Further experiments are now required to confirm the E.coli TK selectivity for 30Ar4 by 
conducting a biotransformation using (R)-131 as the acceptor substrate. The moderate 
yields from the mutant TK biotransformations suggests the (R)-129 may have an 
inhibitory effect on TK but for further evidence the TK inhibition studies are required 
(Fig. 54). 
O
OH
OH
O
H
D469T E.coli TK
(R)-131 30Ar4Li-27
 
Figure 54: Further biotransformations 
 
4.7 Substrate specific activity, Initial rates of reaction of Phenylacetaldehyde and 
2-Phenylpropionaldehyde 
 
The substrate specific activity for D469T and acceptor molecules 131 and 133 was 
calculated to reveal the performance of the enzyme in biocatalytic conditions. D469T 
with propanal revealed a 4-fold and 5-fold greater activity over substrates 133 and 131 
respectively. This suggested the D469T TK mutant exhibited some substrate activity 
towards aryl substituents but they were less readily accepted than propanal.  However 
further research is required for the substrate specific activities for WT-TK with acceptor 
molecule 131 and 123 to rationalise the effects of mutation, if any, on these substrates. 
In particular the biotransformations using WT-TK and D469T-TK with aldehyde 131 
afforded the product 30Ar4 in comparable yields (Table 29). 
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4.8 Other aromatic aldehydes used as acceptor substrate molecules 
 
A diverse range of aromatic aldehydes were screened on a preparative 50 mM scale 
with Li-27 and cofactors in a non-buffered medium at pH 7.0 (pH Stat) with a variety of 
novel TK variants. The poorly soluble aromatic aldehydes containing electron 
donating/withdrawing substituents 134-137, 140, 141, 145 at varying positions of the 
aryl ring gave no ketodiol product as determined by TLC analysis after 48 hours.  The 
reaction mixture was stirred for further 5-7 days with no ketodiol product generated.  
Biotransformations were also conducted on water soluble pyrrol- 142-144, pyridine-
carboxaldehydes 138 and 139 monitored for 7 days with no ketodiol products formed. 
However, erythrulose was isolated as a side product generated by the self-
condensation of Li-27, which indicated the poor substrate affinity of the nitrogen-
containing aromatic rings (Fig. 55). 
Mutant Aldehyde  Initial rate 
[mM h-1] 
TK  
(mg ml-1) 
Spec. activity 
(mmol mg-1min-1) 
Initial rel. 
rate 
 
D469T 
 
O
H
 
 
12.52 
 
0.3 
 
0.70 
 
1 
 
D469T 
 
131
O
H
 
 
2.81 
 
0.3 
 
0.16 
 
0.2 
 
D469T 
O
H 
133 
 
 3.15 
 
0.3 
 
0.18 
 
0.4 
Table 29: The D469T kinetic and specific activity data on substrates 93 and 133 
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Figure 55: Various aldehyde acceptors used in the TK reaction 
 
The rationale behind the poor substrate affinity of aromatic aldehydes is principally two 
fold; the solubility, and the inflexibility of the planar aromatic aldehyde to enter the 
narrow, deep enzyme cleft.  Further work requires important X ray crystallographic data 
to shed light on aromatic acceptor substrates in the enzyme active site.  Increased 
aromatic substrate activity may also be achieved by selecting mutants from another 
library or begin a ‘second cycle’ of saturation mutagenesis with existing TK mutants. 
 
4.9 Summary 
 
We have identified and demonstrated TK mutants with improved substrate activity 
towards aromatic aldehyde substrates in comparision to WT-TK. The biotrans-
formations with TK mutants D469E, D469K and D469T and G6 with benzaldehyde and 
furfural afforded ketodiols in poor yields in (1-4%) with the generation of byproducts (1-
4%). However the biotransformation with D469T-TK with phenylacetaldehyde and 2-
phenylpropionaldehyde as substrates generated moderate yields of 50% and 40% 
respectively.  The ees obtained for 30Ar3 was 88-96% generating the (S)-isomer.  The 
TK mutants were diastereoselective for the (3S,4S)-30Ar4 isomer with des ranging 
from 88 to 96%.  The initial rate experiments with D469T revealed poor substrate 
specificity with aromatic aldehydes 131 and 133 in comparison to propanal as 
substrate due to the poor solubility of the aromatic aldehydes.  Further screening of TK 
mutants is required for aldehydes with a nitrogen containing ring or begin a second 
round of mutagenesis with existing TK mutants. 
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Chapter 5.0 
The biomimetic TK reaction 
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5.1 Reporting the first pioneering biomimetic transketolase reaction 
 
The UCL Department of Chemistry and the UCL Department of biochemical 
engineering have a research programme to develop TK-catalysed carbon-carbon bond 
formation.  Experiments were carried out using the enzyme TK and its cofactor ThDP in 
various buffered and non buffered media.  Several reactions involved the use of 
enzyme and buffer in the reaction mixture with the omission of ThDP, or simply ThDP 
and buffer only.  Ironically this lead to the discovery that using  the buffer 4-morpholine 
propane sulfonic acid 146 (MOPS) with no enzyme or ThDP still led to the formation of 
racemic α,α’-dihydroxyketones (Scheme 77).  The omission of ThDP rules out the 
mechanistic involvement of ThDP via the thiazolium ylid, and indicates that 146 was 
promoting the carbon-carbon bond forming reaction.98 Initial results involving 146 were 
promising, although the problems encountered were the presence of unreacted 
aldehyde after the course of the reaction monitored by TLC and the sluggish nature of 
the reaction requiring at least 72 hr at rt. 
146, 48 h,  rt
O
N
S
O
O
O Na
CO2
R H
O
OH
OH
O
+ ROH
O
O
LiO
Li-27 30 146
 
Scheme 77: Biomimetic reaction using 146 as catalyst 
 
In light of these recent findings the aim of this part of the project was to investigate this 
novel one pot synthesis of racemic ketodiols, in terms of the substrate scope of the 
reaction.  A variety of aldehyde acceptors were used: aromatic and aliphatic aldehydes. 
Optimisation studies and preliminary mechanistic studies were performed. Novel 
catalysts were synthesized and investigated for asymmetric induction in the biomimetic 
TK reaction. 
 
5.1.1 Biomimetic TK research performed prior to PhD studies 
 
To date a variety of acceptor aldehydes have been screened for biomimetic activity 
using MOPS and N-methylmorpholine (NMM).  The aliphatic aldehydes in particular 
afforded moderate yields from 20-40%, however, aromatic aldehydes with electron 
donating and withdrawing substituents have been shown to be poor acceptors and 
gave products in poor yields <10%.  The effect of pH was found to be crucial for 
ketodiol synthesis and the reaction proceeded at pH 7.0-9.0, however, pH 8.0 is 
preferential for greater yields. The reaction can be performed at room temperature and 
requires approximately 24-48 hours for completion.  For reduced reaction times to <12 
hours the temperature was increased to 30 ºC to 40 ºC.  Several co-solvents have 
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shown a marginal increase (≈ 4%) in ketodiol production using a 1:1 THF:H2O or 1:1 
CH3OH:H2O mix, but most importantly it provided miscibility between the catalyst that is 
often insoluble in water and the water-soluble hydroxypyruvate substrate donor.   
 
Thus far several organocatalysts were screened in preliminary investigations.  DABCO 
147, DBU 148, 3-hydroxyquinuclidine109 149 and (R)-(-)-2-pyrrolidinemethanol 151 
were chosen for their catalytic properties in the Baylis-Hillman reaction110. L-Proline 150 
was selected as it is known chiral organocatalyst in the aldol condensation reaction.111 
An imidazolidinone (Macmillian) catalyst 152 used in asymmetric Diels-Alder reaction 
was also screened.112 The results suggested catalysts containing a secondary amine 
motif were less successful in generating ketodiol products than the tertiary amine 
catalysts (Table 30).   
 
Catalyst  Structure Yield % 
 
147 
N
N
 
 
17% 
 
148 
N
N
 
 
0% 
 
149 
N
OH
 
 
27% 
 
150 NH O
OH
 
 
1% 
 
151 NH
OH
 
 
1% 
 
152 
N
N
H
O
Ph HCl 
 
0% 
 
Table 30: Catalysts used for the biomimetic TK reaction 
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5.2 Preparation of lithium hydroxypyruvate as a ketol donor from bromopyruvic 
acid 
 
Srere et al, demonstrated that β-hydroxypyruvic acid is a useful donor with potential to 
drive the equilibrium to completion in the TK reaction.  The relatively high cost involved 
in the preparation of β-hydroxypyruvic acid is one limitation in a large scale synthesis 
using this reaction.  An alternative is synthesis of the lithium salt which has been 
reported113 but poor overall yields are typically observed (23% on a 2.5 g scale) and the 
salt has a low concentration in water (2.5 g from 235 ml of water).  The reaction 
procedure has been modified to omit the recrystallisation step to generate lithium 
hydroxypyruvate Li-27 with a two fold increase in yield (51 %).52  Thus, to 10.0 g of β-
bromopyruvic acid dissolved in 100 ml of water, 1 M lithium hydroxide solution was 
added at such a rate the pH did not exceed pH 9.5.  Studies suggested that within the 
pH range 7-10, a hydroxyl group is deprotonated from the gem-diol 153 which then 
initiates the elimination of the bromine 154 (Scheme 78).47 
OH
Br CO2 LiO H
OH
OH
Br CO2 LiO
H2O+
Slow
O
O CO2 Li
H Br
OH
HO CO2 Li
HO 2H2O
Fast
Ketogem-diol
153 154
 
Scheme 78: Mechanistic investigation of the formation of Li-27 
 
Subsequent reported attempts to produce Li-27 led to comparatively low yields and in 
some instances the precipitation of by-products from the reaction mixture, such as 
lithium bromopyruvate.52 It was found to be essential that the pH level remained in the 
critical region of pH 7-10 as increasing the basicity of the reaction mixture further by a 
small amount lead to the onset of a slow aldol condensation reaction.47  Conversely if 
the reaction mixture was too acidic, the intramolecular nucleophilic substitution SN2 
reaction does not occur (Scheme 79). 
 
Following the literature procedure for the preparation of Li-27 from Turner et al.52 was 
carried out by stirring β-bromopyruvic in the presence of 1 M lithium hydroxide solution 
for an hour at pH 9.3 and then adjusted to pH 5.0 using glacial acetic acid.  The lithium 
hydroxypyruvate present in solution was concentrated in vacuo and left to crystallise 
overnight.  Li-27 is practically insoluble in ethanol, thus by washing the crude product 
isolated with ethanol any starting material was removed from product.  The white solid 
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was filtered and dried in vacuo to generate >95% pure Li-27 (46 %) as a white powder 
Li-27 was characterised by 1H NMR and appeared to be hydrated in D2O.  However 
13C NMR spectroscopy revealed there to be six different 13C environments present in 
solution.  Three quaternary peaks were indicative of carbonyl groups at 203.0, 177.0 
and 167.9 ppm.  This implied that the Li-27 salt exists in solution with the keto- 156 and 
the gem-diol 155 form (Fig. 56).   
 
O
HO CO2 Li
OH
HO CO2 Li
HO
Ketogem-diol
155 156
 
Figure 56: Li-27 exisitng in gem-diol and keto form 
 
The presence of a gem-diol had also been acknowledged by earlier research 
conducted by Bellamy and Williams114 on a similar system which showed that pyruvic 
acid existed in the keto form 158, whilst the lithium monohydrate salt was in the gem-
diol form 157 (Fig. 57). 
 
O
CO2H
OH
CO2 Li
HO
Ketogem-diol
157 158
 
Figure 57: Pyruvic acid and lithium monohydrate salt in different forms 
 
Fortunately the formation of the gem-diol 155 is in equilibrium in solution with its keto-
tautomer 156 and there is no mention in the literature of any problems in using the 
lithium-salt substrate Li-27 in biotransformations.  
 
5.2.1 Other alkaline metal hydroxypyruvates and their reactivity in ketodiol 
synthesis 
 
Other alkaline metal hydroxypyruvates were synthesized from the corresponding metal 
hydroxides using a similar procedure to that used for Li-27 preparation (Scheme 79).   
OH
O
O
XO
27
1) XOH(aq)
2) AcOH
Br
O
O
HO X = Li+, Na+, K+, Cs+
159
 
Scheme 79: The formation of hydroxypyruvate salt 
 
The percentage conversion from the bromopyruvate 159 to the desired hydroxpyruvate 
increased down the alkaline metal series and the colour of the crystals changed from 
white with Li-27 to brown cesium hydroxypyruvate Cs-27.  This may possibly due the 
 117 
small traces of impurities.  All alkaline hydroxypyruvate salts displayed the same 1H 
NMR resonances in D2O as the lithium salt; an approximate 55: 45 ratio in favour of the 
‘keto’ form over the ‘gem-diol’ form.  The hydroxypyruvate salts were investigated 
separately by reacting the substrates with cyclohexanecarboxaldehyde (1.0 equiv) in 
the presence of N-methylmorpholine (1.0 equiv) dissolved in water (50 mM 
concentration) for 48 h.  The ketodiol yields from the various hydroxypyruvate salts 
implied the varying degrees of reactivity in aqueous solution (Table 31). Thus, the 
cation must serve an important function to facilitate the carbon-carbon bond forming 
reaction. The Cs-27 salt was reacted with cyclohexanecarboxaldehyde in the presence 
of NMM in water, and the product 30v was formed in 50% yield.  A significant 30% 
increase in comparison with the lithium salt.  This could be a result of counterion 
effects; the lithium ion is smaller and has a greater charge density than cesium and has 
the ability to polarise anions and induce a more covalent character.  Cesium with its 
low charge density and its large polarisability differs with other alkali metal salts; with 
the lowest degree of solvation properties and ion pairing.   
 
NMM, 48 h,  rt
CO2
H
O
OH
OH
O
+ OH
O
O
XO
Li-27 30v
 
X Formation of HPA salt 
% 
30v 
% 
Lithium 46 25 
Sodium 20 29 
Potassium 72 38 
Cesium 100 50 
 
Table 31: The formation of HPA salt and the ketodiol product 30v 
 
5.3 Aliphatic aldehydes as acceptor molecules for the biomimetic TK reaction 
 
There have been few reactions reported between aliphatic aldehydes and α-keto acids 
in the literature.115  One example is the reaction between pyruvic acid and aliphatic 
aldehydes to yield α-keto-γ-hydroxy acid 160 in a polar solvent48 via a direct aldol 
condensation reaction (Scheme 80). In acidic conditions 160 cyclizes to a lactone 161, 
and in basic conditions to an α-keto-β,γ-unsaturated acid 162 (Scheme 80).48,116,117 
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Scheme 80: The direct aldol condensation of pyruvate and an aliphatic aldehyde in polar solvent 
 
However when Li-27 was used in the reaction with propanal in the presence of 146 
(MOPS) the formation of the α-α’ dihydroxyketone was observed (30s, 18%).  The 
addition occurred at the α-keto carbon of the acid evolving carbon dioxide during the 
reaction (Scheme 81).  The requirement for a tertiary amine such as 146 suggested 
that the mechanism mimics the transketolase reaction (See Chapter 3 and 4). 
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Scheme 81: Reactions of α-keto acids 
 
The reaction between Li-27, propanal with MOPS 146 in a non-buffered media was a 
slow reaction requiring at least 48 h to generate 30s in a low yield.  It had been found 
after screening amines containing similar heterocyclic rings that N-methylmorpholine 
(NMM) also promoted the carbon-carbon bond forming reaction with better yields.  
Therefore both MOPS 146 and predominantly NMM were used as the catalysts in this 
investigation.   
 
Other aliphatic aldehydes were used to synthesize racemic ketodiols as useful tools for 
chiral assay development and as acceptor substrates for the TK reaction.  The reaction 
mixture was stirred using stoichiometric amounts of catalyst NMM, Li-27 and aldehyde 
to generate ketodiol products in low yields ranging from 10-25% (Table 32). 
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NMM, 48 h,  rt
CO2
R H
O
OH
OH
O
+ ROH
O
O
LiO
Li-27 30
 
R 30 Yield % 
 
s 22 
O
 
w 25 
 
v 10 
 
 
x 25 
 
y 25 
 
 
Table 32: The TK biomimetic reaction of ketodiol 30 
 
In all cases with aliphatic aldehydes traces of by-products under non-adjusted pH 
conditions were observed which were easily removed by purification using column 
chromatography.  Cyclohexanecarboxaldehyde was the aliphatic aldehyde of choice for 
further mechanistic studies, biotransformations and the investigations into asymmetric 
biomimetic reactions. 
 
5.4 Aromatic aldehydes as acceptor molecules for the biomimetic TK reaction        
 
The reaction was also carried out using benzaldehyde with Li-27 in non-pH adjusted 
reaction mixtures involving NMM, and was left to stir for 48 h.  The ketodiol was not 
produced instead an isomer was isolated (110 rearranged, 5%). 
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Scheme 82: The formation of ketodiol product 30Ar1 and the rearranged product 110 
 
Spectrum A (Fig. 58) shows the expected 1H NMR spectra of the ketodiol product 
30Ar1 with the distinctive AB system diastereotopic protons HA and HB at 4.30 and 4.38 
ppm.  A singlet at 5.36 ppm is the α-H.  Spectrum B (Fig. 58) shows the ABX system, 
indicating the rearrangement of 30Ar1 to form 110. The methylene protons HA and HB 
are still diastereotopic but the coupling pattern has changed due to the coupling with 
the α-H on the adjacent carbon. 
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Figure 58: 1H NMR of 30Ar1 and 110 
 
The desired ketodiol was however synthesized using NMM at an adjusted pH 7.0 for 
over 48 hours (30Ar1, 5%).  The Cs-27 donor substrate was also investigated in the 
presence of benzaldehyde (1.0 equiv.) and NMM (1.0 equiv.) and reaction was 
maintained at pH 7.0 obtaining 30Ar1 in 10% yield.  The rearranged product 110 could 
be formed via the desired ketodiol 30Ar1 due to the acidity of the α-H and formation of 
the enediol 164 which tautomerises to form the preferred oxo tautomer 165 in 
conjugation with the benzene ring (Scheme 83).  Most important of these initial findings 
was the rearrangement of the isolated ketodiol after one week in water rearranging to 
the more stable constitutional isomer 165. Further investigations involved the use of 
benzaldehyde as the aromatic aldehyde of choice for use in biocatalytic ketodiol 
synthesis. 
 
 
 
A 
B 
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Scheme 83: Mechanism for the rearrangement of ketodiol to generate 165 
 
Other aromatic aldehydes were used as substrates for the biomimetic TK reaction 
(Table 33).  The aromatic ketodiols generated were further used as tools for the 
development of an HPLC assay. The biomimetic reaction with 2-phenylpropion-
aldehyde as the acceptor substrate to generate ketodiol 30Ar4 was determined to be 
anti-diastereoselective (4:1) at pH 7.0 (Chapter 4).  The yields varied in range from 4-
20% with small amounts of isolated ‘rearranged products’ 110a and 110d. 
R
O
OH
OH
110
R H
O
OH
OH
O
+ R +OH
O
O
LiO
Li-27 30
THF:H2O,
 pH 7.0
NMM
 
R Yield (%) 
 
O
 
 
30Ar2 (4) 
110a (2) 
 
 
 
30Ar3 (15) 
110b (0) 
 
 
30Ar4 (20) 
110c (0) 
S
 
30Ar5 (4) 
110d (1) 
MeO
 
 
30Ar6 (5) 
110e (0) 
OMe  
 
30Ar7 (5) 
110f (0) 
 
Table 33 Aromatic aldehydes used in the biomimetic TK reaction conducted pH 7.0 
5.5 Mechanistic implications 
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5.5.1 Postulated reaction mechanism 
 
To date, a reaction mechanism has been proposed to be reminiscent of the Baylis-
Hillman reaction.118  The catalyst used is a tertiary amine and what is proposed is the 
formation of the quaternary amonium enolate 168 which has been described in 
cyclopropanation reactions.119  Thus the carbanion enolate 166 or tartronic acid semi 
aldehyde 167 is formed leading to the conjugate addition of the amine.  The presence 
of another heteroatom or an alcohol side chain in the tertiary amine may through 
hydrogen bonding stabilize enolate. Addition of the aldehyde 169, proton transfer to 
yield 170, subsequent elimination of the tertiary amine and decarboxylation at the end 
of the reaction releases the racemic ketodiol (Scheme 84). 
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Scheme 84 Postulated biomimetic reaction mechanism 
 
5.5.2 NMR investigations using bromopyruvate and hydroxypyruvate 
 
In order to understand why these substituted pyruvates, hydroxy- and bromopyruvate 
react differently in situ, the nature of the anions was monitored under aqueous 
conditions.  Fisher et al. (1982)120 have reported the predominant structure for 3-
bromopyruvate in D2O is the hydrated gem-diol form.  The evidence was based upon 
UV spectroscopy and reported an equilibrium constant of 1.84.121  This equilibrium can 
also be observed via a number of 1H NMR observations taken in D2O.  Rather than a 
single resonance of the methylene protons, two resonances are observed for Li-27; a 
large signal at δ 3.71 ppm and a smaller signal at δ 4.61 ppm.  The two methylene 
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protons are chemical shift equivalent and these two resonances must derive from 
different ‘forms’ of bromopyruvate, most likely the ‘keto’ and the hydrated gem-diol 
form.  Thus, the methylene protons of the keto form are at δ 3.71 ppm and those of the 
gem-diol at δ 4.61 ppm, a ratio 1:21 in favour of the gem-diol at pH 2.61 (Fig. 59, 
spectrum B).  At a higher pH the relative intensities of the keto form only slightly 
increased to 15% at pH 7.35.   
 
Fischer concluded that nucleophilic attack of H2O or -OH on the 3-halogen position in 
comparison with hydration was slow in all cases.  All the α-hydroxypyruvate alkaline 
metal salts synthesised, yielded two resonances, singlets at δ 4.60 ppm (keto) and δ 
3.54 ppm (gem-diol).  In comparison with 3-bromopyruvate, the ratio of these two 
peaks were at approximately 1:1, in slight favour of the keto form at pH 7.50 (Fig. 59, 
spectrum B). The differences between the 3-bromopyruvate and the α-
hydroxypyruvate, is not unexpected, however the electron withdrawing halide in 
bromopyruvate will facilitate attack by water on the keto carbon.  Reports have 
conducted that the gem-diol species is the predominant form in fluoropyruvate at pH 
6.3 (gem-diol:keto ratio, 6:1), but not evident in pyruvate itself.   
 
 
 
 
 
  A 
 
 
 
 
 
 
 
 
  B 
 
 
 
 
 
 
 
 
Figure 59: (A) bromopyruvate, pH 2.61; (B) alkaline 
metal- HPA salt, pH 7.50 
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The degree of gem-diol formation by the respective anions at the 3-carbon position can 
be viewed as a measure of the reactivity on the carbonyl carbon, since the gem-diol is 
formed from the attack a of weakly nucleophilic water molecule as a result of the 
electron-withdrawing effect of the substituents on the third position.  The order F > Br > 
OH > H is in fact observed (Fig. 60).   This ordering of substituent electronegativities 
and gem-diol formation by the respective anions can be used to explain the apparent 
limitations of Li-27 as donor affording moderate ketodiol yield and also predict whether 
fluoropyruvate and pyruvate could be potential donors.  The electron withdrawing 
substituents determines the reactivity of the carbonyl carbon towards nucleophilic 
attack by both an amine and water present in situ.  Thus the keto-moiety in 3-
bromopyruvate is too reactive and predominantly hydrating, effectively removing most 
of the reactive keto form from solution by preventing the formation of the postulated 
quaternary carbanion enolate 168 (Scheme 84), leading to the conjugate addition of 
the tertiary amine catalyst.  In comparison, approximately 55% of Li-HPA exists as the 
‘keto’ form and is less readily hydrated than 3-bromopyruvate affording low to moderate 
ketodiol yield dependent on the alkaline metal HPA salt synthesised.   
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Figure 60: The major forms of pyruvates existing in water 
 
However a preliminary investigation, has recently reported pyruvate (the free acid) and 
the sodium salt failed to give any reaction under these biomimetic conditions.16 In light 
of these findings, there is a need to reassess the model by further consideration of 
different α-keto acid substrates; notably on the free acid or the salt equivalent.  It 
appears the hydroxyl- group and the availability of the keto grpup is an essential 
requirement on the 3-position and must stablise the quaternary carbanion enolate 168, 
similar substituted pyruvates with similar electron withdrawing properties could be 
considered as well as the effect of the hydroxyl-group on a longer carbon chain 
analogue (Fig. 61). 
HO
O
O
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Figure 61 A donor acceptor substrate  
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5.5.3 Synthesis of [1-2H]-cyclohexancarboxyaldehyde and its use in ketodiol 
synthesis 
 
To further elucidate our understanding of the proposed mechanism, a deuterated 
aldehyde was synthesized to investigate any deuterium exchange after coupling of the 
aldehyde (Scheme 85). The initial methodology for synthesizing the deuterated 
aldehyde for mechanistic studies required a two step synthesis, involving the reduction 
of the commercially available cyclohexanecarboxylic acid with lithium aluminium 
deuteride (LiAlD4) to obtain the deuterated alcohol 173 in 70% yield.  The alcohol was 
subjected to mild oxidative conditions using pyridinium chlorochromate (PCC).  Several 
difficulties ensued with the separation of the unreacted alcohol, the deuterated 
aldehyde product 176, and traces of the over-oxidised carboxylic acid.  To rectify this 
problem, an alternative route via the Weinreb amide122 was investigated avoiding the 
problem of over-reduction to the alcohol due to a highly stable metal-chelated 
intermediate. Benzotriazol-1-yloxy)tris(dimethylamino)-phosphonium hexafluorophos-
phate (BOP) was used as a coupling reagent with cyclohexanecarboxylic acid to 
synthesize the Weinreb amide product 56, in 75% yield.  However to scale up the 
reaction the high cost of BOP led to the use of an alternaive method.  Instead, 
cyclohexancarbonyl chloride 174 was reacted directly with the N,O-dimethyl-
hydroxylamine  hydrochloride in the presence of N,N-diisopropyl-ethylamine (DIEA) to 
obtain the Weinreb amide 175 in quantitative yield.  This was then reduced using 
lithium aluminium deuteride (LiAlD4) to the aldehyde 176. Some unreacted starting 
material was readily removed by an acidic workup to give the pure aldehyde in 65% 
yield.  
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O
N
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     65%
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      100%
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Scheme 85: Formation of deuterated aldehyde 176 
 
The biomimetic reaction using the newly synthesised deuterated aldehyde 176 with Li-
27 in the presence of NMM as catalyst (Scheme 86) was investigated at two different 
pHs; at pH 8.0 (maintained using a pH stat autotitrator), and an unadjusted pH which 
was monitored after 48 hours was pH 9.7. 
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Scheme 86: Biomimetic reaction involving deuterated aldehyde 
 
The 1H NMR spectral data of product 30y at different conditions were collated and 
revealed an AB system with diastereotopic protons at δ 4.75 ppm (HA) and δ 4.35 ppm 
(HB) as usual, with α’-H proton at a was observed at δ 4.15 ppm (Fig. 62, spectrum A). 
When using 176 at pH 8.0 (Fig. 62, spectrum B) the α-H absorption was absent from 
the 1H NMR at δ 4.15 ppm of 30yD.  This implied there was no apparent deuterium 
exchange after coupling 
 
 
This was further verified by the 13C NMR data and splitting by the deuterium nucleus of 
the single at δ 80.8 ppm into a triplet (J 25.0 Hz).  At pH 9.7 notable deuterium 
exchange at the α-H with a small amount 1:16 (D:H) deuterium transfer occurring 
implying a slow epimerisation.  Also that tautomerisation at a is not involved in the 
biomimetic mechanism.  This highlighted that although the C-H bond is weaker than C-
D, at pH <9 epimerisation is unlikely to occur and application in a biomimetic 
asymmetric reaction is worthwhile exploring. 
 
 
 
Figure 62: 1H NMR spectra of ketodiol production with 
aldehyde (A); generated ketodiol product at pH 8.0 with 
176 (B); and at pH 9.7 with 176 (C) 
A 
B 
C 
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a
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5.5.4 Deuterium oxide experiments used in ketodiol synthesis 
 
In the biomimetic reaction, metal-hydroxypyruvate salts are soluble in aqueous solution 
and the reaction can proceed successfully if the catalyst and aldehyde are 
homogenous in solution.  Continuing with our on-going mechanistic investigations, the 
reaction was conducted in D2O to investigate the nature of the carbanion or enol 
intermediate 166 upon conjugate addition of the tertiary amine. The D2O reactions 
investigated were at pH 7.0 and pH 8.0 adjusted by a pH stat autotitrator, injecting 
small amounts of 1 M hydrochloric acid if the reaction became slightly basic.  Therefore 
some residual H2O would be present in the reaction (Fig. 63). 
 
 
 
The spectral data of the control reaction conducted in water at pH 8.0 demonstrates a 
clear symmetrical integration of the diastereostopic protons HA and HB in due to the 
(Fig. 63, spectrum A).  The product isolated from the D2O reaction mixture at pH 7.0 
revealed the introduction of deuterium due to the reduced integration of the 
diastereotopic protons compared to α’-H proton at a and the unsymmetrical broadening 
of these absorption peaks due to geminal coupling CH-D.  The increase of pH led to an 
increase in rate of deuterium exchange of the diastereotopic protons as expected, as 
indicated by the severe broadening of the peaks and further reduced peak integrations.  
Figure 63: NMR spectra of ketodiol 
production (A) H2O solution at pH 8.00; (B) 
D2O solution at pH 7.00; (C) D2O solution at 
pH 8.00 
A 
B 
C 
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The products determined by mass spectrometry reveal the presence of compounds 
30yDH, 30yDD and 30y (Fig. 64). 
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Figure 64: Deuterated containing compounds 30yDH and 30yDD 
 
So, by increasing the pH between the values 9-10 will complete the deuterium 
exchange at the diastereotopic protons.  The D2O experiments would be in agreement 
with the formation of the carbanion enolate or enol intermediate 166 prior to the 
addition of the tertiary catalyst.  However deuteriums exchange could also occur after 
30y is formed in D2O media.  Another experiment in D2O was carried out using 30y in 
the presence of NMM (1.0 eq.) only to assess tautomerisation at 166.  These separate 
D2O solutions were maintained at pH 7.0 and pH 8.0 and were left to stir for 2 days. 
 
There is a possibility that deuterium exchange can occur at either the α-H or the 
diastereotopic protons as two enolates can be formed.  It was expected (c.f. 1, 3-
dihydroxypropiophenone) that the α-H is the more acidic, and would lead to enolate 
formation under thermodynamic control.  However, formation of the kinetic enolate was 
observed due to the less sterically crowded α-protons generating 30yDH and 30yDD 
(Scheme 87).  The resulting spectra obtained were comparable to that of spectra B and 
C (Fig. 63), and no enolization of the α’-H at a was observed leading to 30yD.  More 
deuterium labelled experiments maybe required to elucidate the mechanism further. 
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Scheme 87: Pathway favoring kinetic enolate 30yDH and 30yDD 
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5.6 Cinchona alkoloid catalysts for ketodiol synthesis  
 
Cinchonine 177, cinchonidine 178, quinidine 179 and quinine 180 are members of the 
cinchona alkaloid family that are commercially available at low costs (Fig. 65).123  They 
are comprised of two ring structures, quinoline and the nucleophic quinuclidine core, 
comparable in nucleophilicity to that of piperidine, pyridine and morpholine towards 
carbonyl containing molecules.124  The β-hydroxyamine part of the molecule is 
responsible for inducing stereoselectivity, in theory if cinchonine affords one 
enantiomer via catalysis, cinchonidine generates the opposite enantiomer with 
comparable enantioselectivities. The structure of the cinchona alkaloids and its shelf-
life chemical stability makes it a suitable molecule for use in asymmetric synthesis, and 
they were selected for use in the biomimetic reaction. 
 
N
OH
N
R
N
OH
N
R
R =H, Cinchonine (177)
R = OMe, Quinidine (179)
R = H, Cinchonidine (178)
R= OMe, Quinine (180)
 
Figure 65: The cinchona alkoloids 
 
The first cinchona alkaloid screened as a ‘catalyst’ was quinidine 179 (1.0 mol equiv), 
together with Cs-27 (1.0 mol equiv) and cyclohexanecarboxaldehyde (1.0 mol equiv.) 
in aqueous media.  The poor solubility of quinidine led to the reaction being stirred 
vigourously for 72 hours.  However, only a trace amount of ketodiol product was 
detected by TLC analysis.  This problem was circumvented by the introduction of a co-
solvent capable of dissolving the catalyst that was also miscible with water.  The 
reaction mixture was comprised of a THF:water (1:1) solution which provided an overall 
homogeneous system for ketodiol synthesis.  The ketodiol product was detected by 
TLC after 6 hours and was isolated after 24 hours, affording ketodiol product 30y in 
15% yield.   
 
THF:H2O, rt
       15%
+
OH
O
OH +
179 (1.0 eq.) CO2H
O
91 30y
OH
O
O
CsO
Cs-27
 
Scheme 88: Using quindine as a catalyst for biomimetic TK reaction 
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Ketodiol 30y formed using quinidine (1.0 equiv.) was acetylated uder standard 
conditions using pyridine, with the presence of acetic anhydride with catalytic amounts 
of DMAP.  The acetylated ketodiol 99 analysed using chiralpak-AD column at a 1 ml 
min-1 flow rate, eluting with a hexane:isopropanol (98:2) isochratic solvent system.  The 
isomers were detected and successful separated at 12.0 mins and 13.6 mins with 
equal integrations (Fig. 66, spectrum A).  The ketodiol product resulting from the 
quinidine 179 reaction was subjected to acetylation and analysed via HPLC.  A racemic 
mixture was detected with two peaks at 12.0 min and 13.9 min of equal integration (Fig. 
66). 
9930y
O
O
O OO
py, AcO2
100%
OH
OH
O
(3:1)
 
Scheme 49: Acetylation of 30y to generate 99 
 
Figure 66: Diacetylated racemic ketodiol product (A) and quinidine catalysed product (B) 
 
Initially, the cinchonine-catalysed ketodiol product formed using the same reaction 
conditions as for quinine 180 showed some degree of enantioselectivity (Fig. 65, 
spectrum B), in favour of the isomer with the faster eluting time.  It was calculated that 
approximately 70-75% ee of the major isomer was apparently achieved.   
 
Another analytical tool for elucidating the presence of enantiomeric excess is via the 
use of a chiral derivatising agent as previously described; (S)-(–)-α-methoxy-
α(trifluoromethyl)-phenylacetic acid (S)-MTPA was used to form the Mosher’s ester 
(Scheme 89).74  
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Scheme 89: Formation of the Mosher’s ester 101 
A 
B 
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The enantiomeric excess can be determined approximately by the differing chemical 
shifts of Ha and Hb and integrations of these signals in the 1H NMR spectra. The 
cinchonine- catalysed ketodiol product was reacted with N,N’-dicyclohexy-lcarbodiimide 
(DCC) and (S)-MTPA to form the Mosher’s ester at the primary alcohol position 101 in 
67% yield.  Surprisingly the integration from the coupling pattern of the diastereotopic 
protons revealed the presence of a racemic product (Fig. 67).  A further sample of the 
ketodiol genereated from quinindine 177 was acetylated again and analyzed via HPLC 
which verified the cinchonine ketodiol product 30y was indeed racemic. 
 
 
Various attempts have been made to reproduce the initial results indicating high ees, 
solutions containing, 5 mol%, 10 mol%, and 50 mol% of the cinchonine catalyst were 
screened but racemic ketodiol products 30y were again detected via HPLC and upon 
formation of the Mosher’s ester. The concentration of the reaction mixture was also 
investigated, including the standard 50 mM solution to 100 mM, 200 mM and 500 mM 
concentrations, each affording racemic products of 30y, via acetylation and HPLC 
analysis.   
 
It was concluded that a contaminant may have masked the true HPLC data.  The 
acetylated ketodiols were measured at a wavelength of 214 nm, using a 10 µl injection 
sample, and one problem associated with acetylated ketodiols was the low sensitivity 
when detecting the signals.  A larger experimental error may therefore ensue and the 
peaks were sometimes difficult to resolve.  This was circumvented by benzoylating the 
ketodiol product with a more readily detectable chromophore (See chapter 3).  The 
mono-benzoylated ketodiol product 100, gave a better detection sensitivity and 
resolution between the enantiomers increased, but with longer eluting times at 12.0 
and 13.6 mins under isocratic conditions (hexane:isopropanol; 97:3). 
 
The biomimetic TK reaction using stoichiometric amounts of quinine 180 catalyst in a 
1:1 THF:H2O reaction solution was performed resulting in a 17% product yield.  Other 
Figure 67: Racemic mixture of Mosher’s ester 30y 
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reaction condition, involved reducing the catalyst loading to 20 mol%.  The reaction 
became sluggish, but ketodiol was obtained after 48 hours in 5% yield. The ketodiols 
were benzoylated and the 10 µl sample was analysed by HPLC which revealed a 5% 
ee (R-isomer) for the reaction conditions using 20 mol% quinine as catalyst compared 
to the racemic ketodiol product generated when 1.0 equiv of quinine was used (Fig. 
68).   
 
Figure 68: The HPLC trace of quinine catalysed biomimetic reaction  
 
5.6.1 Synthesis of cinchona alkaloid catalysts 
 
The preliminary findings, prompted us to investigate other cinchona alkaloid analogues 
previously used in asymmetric catalytic reactions.  Thus compounds 181-183 were 
synthesized from quinine by modification of the hydroxyl group to the ether 182, 183 or 
to the formation of the ester.181, as previously described (Scheme 90).125 
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Scheme 90: Formation of quinine analogues 
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5.6.2 Organocatalytic TK reaction using the cinchona alkaloid catalysts 
 
The biomimetic reactions were performed with the synthesized cinchona alkaloids 
using 1.0 equiv. or 20 mol% of catalyst in a 1:1 THF:H2O solution. The reactions were 
stirred for 48 hours and purified as before by silica chromatography using a 1:1 
EtOAc:hexane solvent system. The isolated ketodiols were benzoylated and inspected 
under HPLC conditions previously described. The results reveal the products were 
formed in low yield with poor ees obtained. Reducing the catalyst loading lowered the 
yield approximately two-fold. The addition of a bulky side group on the hydroxyl moiety 
increased the ees (Table 34, 183, 20 mol%). 
 
+
OH
O
OH +
THF:H2O, rt
cat. CO2H
O
91 30y
OH
O
O
LiO
Li-27
 
Catalyst  Conversion (%) ee (%) Major isomer 
181, 1.0 eq. 18 8 (R) 
181, 20 mol% 7 4 (S) 
182, 1.0 eq. 15 4 (R) 
182, 20 mol% 4 3 (S) 
183, 1.0 eq. 14 0 - 
183, 20 mol% 5 19 (R)- 
 
Table 34: Biomimetic reaction with acceptor aldehyde 91 with various catalysts 
 
The absolute stereochemistry of 30y, was determined by comparing the HPLC analysis 
from the biotransformation product of mutant D469T TK (Fig. 69) (see previous chapter 
3). 
 
Figure 69: The HPLC trace of the biomimetic reaction using catalyst 183, 20 mol% 
 
Following the proposed mechanism and formation of the zwitterionic species, the 
approach of the aldehyde leads to two diastereomeric transition states that can predict 
the isomer formed. The model suggests the role of the hydroxyl groups in HPA is to 
lock the conformation of the complex by hydrogen bonding to one of the lone pairs of 
N
OBn
N
OMe
183
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the aldehyde carbonyl, but also lowers the energy of the transition state by stabilising 
the negative charge developing on the oxygen atom during the addition. The function of 
the benzyl group which gave the 19% ee is not clearly understood, but presumably due 
to steric interaction may interfere with the addition of the aldehyde to the zwitterionic 
complex (Fig. 70). 
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Figure 70: A postulated intermediate for the generation of ketodiol using 183 
 
Preliminary investigations involving commercially available cinchona phase transfer 
catalyst N-benzylcinchoninium chloride was also investigated, however no product was 
generated.  This is presumably due to problems with quaternisation of the nucleophilic 
tertiary amine moiety.  Other commercially available cinchona ligands; (DHQD)2PHAL 
and (DHQD)2AQN were screened, both affording poor yields of 30y (1%) and ees (3%) 
(Fig. 71). 
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Figure 71: Screening of commercially available cinchona alkaloids 
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5.7 Chiral diamine catalysts for ketodiol synthesis 
 
Further screening of catalysts for the biomimetic reaction, highlighted the importance of 
a tertiary nucleophilic moiety. A class of catalysts investigated were chiral diamines as 
they have been developed by Mukaiyama et al. as effective chiral ligands and effective 
catalysts;126 these can also be used for kinetic optical resolutions as developed by 
Oriyama et al.127  Most recently chiral diamines have been shown to promote the 
Baylis-Hillman reaction enantioselectively, giving good yields and moderate to good 
ees of up to 75% (Table 35, 184a-c). 
R
OOH
R
O
H
O N
N
Me
+
EtOH, 0 C°
cat.
184
 
R 184 Time (d) Yield % Optical Yield % 
O2N  
 
a 
 
2 
 
70 
 
65 
Cl
Cl
 
 
b 
 
3 
 
72 
 
75 
Br
 
 
c 
 
4 
 
 
67 
 
69 
 
Table 35: The reactions were conducted with 30 mol% of the diamine, 1.0 eq. of aldehyde and  
5.0 eq. of methyl vinyl ketone in EtOH at 0 ºC 
 
Chiral diamine catalysts have also been used in direct asymmetric aldol reactions in 
water.128  The catalysts have been designed with appropriate hydrophobic alkyl chains, 
to assemble hydrophobic reactants in water and sequester the transition state from 
water in the presence or absence of additives. A newly discovered diamine/TFA 
bifunctional catalyst system (Scheme 91) has demonstrated excellent reactivity, 
diastereoselectivity and enantioselectivity in water (Table 36, 185a-c).  
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Scheme 91: Catalyst used in direct aldol condensation 
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R 185 time (h) yield % anti:syn ee % 
NC  
 
a 
 
48 
 
99 
 
86:14 
 
87 
MeO2C  
 
b 
 
48 
 
89 
 
90:10 
 
91 
Br
 
 
c 
 
72 
 
43 
 
91:9 
 
97 
 
 
Table 36: Diamine/TFA-catalysed aldol reaction with various arylaldehydes in water 
 
5.7.1 Synthesis of chiral diamine catalysts for the biomimetic TK reaction 
 
The effective use of chiral diamine catalysts in water reported by Barbas III et al. 
prompted investigations with variety of catalysts containing the pyrrolidine ring motif. 
The diamine catalysts were synthesized from (S)-Boc-proline using DCC in the 
presence of a primary/secondary amine.  After 24 hours the insoluble urea by-product 
was removed by filtration followed by an acid/base wash before purifying the product 
by silica gel chromatography to form the amide 187a-f in yields ranging from 75 to 88% 
(Table 37). 
N
Boc
O
OH
DCC
CH2Cl2
NHR1R2+
N
Boc
O
NR1R2
186 187
 
NHR1R2 187 yield % 
 
NH
 
 
a 
 
85 
 
NH
 
 
b 
 
89 
O NH
 
 
c 
 
83 
NH
 
 
d 
 
90 
H
N
O
OMe
 
 
e 
 
76 
HN
 
 
f 
 
85 
 
Table 37: Formation of (S)-Boc-proline 
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The amides were then reduced, by heating under reflux with lithium aluminium hydride 
(LiAlH4) to generate the N-methyldiamine catalysts 188a-f in good yields 50-75% 
(Table 38).129,130 
N
Boc
O
NR1R2 N NR1R2
LiAlH4
THF
187 188
 
 
NHR1R2 188 yield % 
 
NH
 
 
a 
 
60 
 
NH
 
 
b 
 
70 
O NH
 
 
c 
 
63 
NH
 
 
d 
 
50 
H
N
O
OMe
 
 
e 
 
68 
HN
 
 
f 
 
75 
 
Table 38: The reduction of the amide 187 to the diamine catalyst 188. 
 
Two N-H diamine catalysts were also synthesized by cleaving the Boc-protecting group 
using 33% HBr in acetic acid and forming the pyrrolidium bromide 189.131 This was 
subsequently heated under reflux lithium aluminium hydride (LiAlH4) to reduce the 
amide functionality and generate the N-H diamines 190a-b in 55-60% yields (Table 
39).132,133 
 
N
Boc
O
NR1R2 N
H
NR1R2
LiAlH4
THFNH
O
NR1R2HBr
HBr/AcOH
187 189 190
 
NHR1R2 190 yield % 
 
NH
 
 
a 
 
55 
 
NH
 
 
b 
 
60 
 
Table 39: Generation of diamine 190 
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5.7.2 Organocatalytic reaction using the diamine catalyst for the TK reaction 
 
Initially the biomimetic TK reaction was conducted in the presence of diamine catalyst 
(1.0 mol eq.), Cs-27 (1.0 mol eq.) and cyclohexanecarboxaldehyde (1.0 mol eq.) in 1:1 
THF:H2O solution.  The reaction was stirred for 48 hours and product was detected by 
TLC analyses and subsequently purified generating 20-30% of the ketodiol product 
30y.  The biomimetic reactions were also performed at reduced catalytic loading (5-20 
mol%),  the reactions appeared sluggish after 48 hours with lower yields (4-10%). The 
reactions with N-H diamine catalysts 190a and 190b (5 mol%) were performed in 
aqueous media in the presence/absence of water stable lewis acid triflates (scandium 
and ytterbium)134 affording low ketodiol yields (1-4%). The ketodiols were then 
derivatised and the ees were determined (Table 40). 
O2C
OH
O
Cs+
OH
O
OH +
1:1 THF:H2O, rt
diamine cat. CO2H
O
14 15
 
 
 Entry catalyst yield % ee% 
1 188a 30 2 
2 188b  26 5 
3 188c 27 5 
4 188d 20 4 
5 188e 21 4 
6 188f 24 5 
7 188a  7 4 
8 188b  10 5 
9 188c  6 4 
10 188d  6 3 
11 188e  4 5 
12 188f  8 4 
13 190a  4 20 
14 190b 3 4 
15 190a/Sc(OTf)3 1 5 
16 190a/Yb(OTf)3 1 4 
17 190b/Yb(OTf)3 1 2 
18 190b/Sc(OTf)3 1 3 
 
Table 40: Entries 1-6; diamine cat. (1 eq.), aldehyde (1 eq.), Cs-27  
  (1 eq.), Entries: 7-12; diamine cat. 20 mol% , Entries 13-14; 
  diamine cat. 5 mol%, H2O solvent, Entries 15-18; diamine  
  cat  5 mol%, Lewis acid (1 mol%) 
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The results revealed that stoichiometric amounts of N-methyldiamines with reactants 
generate product with low ees (<5%).  The increase in the lipophilicty of the diamine 
did not increase product yield.  A reduction in the catalyst loading decreased the 
product yield 2-fold (entries 7-12), which had no effect on the overall ees obtained 
(<5%).  The N-H diamine (entry 13) was found to be the best catalyst with low catalyst 
loading in water affording ketodiol with 20% ee. The presence of a Lewis acid with the 
chiral diamine ligand, had an adverse effect on product yield, with no ee.   
 
The absolute chemistry of the major enantiomer obtained (entry 13) was determined to 
be the (S)-isomer.  Consideration of the zwitterionic species gave an amine conjugate 
intermediate stabilised by the hydrogen bonding of the secondary amine.  A Re 
stereofacial approach of the prochiral aldehyde would lead to the generation of the 
major (S)-isomer 30y (Fig. 72). 
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Figure 72: The proposed reaction intermediate for the generation of (S)-30y 
 
5.7.3 Summary 
 
We have investigated and assessed the substrate tolerance of this novel one pot 
chemical synthesis of racemic ketodiols in aqueous media. The biomimetic reaction 
with aliphatic aldehydes afforded ketodiol yields in (10-25%) and with aromatic 
aldehyde acceptors generating low ketodiol yields in (4-20%) with minor ‘rearranged’ 
byproduct in conjugation with the aromatic ring (4-15%).  The biomimetic reaction with 
2-phenylpropionaldehyde as an acceptor molecule generated syn-stereoselective (4:1) 
ketodiol product at pH 7.0.  The use of Cs-27 as an alternative donor to Li-27 revealed 
an 2-fold increase in ketodiol production with cyclohexanecarboxaldehyde as substrate 
in comparable to a 2-fold increase with benzaldehyde used as substrate.  Preliminary 
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mechanistic investigations were performed enhancing our understanding of the 
reaction mechanism.  Newly synthesized cinchona alkaloid catalysts and diamine chiral 
catalysts in low catalyst loading were screened with cyclohexanecarboxaldehyde in the 
biomimetic reaction obtaining 20% ee.  Designing further chiral tertiary catalysts to 
improve ee is desirable. 
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Future work 
 
We have shown mutant transketolases obtained by directed evolution, with improved 
substrate specificity towards non-natural aliphatic and aromatic aldehydes.  The use of 
a novel, rapid, colorimetric assay for screening biological active mutants in a 96 well 
plate format has successfully identified a number of active mutants, principally D469T 
and D469E with enhanced substrate specificity towards non-hydroxylated aldehyde 
acceptors.  The course of our studies revealed the high enantioselective nature of the 
reaction for cyclic substrates generating (S)-ketodiol products with >99% ees obtained.   
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Scheme 92: Biotransformations using E.. coli TK. 
 
However it would be also desirable to locate TK mutants generating (R)-ketodiol 
products.  The H26Y mutant has been shown to generate the (R)-isomer with propanal 
and other linear aliphatic aldehydes, in comparison to the poor substrate affinity with 
cyclic aliphatic aldehydes.  Further evaluation of the H26 library or other phylogenetic 
TK libraries is required to isolate a mutant or mutants with high substrate affinity for 
cyclic aldehydes generating the (R)-ketodiol product. 
 
We have also reported the first novel aromatic aldehyde substrates accepted by E. coli 
TK mutants D469E, D469K, D469T and G6 with benzaldehyde and furfural affording 
ketodiols in poor yields (1-4%) with the generation of byproducts.  On closer inspection 
it was revealed the byproduct generated from the TK biotransformation with 
benzaldehyde was a ‘double addition product’ 111.  Further investigation into the 
generation of 111 can provide insight into the differences between the mechanistic 
action of aromatic aldehydes in comparison to aliphatic aldehydes as substrates in the 
enzyme’s active site. Performing different reaction conditions to circumvent the 
generation of 111 to obtain the desired ketodiol product 30Ar1 is also worth pursuing. 
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Scheme 93: Generation of ‘double addition product 111’ 
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The TK biocatalytic synthesis of aromatic ketodiols is currently in its infancy, expanding 
the substrate scope further to accept nitrogen containing aromatic and other heterocylic 
aldehydes is desirable.  The insolubility of some aromatic aldehydes containing 
electron withdrawing/donating substituents on various positions on the aryl ring is a 
hindrance to ketodiol synthesis.  Investigations in catalytic activity, stability and the 
interactions of solvent with protein structure in a mixed water-organic solvent system 
are certain factors that need to be addressed.  
 
To elucidate our understanding of the highly stereospecifc nature of TK mutants on 
aliphatic and aromatic aldehyde acceptor molecules, further work would involve 
important X-ray crystallographic data on the D469 TK mutants.  Most recently Tittmann 
et al. have provided an X-ray structure of E.coli TK with acceptor aldose ribose-5-
phosphate noncovalently bound in the active site.31  Ideally an X-ray crystal structure of 
mutant E.coli TK in the presence of a non-phosphorylated acceptor molecule trapped in 
the enzyme’s active site would provide us with a ‘snapshot’ of the reactive intermediate 
accountable for the catalytic activity and the high stereospecificity of the D469 TK 
mutants.  
. 
 
Figure 73: An X-ray crystal structure of a trapped F6P-ThDP intermediate 
 
Further investigations of this novel one pot synthesis of racemic dihydroxyketones; in 
terms of substrate scope of the reaction is required.  Such as the use of a variety of 
aldehyde acceptors: aromatic, aliphatic hydrophobic and hydrophilic aldehydes to 
generate useful ‘carbon scaffolds’ for pharmaceutical and agrochemical purposes. 
Alternative donors other than hydroxypyruvate (HPA) will be investigated to assess the 
general synthetic utility of the reaction. Do other α-keto acids; such as 3-
mercaptopyruvic acid and 3-phenylpyruvic acid work in a similar manner to that of 
hydroxypyruvate? (Fig. 74). 
 
ThDP 
F6P 
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Figure 74 Phenylpyruvate 191 and Mercaptopyruvate 192 
 
The newly synthesized cinchona alkaloid catalysts and diamine chiral catalysts in low 
catalyst loading has shown enantioselectivites with cyclohexanecarboxaldehyde in the 
biomimetic reaction obtaining 20% ee.  Further screening of the catalysts with 
commercially available chiral aldehydes is worth pursuing.  Other available catalysts 
such as chiral phosphorus ligands was overlooked in these studies.  A screening of 
several phosphorus ligands is worth considering with a systematic approach to the 
development of designing chiral tertiary catalysts to improve the ees currently obtained. 
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Chapter 7.0 
 
Experimental 
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General Experimental 
 
1H NMR and 13C NMR were recorded using Bruker AMX 300 MHz, Avance-500 MHz 
and Avance-600 MHz machines. 19F NMR were recorded using a Bruker AMX 300 
MHz machine.  NMR spectra were recorded at 298 K unless otherwise indicated.  
Splitting patterns are abbreviated as singlet (s), doublet (d), triplet (t), double doublets 
(dd), quartet (q) multiplet (m).  The chemical shifts are given in ppm (δ), relative to 
tetramethylsilane (TMS) as reference and coupling constants (J) are given in Hertz.  
When necessary, assignments were aided by DEPT-135 and decoupling experiments.  
IR Spectra were obtained from a Nicolet FT-IR machine and Shamadzu FTIR-8700 are 
reported in wavenumbers (cm-1) and the characteristic bands are abbreviated by (s) 
strong absorption, (m) medium absorption, (w) weak absorption.  ES+ mass spectra 
were acquired using Thermo Finnegan MAT 900XP and Micro Mass Quattro LC.  CI 
spectra and HRMS were obtained using, Fisons VG70-SE and LTQ Orbitrap XL 
(courtesy of EPSRC National Mass Spectrometry Service Centre, Swansea University). 
Normal Phase High-Performance liquid Chromatography (HPLC) was measured 
using a U.V detector prostar/dynamic system24 (2 Volts) absorbance with 214 nm.  
The analytes were separated and ees determined by using a Chirapak AD/OD columns 
(Daicel; Chiral Technologies Europe, France) 25 cm × 0.46 cm. The polar stationary 
phase (isopropanol) and nonpolar mobile phase (hexane) were used as indicated.  
Thin Layer Chromatography (TLC) was carried out on pre-coated aluminium backed 
silica plates (Merck 60 F254 normal phase) and examined under UV fluorescence at 
254 nm or 297 nm, or using phosphomolybdic acid (PMA) [PMA hydrate (12 g) and 
ethanol (250 ml)] as a general stain.  Flash silica chromatography was carried out on 
silica gel using BDH silica 40 (63 µm).  All chemicals were used as received from 
Aldrich Chemical Co., BDH laboratory supplies, Fischer Chemical Co. and Lancaster 
Chemical Co. without further purification unless where stated.  Solvents used were of 
the analytical and HPLC grade.  Dry solvents were obtained using anhydrous alumina 
columns.135  Optical rotations were recorded on a Perkin Elmer model 343 
polarimeter at 589 nm, quoted in deg cm2 g–1 and conc (c) in g/100 ml. Melting points 
(M.p.) were established using a Gallenkamp apparatus and measured in °C.  The 
Colorimetric assay used FLUOstar Optima plate reader (BMG Labtechnologies, 
Aylesbury, UK), and was measured at OD485nm. 
 
TK Cell-free lysate preparation.  
Luria Bertani-agar plates with ampicillin (150 µg/ml) for growth selection were streaked 
with Escherichia coli XL10 transformed with the plasmid containing the appropriate TK 
mutant gene from glycerol stocks (25% v/v glycerol stored at –80 °C) and incubated for 
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16 h at 37 °C. A single colony was picked and used to inoculate 250 ml shake flasks 
containing 25 mL LB-glycerol (containing ampicillin 150 µg/ml) and incubated overnight 
at 37 °C and 200 rpm using an SI 50 orbital shaker (Stuart Scientific, Redhill, UK). The 
overnight culture was used to inoculate a 1 L shake flask containing 100 ml LB-glycerol 
Amp media (10% v/v), and incubated at 37 °C and 200 rpm. The fermentation was 
monitored by OD600 until the absorbance was no greater than 4.  The culture was 
pelleted by centrifugation at 4000 rpm for 20 minutes at 4 °C and approximately 2 g of 
cell paste was obtained and then resuspended in cold sodium phosphate buffer (5 mM, 
pH 7) to a final suspension of 1 g cell paste per 10 ml buffer.  The cells were then 
disrupted by sonication for 3 minutes at 4 °C using a Soniprep 150 sonicator (MSE, 
Sanyo, Japan), and centrifuged at 4500 rpm for 20 minutes at 4 °C. The supernatant 
cell-free lysate (approximately 20 ml) was aliquoted and stored at -20 °C until needed.  
The TK protein concentration of cell-free lysate was determined to contain 
approximately 0.3 mg ml-1  
 
TK conversions.  
The biotransformations were conducted in 50 mM reaction concentrations.  ThDP (22 
mg, 48 µmol) and MgCl2.6H2O (39 mg, 180 µmol) were dissolved in H2O (10 ml) and 
the pH adjusted to 7 using 0.1 M NaOH. To this stirred solution, at 25 ºC, was added 
TK clarified lysate (2 ml, containing approximately 0.3 mg ml-1) and the mixture stirred 
for 20 min. In another flask, Li-1 (110 mg, 1.00 mmol) and the aldehyde (1.00 mmol) 
were dissolved in H2O (8 ml) and the pH adjusted to 7 with 0.1 M NaOH. Following the 
20 min enzyme/cofactor pre-incubation, the 1/aldehyde mixture was added to the 
enzyme solution and the mixture stirred at rt for 24 h. During this time, the pH was 
maintained at 7.0 by addition of 1 M HCl using a pH stat (Stat Titrino, Metrohm) and the 
reactions were followed by TLC analysis. Silica was added and the reaction mixture 
concentrated to dryness, dry loaded onto a flash silica gel column, and purified as 
indicated. 
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Screening of libraries for activity  
Preparation of cell samples: The 96-well reaction plates were thawed from -80 °C 
resulting in the freeze-thaw lysis of the 100 µl cell cultures. A 12x cofactor stock 
solution (28.8 mM ThDP, 108 mM MgCl2, 50 mM Tris, pH 7.0; 25 µl) was added to 
each well and the plate was then incubated at 25 °C for 20 min. A 4 x Li-27 stock 
solution (200 mM in 50 mM Tris, pH 7.0; 75 µl) and an aldehyde stock solution (150 
mM in 50 mM Tris, pH 7.0; 100 µl) were then added to each well and the plate 
incubated at 25 °C for a further 2 h.  
 
Assaying reaction plates for production of ketodiol: 50 µl of reaction mixture were 
transferred from each well to a fresh 96-well plate containing 50 µl of 50 mM Tris, pH 
7.0 and 20 mg of MP-Carbonate Scavenger Resin (Biotage), which was added to each 
well using a resin loader (Radleys). After 2 h, Tris (100 µl, 50 mM, pH 7.0) was added 
to each well, with mixing, and 50 µl from each well transferred to a fresh 96-well plate. 
A plate reader (Fluostar, BMG-labtech) fitted with an autoinjector was then used to add 
2,3,5-triphenyltetrazolium chloride (20 µl, 0.2% solution in methanol) then 3M NaOH 
(10 µl). The plate was shaken for 10 s, left for 1 min and an absorbance reading taken 
of each well at 485 nm. 
 
Colorimetric assay to determine the initial rate velocity 
D469T TK lysate, 60 µl was incubated with 100 µl cofactor solution (TPP (2.4 mM), and 
MgCl2 (9 mM)) for 20 mins at 20 °C. Li-27 (7.4 mg, 50 mmol) and aldehyde (50 mmol) 
was added to the reaction mixture. Aliquots (50 µl) were taken at hourly intervals and 
the reaction was quenched with 50 µl methanol. The aliquots were transferred onto a 
microwell plate containing 10 mg MP-Carbonate resin (Biotage AB) and incubated at 
20 °C for 3 h.92 50 µl of the quenched reaction sample was transferred without resin 
into a microwell plate.  50 µl of each concentration was diluted with 100 µl of water. 
Automated injection of 20 µl of tetrazolium red solution (0.2% of 2,3,5 
triphenyltetrazolium chloride in methanol) and 10 µl 3 M NaOH (aq) with shaking by 
FLUOstar Optima plate reader, was followed by immediate measurement at OD485nm.92 
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Lithium hydroxypyruvate52 
 
O Li
O
O
OH
O Li
O OH
HO OH
'Keto' 'gem-diol'
 Li-27 
 
    
Bromopyruvic acid (10.05 g, 0.06 mol) was dissolved in water (100 ml) and 1 M LiOH 
solution was added at such a rate that the pH did not exceed 9.5 whilst stirring.  Glacial 
acetic acid was added dropwise into the solution to adjust it to pH 5.0.  The mixture 
was concentrated in vacuo to approximately a 20 ml final volume and the concentrate 
was left to crystallise overnight.  The crude product was washed with ethanol and 
collected by filtration then suspended in ethanol (50 ml) at 40 °C for 30 min. The 
product was collected by filtration and washed with ethanol (50 ml) affording a white 
powder (2.977 g, 46%). M.p. 115-125; IR (KBr) 3462-2619 (br, O-H), 1708 (s, C=O);  
1H NMR (300 MHz; D2O) δ 3.60 (2H, s, CH2, keto), 4.64 (2H, s,CH2, gem-diol);          
13C NMR (75 MHz; D2O) δ 65.8 (CH2), 66.5 (CH2), 94.8 (gem-diol), 167.9 (C=O) (keto), 
177.0 (C=O) (gem-diol), 203.0 (C=O) (keto); m/z (ES+) 220 (2M+, 100%), 152 (MNa+, 
20). 
 
Sodium -hydroxypyruvate 
 
'Keto' 'gem-diol'
O Na
O
O
OH
O Na
O OH
HO OH
 Na-27 
    
 
Bromopyruvic acid (10.06 g, 0.06 mol) was dissolved in water (100 ml) and 1 M NaOH 
solution was added at such a rate that the pH did not exceed 9.5 whilst stirring.  Glacial 
acetic acid was added dropwise into the solution to adjust it to pH 5.  The mixture was 
concentrated in vacuo to approximately a 20 ml final volume and the concentrate was 
left to crystallise overnight.  The crude product was washed with ethanol and collected 
by filtration then suspended in ethanol (50 ml) at 40 °C for 30 min.  The product was 
collected by filtration and washed with ethanol (50 ml) affording a white powder     
(1.517 g, 20%). M.p. 120-130; IR (KBr) 3462-2619 (br, O-H), 1708 (s, C=O); 1H NMR 
(300 MHz; D2O) δ 3.60 (2H, s, CH2, keto), 4.64 (2H, s,CH2, gem-diol); 13C NMR (75 
MHz; D2O) δ 65.8 (CH2), 66.5 (CH2), 94.8 (gem-diol), 167.9 (C=O) (keto), 177.0 (C=O) 
(gem-diol), 203.0 (C=O) (keto); m/z (ES+) 103 (M-Na+ 100%). 
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Potassium hydroxypyruvate52 
 
'Keto' 'gem-diol'
O K
O
O
OH
O K
O OH
HO OH
K-27 
 
    
Bromopyruvic acid (10.01 g, 0.06 mol) was dissolved in water (100 ml) and 3 M KOH 
solution was added at such a rate that the pH did not exceed 9.5 whilst stirring.  Glacial 
acetic acid was added dropwise into the solution to adjust it to pH 5.  The mixture was 
concentrated in vacuo to approximately a 20 ml final volume and the concentrate was 
left to crystallise overnight.  The crude product was washed with ethanol and collected 
by filtration then suspended in ethanol (50 ml) at 40 °C for 30 min.  The product was 
collected by filtration and washed with ethanol (50 ml) affording an orange powder 
(6.123g, 72%). M.p. 125-135; IR (KBr) 3462-2619 (br, O-H), 1708 (s, C=O); 1H NMR 
(300 MHz; D2O) δ 3.60 (2H, s, CH2, keto), 4.64 (2H, s,CH2, gem-diol); 13C NMR (75 
MHz; D2O) δ δ 65.8 (CH2), 66.5 (CH2), 94.8 (gem-diol), 167.9 (C=O) (keto), 177.0 
(C=O) (gem-diol), 203.0 (C=O) (keto); m/z (ES+) 103 (M-K+, 100%). 
 
Cesium hydroxypyruvate 
 
'Keto' 'gem-diol'
O Cs
O
O
OH
O Cs
O OH
HO OH
Cs-27 
 
    
Bromopyruvic acid (10.15 g, 0.06 mol) was dissolved in water (100 ml) and 4 M cesium 
hydroxide solution was added at such a rate that the pH did not exceed 9.5 whilst 
stirring.  Glacial acetic acid was added dropwise into the solution to adjust it to pH 5.  
The mixture was concentrated in vacuo to approximately a 20 ml final volume and the 
concentrate was left to crystallise overnight.  The crude product was washed with 
ethanol and collected by filtration then suspended in ethanol (50 ml) at 40 °C for 30 
min.  The product was collected by filtration and washed with ethanol (50 ml) affording 
an orange-brown powder (14.012g, >99%). M.p. 135-145; IR (KBr) 3462-2619 (br, O-
H), 1708 (s, C=O); 1H NMR (300 MHz; D2O) δ 3.60 (2H, s, CH2, keto), 4.64 (2H, s,CH2, 
gem-diol); 13C NMR (75 MHz; D2O) δ 65.8 (CH2), 66.5 (CH2), 94.8 (gem-diol), 167.9 
(C=O) (keto), 177.0 (C=O) (gem-diol), 203.0 (C=O) (keto); m/z (ES+) 103 (M-Cs+, 
100%).  
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1, 3-Dihydroxy-4-methoxy-butan-2-one100 
O
O
OH
OH
30n 
Following the TK conversion protocol, WT-TK gave 30n as an oil (40 mg, 30%). [α]20D= 
+2.0 (c 2.0, CHCl3), lit. [α]25J= +3.0 (C 0.017, MeOH); IR (Neat): 3415br s, 2923s, 
1727s; 1H NMR (300 MHz; CDCl3) δ 3.36 (3H, s, OCH3), 3.61 (1H, dd, J 9.9 and 4.4, 
CHHOMe), 3.70 (1H, dd, J 9.9 and 4.4, CHHOMe), 4.38 (1H, t, J 4.4 and 4.4, CHOH), 
4.43 (1H, d, J 19.7, CHHOH), 4.53 (1H, d, J 19.7, CHHOH); 13C NMR (75 MHz; CDCl3) 
δ 59.5 (OCH3), 66.7 (CH2), 73.4 (CH2), 74.8 (CHOH) 210.8 (C=O); m/z (FTMS) 
[M+NH4]+ calcd for C5H14O4N requires 152.0917, found 152.0919. 
 
1,3-Dihydroxypentan-2-one52 
 
O
OH
OH
 30s 
   
To a stirred solution of Li-27 (0.33 g, 3.00 mmol) in water (60 ml) at rt, was added 
propanal (217 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 3.00 mmol).  The 
reaction mixture was stirred at rt for 48 h, and monitored by TLC.  The solvent was 
removed in vacuo and the crude product dry loaded onto a flash silica chromatography 
column (EtOAc: 40-60% petroleum ether, 2:1) affording 30s (0.0789 g, 22%) as a white 
solid. Rf 0.29 (EtOAc: petroleum ether, 2:1); M.p. 102-106; IR (KBr) 3407 (br, O-H), 
2925-2855 (C-H); 1720 (s, C=O); 1H NMR (300 MHz; MeOD) δ 0.95 (3H, m, CH3), 1.59 
(1H, m, CH3-CHH) 1.79 (1H, m, CH3CHH), 4.11 (1H, m, CHOH), 4.39 (1H, d, J 19.3, 
O=C-CHH), 4.47 (1H, d, J 19.3, O=C-CHH); 13C NMR (75 MHz; MeOD) δ 9.7 (CH3), 
28.0, 66.6 (CH2OH), 77.5 (CHOH) 214.1 (C=O); m/z (ES+) 118 (M+, 20%), 136 
([M+H2O]+, 45%), 60 ([M-C4H2O2]+. 47%). 
 
Biotransformation Product; The 50 mM TK reaction using WT-TK generated white 
solid (S)-30s (0.360 g, 77%), 59% ee (S-isomer); [α]20D= +13.3 (c 0.15, CHCl3), spectra 
assignments same as above. 
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1-Cyclopropyl -1,3-dihydroxy-2-propanone106 
 
 
OH
O
OH
   30v  
   
To a stirred solution of Li-27 (0.33 g, 3.00 mmol) in water (60 ml) at rt, was added 
cyclopropanecarboxaldehyde (224 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 
3.00 mmol).  The reaction mixture was stirred at rt for 48 h, and monitored by TLC.  
The solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (neat EtOAc) affording product 30v (0.039 g, 10%) as a 
colourless oil.  Rf 0.50; IR (KBr) 3380 (b, O-H), 3007-2923 (C-H) 1723 (s, C=O); 1H 
NMR (300 MHz; CDCl3) δ 1.24-1.76 (4H, m), 2.19 (1H, m), 2.69 (2H, s, OH), 4.30 (1H, 
d, J 3.0), 4.37 (1H, d, J 21.0, CHHOH), 4.50 (1H, d, J 21.0, CHHOH); 13C NMR (75 
MHz; CDCl3) δ 25.8, 29.1, 43.0, 65.9 (CH2OH), 77.0 (CHOH), 211.4 (C=O); m/z (GC-
CIP) calcd [M+NH4]+ for C6H14NO3 requires 148.0968 found 148.0969. 
 
Biotransformation product (S)-30v: The ees was determined from the HPLC 
benzoylated method (See 94).  The 50 mM TK reaction using WT-TK gave 30v (3 mg, 
2%) in 72% ee (1S-isomer), H26Y-TK gave no reaction, D469T-TK, gave 33v (3 mg, 
2%) in 99% ee (1S-isomer), and D469L-TK gave 30v (14 mg, 10%) in 99% ee (1S-
isomer), D469K-TK, 15 30v (2 mg, 2%) in 99% ee (1S-isomer) and D469E-TK 
generated (S)-30v a colourless oil (13 mg, 10%) in 99% ee (1S-isomer), [α]20D= +70.0 
(c 0.3, CHCl3).  The absolute stereochemistry of 30v generated using D469E-TK was 
determined using the Moshers derivatisation method (See 95). 
 
 
1-Cyclopentyl -1,3-dihydroxy-2-propanone106 
     
 
OH
O
OH
30x 
 
To a stirred solution of Li-27 (0.33 g, 3.00 mmol) in water (60 ml) at rt, was added 
cyclopentanecarboxaldehyde (320 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 
3.00 mmol).  The reaction mixture was stirred at rt for 48 h, and monitored by TLC.  
The solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc:hexane, 1:1) affording product 30x (0.119 g, 25%) as 
a white solid.  Rf  0.21 (EtOAc:hexane, 1:1); M.p. 115-125; IR (KBr) 3411 (br, O-H), 
2952-2868 (C-H); 1718 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 1.31-1.75 (8H, m), 2.18 
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(1H, m) 3.04 (2H, s, OH), 4.30 (1H, m, CHOH), 4.36 (1H, d, J 21.0, CHHOH), 4.50 (1H, 
d, J 21.0, CHHOH); 13C NMR (75 MHz; CDCl3) δ 25.6, 29.0, 42.9, 65.8 (CH2OH), 76.9 
(CHOH), 211.4 (C=O); m/z (GC-CIP) found [M+NH4]+ 176.1281 for C8H18NO3 requires 
176.1281. 
 
 Biotransformation Product (S)-30x: The ees was determined from the HPLC 
benzoylated method (See 96).  The 50 mM TK reaction using WT-TK gave 30x (2 mg, 
1%) as a racemate, H26Y-TK gave 30x (3 mg, 2%) in 30% ee (1R-isomer), D469T-TK 
gave 30x (47mg, 30%) in 99% ee (1S-isomer) and D469K-TK gave 30x (16mg, 10%) 
in 25% ee (1S-isomer), and  D469E-TK gave 30x (63 mg, 40%) in 99% ee (S-isomer), 
[α]20D= +33.0 (c 0.5, CHCl3). The absolute stereochemistry of 30x was determined 
using the Moshers derivatisation method (See 98). 
 
1-Cyclohexyl -1,3-dihydroxy-2-propanone51 
 
     
    
OH
O
OH 30y  
   
To a stirred solution of Cs-27 (0.71 g, 3.00 mmol) in water (60 ml) at rt, was added 
cyclohexanecarboxaldehyde (363 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 3.00 
mmol).  The reaction mixture was stirred at rt for 48 h, and monitored by TLC.  The 
solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc:hexane, 1:1) affording 30y (0.24 g, 47%) as a white 
solid. Rf 0.21; M.p. 110-120; IR (KBr) 3429 (b, O-H), 1712 (s, C=O), 2925-2855 (C-H); 
1H NMR (300 MHz; CDCl3) δ 0.89 -1.30 (11H, m), 2.96 (2H, s, OH), 3.96 (1H, d, J 6.0, 
CHOH), 4.34 (1H, d, J 19.5, CHHOH), 4.45 (1H, d, J 19.5, CHHOH); 13C NMR (75 
MHz; CDCl3) δ 27.4, 27.7, 30.4, 42.9, 67.4 (CH2OH), 80.7 (CHOH), 214.3 (C=O); m/z 
(ES+) 172.8 ([M]+, 10), 343.2 ([2M]+, 100); m/z (HRMS) calcd [M+H]+ for C9H17O3 
requires 173.11722, found 173.11736.  
 
Biotransformation Product (S)-30y: The ees was determined from the HPLC 
benzoylated method (See 100).  The 50 mM TK reaction using WT-TK gave 30y (1 mg, 
1%) as a racemate, D469T-TK gave 30y (5 mg, 3%) in 99% ee (1S-isomer); D469K-TK 
gave 30y (5 mg, 3%) in 25% ee (1S-isomer), and D469E-TK generated 30y gave (17 
mg, 30%) in 97% ee (1S-isomer), [α]20D= +33.0 (c 0.5, CHCl3). in 97% ee (1S-isomer).  
The absolute stereochemistry with D469E-TK was determined using the Moshers 
derivatisation method (See 101). 
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1, 3-Dihydroxypropiophenone136 
 
OH
OH
O
 30Ar1 
 
To a stirred solution of Cs-27 (0.71 g, 3.00 mmol) in water (60 ml) at rt, was added 
benzaldehyde (363 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 3.00 mmol).  The 
pH of the solution was then adjusted to pH 7.0 by adding 1 M HCl or 1 M NaOH 
solution dropwise.  The reaction mixture was stirred at rt for 48 h, and monitored by 
TLC.  The solvent was removed in vacuo and the crude product dry loaded onto a flash 
silica chromatography column (EtOAc:hexane, 1:1) affording 30Ar1 (0.05 g, 10%) as 
an colorless oil. Rf 0.75; IR (Neat) 3429 (b, O-H), 1712 (s, C=O); 1H NMR (300 MHz; 
CDCl3) δ 4.20 (1H, d, J 19.0, CHHOH), 4.33 (1H, d, J 19.0, CHHOH), 5.23 (1H, s, 
HOCH), 7.20-7.43 (5H, m, Ar). 13C NMR (75 MHz; CDCl3) δ 65.1 (CH2), 77.7 (CHO), 
128.5, 129.3, 130.2, 137.3, 209.1 (C=O); m/z (ES+) 167.6 (M+, 94%), 77.7 (C6H6+, 
10%), 58.9 (C2H2O2+, 25%).   
 
Biotransformation product generated in a 50 mM TK reaction using D469E gave     
(5 mg, 3%) as an oil; [α]20D= +74.0 (c 0.5, CHCl3). The spectral assignment is the same 
as above. 
 
1-Furan-2-yl-1, 3-dihydroxy-propan-2-one45 
O
OH
O
OH
30Ar2 
To a stirred solution of Li-27 (0.111 g, 1.00 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added furfural (83 µl, 1.00 mmol) and N-methylmorpholine (101 µl, 1.00 mmol).  
The pH of the solution was then adjusted to pH 7.0 by adding 1 M HCl or 1 M NaOH 
solution added dropwise.  The reaction mixture was stirred at rt for 24 h, and monitored 
by TLC.  The solvent was removed in vacuo and the crude product dry loaded onto a 
flash silica chromatography column (EtOAc:hexane, 1:1) affording compound 30Ar2 
(0.006 g, 4%) as a brown oil; Rf 0.40; IR (Neat) 3391 (s, O-H), 1708 (C=O), 694 (Ar-H); 
1H NMR (300 MHz; CDCl3) δ 3.39 (2H, s, OH), 4.28 (1H, d, J 19.5, CHHOH), 4.43 (1H, 
d, J 19.5, CHHOH), 5.30 (1H, s, HOCH), 6.35 – 6.47 (2H, m), 7.41 (1H, m), 13C NMR 
(125 MHz; CDCl3) δ 66.1 (CH2), 71.0 (CHOH), 110.5, 111.0, 143.6, 149.6 (CCHOH), 
207.8 (C=O); m/z (CI) calcd for C7H9O4 [M+Na]+ requires 157.05008, found 157.04964. 
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Biotransformation product (S)-30Ar2 generated in a 50 mM TK reaction using 
D469E gave (8 mg, 5%) as an oil; [α]20D= +54.0 (c 0.4, CHCl3). The spectral 
assignment is the same as above. 
 
1,3-dihydroxy-4-phenylbutan-2-one51 
 
OH
O
OH
30Ar3 
 
To a stirred solution of Li-27 (0.112 g, 1.00 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added phenylacetaldehyde (120 µl, 1.00 mmol) and N-methylmorpholine (101 µl, 
1.00 mmol).  The reaction mixture was stirred at rt for 24 h, and monitored by TLC.  
The solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc:hexane, 1:1) affording compound 30Ar3 (0.018 g, 
10%) as a colourless crystals, Rf  0.30; M.p. 122-130; IR (Neat) 3262 (br, O-H), 2966-
2883 (C-H); 1720 (s, C=O); 1H NMR (500 MHz; CDCl3) δ 2.43 (2H, s, OH), 2.84 (1H, 
dd, J 13.9 and 8.1, CHHPh) 3.08 (1H, dd, J 13.9 and 4.5, CHHPh), 4.28 (1H, d, J 18.0, 
CHHOH), 4.38 (1H, d, J 18.0, CHHOH), 4.42 (1H, m, CHOH), 7.18-7.34 (5H, m, Ar); 
13C NMR (125 MHz; CDCl3) δ 40.4 (CH2Ph), 66.2 (CH2OH), 76.0 (CHOH), 127.2, 
128.8, 129.4, 135.9, 211.6 (C=O); m/z (FTMS + p NSI) calcd [2M+Na]+ for C20H24O6Na 
requires 383.1471, found 383.1454.  
 
Biotransformation Product (S)-30Ar3: The ees was determined from the HPLC 
benzoylated method (See 123).  The 50 mM TK reaction using WT-TK gave 30Ar3 (9 
mg, 5%) in 93% ee (1S-isomer), G6-TK gave 30Ar3 (90 mg, 50%) in 92% ee (1S-
isomer), D469T-TK gave 30Ar3 (90 mg, 50%) in 96% ee (1S-isomer); D469K-TK gave 
30Ar3 (81 mg, 45%) in 95% ee (1S-isomer), H26Y-TK gave 30Ar3 (9 mg, 5%) in 88% 
ee (1S-isomer), and D469E-TK generated 30Ar3 gave (77 mg, 43%) in 90% ee (1S-
isomer), [α]20D= +30.0 (c 0.5, CHCl3).  The absolute stereochemistry with D469E-TK 
was determined using the Moshers derivatisation method (See 126). 
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1,3-Dihydroxy-4-phenyl-pentan-2-one 
 
OH
O
OH
30Ar4 
 
To a stirred solution of Li-27 (0.11 g, 1.00 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added 2-phenylpropanal (134 µl, 1.00 mmol) and N-methylmorpholine (101 µl, 
1.00 mmol).  The reaction mixture was stirred at rt for 24 h, and monitored by TLC.  
The solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc:hexane, 1:1) affording compound 30Ar4 (0.020 g, 
10%) as a colourless crystals, Rf  0.30; M.p. 120-130; IR (Neat) 3407 (br, O-H), 2925-
2855 (C-H); 1720 (s, C=O); 1H NMR (500 MHz; CDCl3) δ 1.28 (0.6H, d, J 4.3 Hz, CH3), 
1.43 (2.4H, d, J 4.3, CH3) 3.19-3.24 (1H, m, CHCH3), 4.22 (1H, d, J 12.0, CHHOH), 
4.26 (1H, d, J 12.0, CHHOH), 4.38 (0.2H, m, CHOH); 4.42 (0.8H, m, CHOH); 7.21-7.37 
(5H, m, Ar); 13C NMR (125 MHz; CDCl3) δ 14.2 (CH3), 43.6 (CHCH3), 67.1 (CH2OH), 
79.5 (CHOH), 127.4, 127.7, 129.0, 142.0, 211.5 (C=O); m/z (FTMS + p NSI) calcd 
[M+Na]+ for C11H14O3 requires 217.0835, found 217.0836. The 2-isomer mixture of 
(3RS,4R)-1,3-dihydroxy-4-phenylpentan-2-one (4R)-30Ar4 (0.019 g, 10%) was 
prepared using an identical method and 131 
 
(3S,4S)-1,3-Dihydroxy-4-phenyl-pentan-2-one 
 
OH
O
OH
(3S,4S)-30Ar4 
 
ThDP (23 mg, 48 µmol) and MgCl2.6H2O (40 mg, 180 µmol) were dissolved in H2O (10 
ml) and the pH adjusted to 7 with 0.1 M NaOH. To this stirred solution, at 25 ºC, was 
added D469T-TK clarified lysate (2 ml) and the mixture stirred for 20 min. In another 
flask, Li-27(110 mg, 1 mmol) and 2-phenylpropanal (134 µl, 1 mmol) were dissolved in 
H2O (8 ml) and the pH adjusted to 7 with 0.1 M NaOH. Following the 20 min 
enzyme/cofactor pre-incubation, the Li-27/2-phenylpropanal mixture was added to the 
enzyme solution and the mixture stirred at 25 ºC for 24 h. During this time, the pH was 
maintained at 7.0 by addition of 1 M HCl using a pH stat.  Silica was added and the 
reaction mixture concentrated to dryness before dry loading onto a flash silica gel 
column. Following column purification (EtOAc:CH3OH, 1:1), compound (3S,4S)-30Ar4 
was isolated as colorless crystals (0.080 g, 40%). Rf 0.30; Mp (ºC) 120-130;  
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[α]25D= +30.9 (c 0.22, CHCl3); IR (Neat): 3407 (b, O-H), 2925-2855 (C-H); 1720 (s, 
C=O); 1H NMR (300 MHz; CDCl3) δ 1.26 (0.25H, d, J 7.1, CH3), 1.42 (2.75H, d, J 7.1, 
CH3) 3.19-3.24 (1H, m, CHCH3), 4.19 (1H, d, J 19.8, CHHOH), 4.27 (1H, d, J 19.8, 
CHHOH), 4.33 (1H, d, J 4.5, CHOH); 4.40 (0.92H, m, CHOH,); 4.42 (0.08H, m, CHOH), 
7.21-7.37 (5H, m, Ar)  13C NMR (75 MHz; CDCl3) δ 14.2 (CH3), 43.6 (CHCH3), 67.1 
(CH2OH), 79.5 (CHOH), 127.4, 127.7, 129.0, 142.0, 211.5 (C=O); m/z (FTMS + p NSI) 
calcd [M+Na]+ for C11H14O3 requires 217.0835, found 217.0836.   
 
Other TK mutants: The 50 mM TK reaction using WT-TK gave (3S,4S)-30Ar4 (68 mg, 
35%) (58 mg, 30%) in 76% de, H26Y-TK no reaction, and D469K-TK gave (3S,4S)-
30Ar4 (74 mg, 38%) in 89% de, G6-TK gave (3S,4S)-30Ar4 (74 mg, 38%) in 88% de, 
and  D469E-TK gave (3S,4S)-30Ar4 (57 mg, 30%) in 90% de. The absolute 
stereochemistry of (3S,4S)-30Ar4 was determined using the Moshers derivatisation 
method. 
 
1,3-dihydroxy-1-(thiophen-2-yl)propan-2-one 
S
OH
O
OH
30Ar5 
To a stirred solution of Li-27 (0.110 g, 1.00 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added 2-thiophenecarboxaldehyde (93 µl, 1.00 mmol) and N-methylmorpholine 
(101 µl, 1.00 mmol).  The pH of the solution was then adjusted to pH 7.0 by adding 1 M 
HCl or 1 M NaOH solution added dropwise.  The reaction mixture was stirred at rt for 
24 h, and monitored by TLC.  The solvent was removed in vacuo and the crude product 
dry loaded onto a flash silica chromatography column (EtOAc:hexane, 1:1) affording 
compound 30Ar5 (0.006 g, 4%) as a brown oil, IR (Neat) 3391 (s, O-H), 1708 (C=O), 
694 (Ar-H); Rf 0.40; 1H NMR (300 MHz; CDCl3) δ 3.86 (2H, s, OH), 4.36 (1H, d, J 19.5, 
CHHOH), 4.42 (1H, d, J 19.5, CHHOH), 5.52 (1H, s, HOCH), 7.01-7.10 (2H, m), 7.35 
(1H, m); 13C NMR (125 MHz; CDCl3) δ 65.2 (CH2), 73.1 (CHO), 126.6, 127.1, 127.5, 
140.1, 207.8, (C=O); m/z (CI): calcd [M]+ for C7H9O3S requires 173.02724, found 
173.02695. 
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1,3-Dihydroxy-1-(4-methoxy-phenyl)-propan-2-one 
OH
O
OH
MeO 30Ar6 
To a stirred solution of Li-27 (0.113 g, 1.04 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added p-anisaldehyde (122 µl, 1.00 mmol) and N-methylmorpholine (101 µl, 1.00 
mmol).  The reaction mixture was stirred at rt for 24 h, and monitored by TLC.  The 
solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc: hexane, 1:1) affording compound 30Ar5 (9 mg, 5%) 
as a colorless oil.  Rf  0.40; IR (Neat) 3391 (s, O-H), 1708 (C=O), 694 (Ar-H); 1H NMR 
(300 MHz; CDCl3) δ 3.81 (3H, s), 3.85 (2H, s, OH), 4.21 (1H, d, J 19.4, CHHOH), 4.33 
(1H, d, J 19.4, CHHOH), 5.19 (1H, s, CHOH), 6.90 (2H, d, J 6.0, Ar), 7.23 (2H, d, J 6.0, 
Ar); 13C NMR (125 MHz; CDCl3) δ 55.4 (OCH3), 65.2 (CH2), 77.2 (CHO), 114.8, 129.4, 
147.4, 160.4, 209.3 (C=O); m/z (HRMS) [M+Na]+ calcd for C10H13O4Na requires 
219.06333, found 219.06239. 
 
1.3-Dihydroxy-1-(3-methoxy-phenyl)-propan-2-one 
OH
O
OH
OMe 30Ar7 
To a stirred solution of Li-27 (0.110 g, 1.00 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added m-anisaldehyde (122 µl, 1.00 mmol) and N-methylmorpholine (101 µl, 1.00 
mmol).  The reaction mixture was stirred at rt for 24 h, and monitored by TLC.  The 
solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc: hexane, 1:1) affording compound 30Ar6 (0.008 g, 
5%) as a colorless oil; IR (Neat) 3391 (s, O-H), 1708 (C=O), 694 (Ar-H); 1H NMR (300 
MHz; CDCl3) δ 3.78 (3H, s, OCH3), 376 (2H, s, OH), 4.21 (1H, d, 19.5, CHH), 4.33 (1H, 
d, 19.5, CHH), 5.18 (1H, s), 6.81 (3H, m, Ar), 7.27 (1H, m, Ar), 13C NMR (125 MHz; 
CDCl3) δ 55.6 (OCH3), 65.5 (CH2), 77.6 (CHOH), 113.0, 114.8, 119.3, 130.4, 138.5, 
160.1, 209.0 (C=O); m/z (HRMS) [M+Na]+ calcd for C10H13O4Na requires 219.06333, 
found 219.06239. 
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[1-2H]-1-Cyclohexyl -1,3-dihydroxy-2-propanone 
 
O
OH
DHO 30yD 
 
To a stirred solution of Cs-27 (0.71 g, 3.00 mmol) in water (60 ml) at rt, was added     
[1-2H]-1-cyclohexanecarboxaldehyde (363 µl, 3.00 mmol) and N-methylmorpholine 
(364 µl, 3.00 mmol). The reaction mixture was stirred and adjusted to pH 8, and 
maintained at pH 8 for 48 h at rt.  The solvent was removed in vacuo and the crude 
product dry loaded onto a flash silica chromatography column (EtOAc:hexane, 1:1) 
affording the product 30yD (0.202 g, 40%) as a white solid.  Rf 0.21; IR (KBr) 3429 (br, 
O-H), 1712 (s, C=O), 2925-2855 (C-H); 1H NMR (300 MHz; CDCl3) δ 0.89 -1.30 (11H, 
m), 4.35 (1H, d, J 19.5, CHHOH), 4.45 (1H, d, J 19.5, CHHOH); 13C NMR (75 MHz; 
CDCl3) δ 25.9, 26.5, 29.5, 42.0, 66.2 (CH2OH), 80.8 (t, JCD 25.0, CDOH), 211.7 (C=O); 
m/z (HRMS) C9H16O3D requires 174.12404, found 174.12394. 
 
[1-2H]-Cyclohexyl -1,3-dihydroxy-2-propanone 
 
O
OH
OH D 30yDH 
             
 
To a stirred solution of Cs-27 (0.71 g, 3.00 mmol) in D2O (60 ml) at rt, was added 
cyclohexanecarboxaldehyde (363 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 3.00 
mmol).  The reaction mixture was stirred and adjusted to pH 8, and maintained at pH 
8.0 for 48 h at rt.  The solvent was removed in vacuo and the crude product dry loaded 
onto a flash silica chromatography column (EtOAc:hexane, 1:1) affording a mixture of 
products 30yDH (0.202 g, 40 %) as a white solid, Rf  0.21; M.p. 110-120; IR (KBr) 
3429 (br, O-H), 1712 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 0.89 -1.30 (11H, m), 4.35 
(1H, d, J 19.5, CHHOH), 4.45 (1H, d, J 19.5, CHHOH); 13C NMR (75 MHz; CDCl3) δ 
25.9, 26.5, 29.5, 42.0, 66.2 (t, JCD 25.0, CHDOH), 80.8 (CHOH), 211.7 (C=O); m/z 
(HRMS): calcd [M+H]+ for C9H16DO3 requires 174.12559, found 174.12632 (100%);  
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(2R,3'S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-4'-
methoxy-2'-oxo-butyl ester100 
HO
O
O
O
CF3
MeO Ph
O
Ha Hb
 (R)-82n (major isomer) 
The reaction was carried out under anhydrous conditions. To a stirred solution of (S)-
30n (0.010 g, 0.07 mmol) in CH2Cl2 (3 ml) was added triethylamine (34 µl, 0.25 mmol) 
and (S)-MTPA chloride (20 µl, 0.08 mmol) in CH2Cl2 (2 ml) and the reaction was stirred 
for 12 h at rt. The product was dry loaded onto silica gel and purified using flash 
chromatography (EtOAc:hexane, 1:1) to afford (R)-82n as a colourless oil (0.015 g, 
61%), (2R,3S) 57% ee (from integrations of Ha and Hb 1H NMR signals of (R)-82n).      
Rf 0.40; [α]20D= +23.2 (c 0.25, CHCl3); IR (Neat) 3415 (br, O-H), 2923 (s, C-H), 1727 (s, 
ester); 1H NMR (300 MHz; CDCl3) δ 3.38 (3H, s, OCH3), 3.61 (3H, s, OCH3) 3.57–3.70 
(2H, m, CH2), 4.36 (1H, m, CHOH), 5.13 (1H, d, J 17.5, CHHO (2R,3'S)), 5.17 (1H, d, J 
17.5, CHHO (2R,3'S)), 7.42 (3H, m, Ph), 7.62 (2H, m, Ph). 13C NMR (150 MHz; CDCl3) 
δ 55.8 (OCH3), 59.5 (OCH3), 68.1, 72.8, 75.0, 84.5 (q, JCF 27, CCF3), 123.1 (q, JCF 285, 
CF3), 127.5, 128.5, 129.8, 131.5, 166.1 (C=O ester), 202.9 (C=O, ketone); 19F NMR 
(282 MHz; CDCl3) δ -72.2. 
 
(2R,3'R)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-4'-
methoxy-2'-oxo-butyl ester100 
HO
O
O
O
CF3
MeO Ph
O
Ha Hb
 (R)-82n (minor isomer) 
The reaction was carried out under anhydrous conditions. To a stirred solution of (S)-
30n (0.010 g, 0.07 mmol) in CH2Cl2 (3 ml) was added triethylamine (34 µl, 0.25 mmol) 
and (S)-MTPA chloride (20 µl, 0.08 mmol) in CH2Cl2 (2 ml) and the reaction was stirred 
for 12 h at rt. The product was dry loaded onto silica gel and purified using flash 
chromatography (EtOAc:hexane, 1:1) to afford (R)-82n as a colourless oil (0.015 g, 
61%).  Rf 0.40; [α]20D= +23.2 (c 0.25, CHCl3); IR (Neat) 3415 (br, O-H), 2923 (s, C-H), 
1727 (s, ester); 1H NMR (300 MHz; CDCl3) δ 3.38 (3H, s, OCH3), 3.61 (3H, s, OCH3) 
3.57–3.70 (2H, m, CH2), 4.36 (1H, m, CHOH), 5.02 (1H, d, J 17.5, CHHO (2R,3'R)), 
5.29 (1H, d, J 17.5, CHHO (2R,3'R)), 7.42 (3H, m, Ph), 7.62 (2H, m, Ph). 13C NMR (150 
MHz; CDCl3) δ 55.8 (OCH3), 59.5 (OCH3), 68.1, 72.8, 75.0, 84.5 (q, JCF 27, CCF3), 
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123.1 (q, JCF 285, CF3), 127.5, 128.5, 129.8, 131.5, 166.1 (C=O ester), 202.9 (C=O, 
ketone); 19F NMR (282 MHz; CDCl3) δ -72.2. 
(2S,3'S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-4'-methoxy 
-2'-oxo-butyl ester100 
HO
O
O
O
CF3
MeO Ph
O
Ha Hb
 (S)-82n (major Isomer) 
The same procedure was used as that described above for (R)-82n using (R)-MTPA to 
give (S)-82n as a colourless oil (0.010 g, 40%) (2S,3'S) 57% ee (from integrations of Ha 
and Hb 1H NMR signals of (S)-82n). Rf 0.45; [α]20D= -10.6 (c 0.25, CHCl3); 1H NMR 
(500 MHz; CDCl3) δ 3.38 (3H, s, OCH3), 3.61 (3H, s, OCH3) 3.57–3.70 (2H, m, CH2), 
4.36 (1H, m, CHOH), 5.02 (1H, d, J 17.5, CHHO (2S,3'S)), 5.29 (1H, d, J 17.5, CHHO 
(2S,3'S)), 7.42 (3H, m, Ph), 7.62 (2H, m, Ph); 13C NMR (150 MHz; CDCl3) δ 55.8 
(OCH3), 59.5 (OCH3), 68.1, 72.8, 75.0, 84.5 (q, JCF 27, CCF3), 123.1 (q, JCF 285, CF3), 
127.5, 128.5, 129.8, 131.5, 166.1 (C=O ester), 202.9 (C=O, ketone); 19F NMR (282 
MHz; CDCl3) δ -72.2.  
(2S,3'R)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-4'-methoxy 
-2'-oxo-butyl ester100 
HO
O
O
O
CF3
MeO Ph
O
Ha Hb
 (S)-82n (minor Isomer) 
The same procedure was used as that described above for (R)-82n using (R)-MTPA to 
give (S)-82n as a colourless oil (0.010 g, 40%) (2S,3'S) 57% ee (from integrations of Ha 
and Hb 1H NMR signals of (S)-82n). Rf 0.45; [α]20D= -10.6 (c 0.25, CHCl3); 1H NMR 
(500 MHz; CDCl3) δ 3.38 (3H, s, OCH3), 3.61 (3H, s, OCH3) 3.57–3.70 (2H, m, CH2), 
4.36 (1H, m, CHOH), 5.13 (1H, d, J 17.5, CHHO (2S,3'R)), 5.17 (1H, d, J 17.5, CHHO 
(2S,3'R)), 7.42 (3H, m, Ph), 7.62 (2H, m, Ph); 13C NMR (150 MHz; CDCl3) δ 55.8 
(OCH3), 59.5 (OCH3), 68.1, 72.8, 75.0, 84.5 (q, JCF 27, CCF3), 123.1 (q, JCF 285, CF3), 
127.5, 128.5, 129.8, 131.5, 166.1 (C=O ester), 202.9 (C=O, ketone); 19F NMR (282 
MHz; CDCl3) δ -72.2.  
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(2R,3'S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3',4'-dihydroxy-2'-oxo-
butyl ester100 
HO
O
O
O
CF3
MeO Ph
HO
Ha Hb
 (R)-82r 
The reaction was carried out under anhydrous conditions. To a stirred solution of         
L-erythrulose (0.03 g, 0.25 mmol) in CH2Cl2 (5 ml was added triethylamine (34 µl, 0.25 
mmol) and (S)-MTPA chloride (20 µL, 0.17 mmol) in CH2Cl2 (2 ml) and the reaction 
was stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using 
flash chromatography (EtOAc) to afford (R)-82r as a colourless oil (0.054 g, 63%), 
(2R,3'S) >95% ee (from integrations of Ha and Hb 1H NMR signals (R)-82r).  Rf 0.45 
(EtOAc); [α]20D= +10.2 (c 0.4, CHCl3); IR (Neat) 3429 (b, O-H), 2925, 1712 (s, C=O); 
1H NMR (300 MHz; CDCl3) δ 3.64 (3H, s, OMe), 3.89 (1H, dd, J 10.6 and 3.8, 
CHHOH), 3.95 (1H, dd, J 10.6 and 3.8, CHHOH), 4.35 (1H, dd, J 3.8 and 3.8, CHOH), 
5.11 (1H, d, J 17.0, CHHO (2R,3'S)), 5.19 (1H, d, J 17.0, CHHO (2R,3'S)), 7.43 (3H, m, 
Ph), 7.62 (2H, m, Ph), no (2R,3'R isomer detected); 13C NMR (75 MHz; CDCl3) δ 55.9 
(OCH3), 63.5, 68.0, 76.4, 84.6 (q, JCF  28, CCF3), 123.1 (q, JCF 288, CF3), 127.5, 128.6, 
129.9, 131.7, 166.5 (C=O ester), 203.3 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -
72.2; m/z (FTMS) [M+NH4] calcd for C14H19F3O6N requires 354.1159; found 354.1162.  
129.9, 131.7, 166.5 (C=O ester), 203.3 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -
72.2; m/z (FTMS) [M+NH4] calcd for C14H19F3O6N requires 354.1159; found 354.1162.  
 
(2S,3'S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3',4'-dihydroxy-2'-oxo-
butyl ester100 
HO
O
O
O
CF3
MeO Ph
HO
Ha Hb
 (S)-82r 
The same procedure was used as that described above for (R)-82r using (R)-MTPA to 
give (S)-82r as a colourless oil (0.044 g, 51%) (2S,3'S) >95%  ee (from integrations of 
Ha and Hb 1H NMR signals of (S)-82r). Rf 0.45 (EtOAc); [α]20D= -14.4 (c 0.5, CHCl3), 1H 
NMR (500 MHz; CDCl3) δ 3.63 (3H, s, OMe), 3.92 (2H, m, CH2OH), 4.35 (1H, dd, J 4.0 
and 3.8, CHOH), 5.05 (1H, d, J 17.0, CHHO (2S,3'S)), 5.23 (1H, d, J 17.0, CHHO 
(2S,3'S)), 7.43 (3H, m, Ph), 7.62 (2H, m, Ph), no (2S,3'R isomer detected); 13C NMR 
(125 MHz; CDCl3) δ 55.8 (OCH3), 63.5 (CH2OH), 67.9 (CH2C=O), 76.3 (CHOH), 84.6 
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(q, JCF  28, CCF3), 123.1 (q, JCF 288, CF3), 127.5, 128.5, 129.9, 131.7, 166.4 (C=O 
ester), 203.1 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2. 
 
(2R,3'S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-2'-oxo-
pentyl ester100 
HO
O
O
O
CF3
MeO Ph
Ha Hb
 (R)-82s (major isomer) 
The reaction was carried out under anhydrous conditions. To a stirred solution of (S)-
30s (0.03 g, 0.25 mmol) in CH2Cl2 (5 ml) was added DCC (0.06 g, 0.28 mmol) and 
DMAP (0.01 g, 0.02 mmol) in CH2Cl2 (10 ml) at 0 ºC and the reaction was stirred for 2 
min. (S)-MTPA (0.03 g, 0.08 mmol) was added and the reaction stirred for 30 min, then 
further (S)-MTPA (0.02 g, 0.08 mmol) added and the mixture stirred for 48 h at rt. The 
solvent was removed in vacuo, the crude product dry loaded onto silica gel and purified 
using flash chromatography (EtOAc:hexane, 3:2) to afford (R)-82s as a colourless oil 
(0.035 g, 59%), (2R,3'S)-55% ee (from the integrations of Ha and Hb 1H NMR signals 
from (R)-82s). Rf 0.45; [α]20D= +13.3 (c 0.15, CHCl3); IR (Neat) 3429br s, 2925s, 
1712s; 1H NMR (500 MHz; CDCl3) δ 1.00 (3H, m, CH3), 1.65 (1H, m, CHHCH3) 1.89 
(1H, m, CHHCH3), 2.86 (1H, d, J 6.0, OH), 3.64 (3H, s, OMe), 4.29 (1H, m, CHOH), 
5.05 (1H, s, CH2O (2R,3'S)), 7.54 (3H, m, Ph), 7.61 (2H, m, Ph); 13C NMR (125 MHz; 
CDCl3) δ 8.8 (CH3), 27.2 (CH2CH3), 55.8 (OCH3), 67.2, 76.2, 123.2 (q, JCF 283, CF3), 
127.6, 128.6, 129.9, 131.8, 166.3 (C=O ester), 204.2 (C=O, ketone); 19F NMR (282 
MHz; CDCl3) δ -72.2; m/z (FTMS) calcd [M+NH4] for C15H21F3O5N requires 352.1366; 
found 352.1371. 
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(2R,3'R)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-2'-oxo-
pentyl ester100 
HO
O
O
O
CF3
MeO Ph
Ha Hb
 (R)-82s (minor isomer) 
The reaction was carried out under anhydrous conditions. To a stirred solution of (S)-
30s (0.03 g, 0.25 mmol) in CH2Cl2 (5 ml) was added DCC (0.06 g, 0.28 mmol) and 
DMAP (0.01 g, 0.02 mmol) in CH2Cl2 (10 ml) at 0 ºC and the reaction was stirred for 2 
min. (S)-MTPA (0.03 g, 0.08 mmol) was added and the reaction stirred for 30 min, then 
further (S)-MTPA (0.02 g, 0.08 mmol) added and the mixture stirred for 48 h at rt. The 
solvent was removed in vacuo, the crude product dry loaded onto silica gel and purified 
using flash chromatography (EtOAc:hexane, 3:2) to afford (R)-82s as a colourless oil 
(0.035 g, 59%). Rf 0.45; [α]20D= +13.3 (c 0.15, CHCl3); IR (Neat) 3429br s, 2925s, 
1712s; 1H NMR (500 MHz; CDCl3) δ 1.00 (3H, m, CH3), 1.65 (1H, m, CHHCH3) 1.89 
(1H, m, CHHCH3), 2.86 (1H, d, J 6.0, OH), 3.64 (3H, s, OMe), 4.29 (1H, m, CHOH), 
4.93 (1H, d, J 17.0, CHHO (2R,3'R)), 5.17 (1H, d, J 17.0, CHHO (2R,3'R)), 7.54 (3H, 
m, Ph), 7.61 (2H, m, Ph); 13C NMR (125 MHz; CDCl3) δ 8.8 (CH3), 27.2 (CH2CH3), 55.8 
(OCH3), 67.2, 76.2, 123.2 (q, JCF 283, CF3), 127.6, 128.6, 129.9, 131.8, 166.3 (C=O 
ester), 204.2 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2; m/z (FTMS) calcd 
[M+NH4] for C15H21F3O5N requires 352.1366; found 352.1371. 
 
 (2S,3'S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-2'-oxo-
pentyl ester100 
HO
O
O
O
CF3
MeO Ph
Ha Hb
 (S)-82s (major isomer) 
The same procedure was used as that described above for (S)-30s using (S)-MTPA to 
give (S)-82s as a colourless oil (0.030 g, 57%) (2S,3'S)-55% ee (from integrations of Ha 
and Hb 1H NMR signals from (S)-82s). Rf 0.45; [α]20D= -37.0 (c. 0.1, CHCl3); 1H NMR 
(300 MHz; CDCl3) δ 1.00 (3H, t, J 7.4, CH3), 1.69 (1H, m, CHHCH3) 1.89 (1H, m, 
CHHCH3), 2.87 (1H, d, J 5.3, OH), 3.64 (3H, s, OMe), 4.29 (1H, m, CHOH), 4.93 (1H, 
d, J 17.0, CHHO (2S,3'S)), 5.17 (1H, d, J 17.0, CHHO (2S,3'S)), 7.54 (3H, m, Ph), 7.61 
(2H, m, Ph); 13C NMR (75 MHz; CDCl3) δ 8.7 and 8.8 (CH3), 27.2, 55.8 (OCH3), 67.2, 
76.2, 123.2 (q, JCF 283, CF3), 127.6, 128.5, 128.7, 129.9, 166.2 (C=O ester), 204.2 
(C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2. 
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(2S,3'R)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3'-hydroxy-2'-oxo-
pentyl ester100 
HO
O
O
O
CF3
MeO Ph
Ha Hb
 (S)-82s (minor isomer) 
The same procedure was used as that described above for (S)-30s using (S)-MTPA to 
give (S)-82s as a colourless oil (0.030 g, 57%) Rf 0.45; [α]20D= -37.0 (c. 0.1, CHCl3);   
1H NMR (300 MHz; CDCl3) δ 1.00 (3H, t, J 7.4, CH3), 1.69 (1H, m, CHHCH3) 1.89 (1H, 
m, CHHCH3), 2.87 (1H, d, J 5.3, OH), 3.64 (3H, s, OMe), 4.29 (1H, m, CHOH), 5.05 
(1H, s, CH2O (2S,3'R)), 7.54 (3H, m, Ph), 7.61 (2H, m, Ph); 13C NMR (75 MHz; CDCl3) 
δ 8.7 and 8.8 (CH3), 27.2, 55.8 (OCH3), 67.2, 76.2, 123.2 (q, JCF 283, CF3), 127.6, 
128.5, 128.7, 129.9, 166.2 (C=O ester), 204.2 (C=O, ketone); 19F NMR (282 MHz; 
CDCl3) δ -72.2. 
 
(3S)-3-Cyclopropyl-3-hydroxy-2-oxopropyl benzoate106 
 
O
O
OH O 94 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of     
(S)-30v (0.010 g, 0.06 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and benzoyl chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. 
The product was dry loaded onto silica gel and purified using flash chromatography 
(Hexane: EtOAc, 4:1) to afford 94 as a colourless oil (0.010 g, 71%). Rf 0.45; [α]25D= 
+74.0 (c 0.35, CHCl3); IR (Neat) 3442 (br, O-H) 2931s, 1722 (s, C=O, ester); 1H NMR 
(300 MHz; CDCl3) δ 1.20-1.72 (4H, m), 1.55 (1H, OH), 2.32 (1H, m), 3.05 (1h, d, J 5.0 
Hz, OH) 4.45 (1H, d, J 4.0 Hz, CHOH,), 4.97 (1H, d, CHH, J 17.0 Hz), 5.16 (1H, d, 
CHH, J 17.0 Hz), 7.26-7.48 (2H, m, Ar), 7.58 (1H, m, Ar), 8.02 (1H, m, Ar); 13C NMR 
(125 MHz; CDCl3) δ 25.5, 25.9 (signal overlap), 29.2, 66.4 (CH2O), 77.3 (CHOH), 
128.5, 129.0, 130.0, 133.5, 165.2 (C=O ester), 205.5 (C=O, ketone); m/z (HRMS) calcd 
[M+H]+ for C13H14O4 requires 234.12145, found 234.19234; HPLC conditions: chiralpak 
AD column, hexane:i-PrOH, 97:3, 1 ml min-1, retention times: 34.9 min (S-isomer, 
>99% ee), with no R-isomer was detected. 
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(2S,3’S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3’-cyclopropyl-3’-
hydroxy-2’-oxo-propyl ester133 
HO
O
O
O
CF3
Ph OMe
Ha Hb 95 (major isomer) 
The reaction was carried out under anhydrous conditions. To a stirred solution of     
(S)-30v (0.010 g, 0.08 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) in CH2Cl2 (2 ml) and the reaction was 
stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using flash 
chromatography (Hexane:EtOAc, 4:1) to afford 95 as a colourless oil (0.013 g, 87%), 
(2S,3S) 92% ee (from integrations of Ha and Hb 1H NMR signals of 95). Rf 0.45; [α]25D= 
+45.0 (c 0.2, EtOH); IR (Neat) 3420 (b, O-H), 2930, 2855, 1734 (s, C=O);  
1H NMR (300 MHz; CDCl3) δ 0.55 (2H, m), 0.71 (2H, m), 1.03 (1H, m), 3.09 (1H, d, J 
4.3 Hz), 3.60 (3H, s, OCH3), 3.63 (1H, m), 4.95 (1H, d, J 15.0 Hz, CHHO (2S,3’S)), 
5.37 (1H, d, J 15.0, CHHO (2S,3’S)), 7.43 (3H, m, Ph), 7.63 (2H, m, Ph); 13C NMR (125 
MHz; CDCl3) δ 14.7, 55.8 (OCH3), 66.9, 78.1, 127.6, 128.5, 129.9, 131.8, 166.2 (C=O 
ester), 203.0 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.3; m/z (FTMS) calcd 
[M+NH4]+ for C16H21F3O5N requires 364.1366, found 364.1364. 
 
(2S,3’R)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3’-cyclopropyl-3’-
hydroxy-2’-oxo-propyl ester133 
HO
O
O
O
CF3
Ph OMe
Ha Hb 95 (minor isomer) 
The reaction was carried out under anhydrous conditions. To a stirred solution of     
(S)-30v (0.010 g, 0.08 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) in CH2Cl2 (2 ml) and the reaction was 
stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using flash 
chromatography (Hexane:EtOAc, 4:1) to afford 95 as a colourless oil (0.013 g, 87%).    
Rf 0.45; [α]25D= +45.0 (c 0.2, EtOH); IR (Neat) 3420 (b, O-H), 2930, 2855, 1734 (s, 
C=O); 1H NMR (300 MHz; CDCl3) δ 0.55 (2H, m), 0.71 (2H, m), 1.03 (1H, m), 3.09 (1H, 
d, J 4.3 Hz), 3.60 (3H, s, OCH3), 3.63 (1H, m), 5.05 (1H, d, J 18.0 Hz, CHHO (2S, 
3’R)), 5.17 (1H, d, J 18.0 Hz, CHHO (2S, 3’R)), 7.43 (3H, m, Ph), 7.63 (2H, m, Ph);    
13C NMR (125 MHz; CDCl3) δ 14.7, 55.8 (OCH3), 66.9, 78.1, 127.6, 128.5, 129.9, 
131.8, 166.2 (C=O ester), 203.0 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.3; 
m/z (FTMS) calcd [M+NH4]+ for C16H21F3O5N requires 364.1366, found 364.1364. 
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 (3S)-3-Cyclopentyl-2-oxobutyl benzoate106 
 
O
O
OOH 96 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of      
(S)-30x (0.01 g, 0.06 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and benzoyl chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. 
The product was dry loaded onto silica gel and purified using flash chromatography 
(Hexane:EtOAc, 4:1) to afford 96 as a colourless oil (0.013 g, 79%), Rf 0.45; [α]25D = 
+26.6 (c 0.3, CHCl3); IR (Neat) 3484 (br, O-H), 2931s, 1722 (s, C=O, ester); 1H NMR 
(300 MHz; CDCl3) δ1.25-1.84 (10H, m), 2.32 (1H, m), 3.05 (1h, d, J 5.0, OH) 4.45 (1H, 
d, J 3.6, CHOH,), 5.04 (1H, d, CHH, J 17.0), 5.16 (1H, d, CHH, J 17.0),  7.29-7.35 (1H, 
m), 7.46 (2H, t, J 7.8, Ar), 7.61 (1H, t, J 7.4, Ar); 8.08 (1H, d, J 9.0, Ar); 13C NMR (125 
MHz; CDCl3) δ 25.5, 25.9 (signal overlap), 26.0, 29.2,, 42.7, 66.4 (CH2O), 77.3 
(CHOH), 128.6, 129.1, 130.0, 133.6, 165.9 (C=O ester), 205.5 (C=O, ketone); m/z 
(HRMS) calcd [M+H]+ for C15H19O4 requires 263.12833, found 263.12787; HPLC 
conditions: chiralpak AD column, hexane:i-PrOH, 97:3, 1 ml min-1, retention times: 31.8 
min (S-isomer, >99% ee) with no R-isomer detected. 
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(2R,3’S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3’-cyclopentyl-3’-
hydroxy-2’-oxo-propyl ester106 
 
HO
O
O
O
CF3
Ph OMe
Ha Hb 97 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of (S)-
30x (0.010 g, 0.05 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 mmol) 
and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. The 
product was dry loaded onto silica gel and purified using flash chromatography 
(EtOAc:hexane:, 1:4) to afford 97 as a colourless oil (0.020 g, 87%), (2S,3’S) >99% ee 
(from integrations of Ha and Hb 1H NMR signals of 97). Rf 0.50; [α]25D= +30.0 (c 0.1, 
CHCl3); IR (Neat) 3420 (br, O-H), 2930, 2855, 1734 (s, ester); 1H NMR (600 MHz; 
CDCl3) δ 1.34-1.78 (8H, m), 2.23 (1H, m) 2.90 (1H, d, J 5.1, OH) 3.64 (3H, s, OCH3) 
4.31 (1H, d, J 4.2), 5.05 (1H, d, J 16.9, CHHO (2R,3S)), 5.08 (1H, d, J 16.9, CHHO 
(2R, 3S)), no (2S, 3S) isomer detected, 7.43 (3H, m, Ph), 7.63 (2H, m, Ph); 13C NMR 
(150 MHz; CDCl3) δ 25.7, 25.8, 25.9, 29.1, 42.8, 55.9 (OCH3), 67.4, 77.0 (CHOH), 84.7 
(q, JCF 27, CCF3), 123.2 (d, JCF  287, CF3), 127.6, 128.6, 130.0, 131.9, 166.2 (C=O 
ester), 204.0 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2; m/z (FTMS) calcd 
[M+NH4]+ for C18H21F3O5NH4 requires 393.1712 found 393.1712. 
 
Figure 75 1H NMR spectra of compound 97 
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(2S,3’S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3’-cyclopentyl-3’-
hydroxy-2’-oxo-propyl ester106 
HO
O
O
O
CF3
Ph OMe
Ha Hb
 98 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of     
(S)-30x (0.01 g, 0.05 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. 
The product was dry loaded onto silica gel and purified using flash chromatography 
(EtOAc:hexane, 1:4) to afford 98 as a colourless oil (0.018 g, 78%), (2S,3S) >99% ee 
(from integrations of Ha and Hb 1H NMR signals of 98). Rf 0.50; [α]25D= -60.0 (c 0.1, 
CHCl3); IR (Neat) 3430 (b, O-H), 2930, 1732 (s, C=O, ester); 1H NMR (600 MHz; 
CDCl3) δ 1.17-1.95 (8H, m), 2.23 (1H, m) 2.91 (1H, m) 3.65 (3H, s, OCH3) 4.31 (1H, d, 
J 3.6), 4.92 (1H, d, J 12.0, CHHO (2S,3’S)), 5.20 (1H, d, J 12.0, CHHO (2R, 3’S)), no 
(2R, 3’S) isomer detected, 7.43 (3H, m, Ph), 7.62 (2H, m, Ph); 13C NMR (150 MHz; 
CDCl3) δ 25.1, 25.7, 25.9, 29.1, 41.9, 55.9 (OCH3), 67.4, 77.2 (CHOH), 84.7 (q, JCF 27, 
CCF3), 123.2 (d, JCF 287, CF3), 127.6, 128.6, 130.0, 131.9, 166.2 (C=O ester), 204.0 
(C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2; m/z (FTMS) calcd [M+NH4]+ for 
C18H21F3O5NH4 requires 393.1712, found 393.1712 (Fig. 74). 
 
Figure 76 1H NMR of spectra of compound 98  
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(3S)-3-(Acetyloxy)-3-cyclohexyl-2-oxopropyl acetate 
 
O
O
O
O
O
99 
 
To a stirred solution of 30y (0.03 g, 0.17 mmol) in anhydrous pyridine (3 ml) at rt was 
added acetic anhydride (1 ml) under an argon atmosphere.  The volatile solvents were 
removed in vacuo.  The remaining residue was dissolved in 50 ml EtOAc and was 
washed with 0.3 M KHSO4 (2 × 50 ml) and sat. NaHCO3  (2 × 50 ml).  The organic layer 
was dried under magnesium sulfate and the solvent removed in vacuo affording a 
brown oil 99 (0.043 g, >99 %).  Rf 0.40 (EtOAc:hexane, 1:4); IR (Neat) 3420 (b, O-H), 
2930, 2855, 1734 (s, C=O, ester); 1H NMR (300 MHz; CDCl3) δ 0.91-1.89 (11H, m), 
2.10 (3H, s), 2.11 (3H, s), 4.71 (1H, d, J 18.0), 4.79 (1H, d, J 18.0), 4.91 (1H, d, J 6.0); 
13C NMR (75 MHz; CDCl3) δ 20.4 (CH3), 20.5 (CH3), 25.8, 27.3, 28.9, 39.6, 67.0 
(CH2O), 80.3 (CHO), 170.1 (C=O), 170.5 (C=O), 200.8 (C=O); m/z (CI) calcd [MH]+ for 
C13H21O5 requires 257.13890 found 257.13790. HPLC conditions: chiralpak AD 
column, hexane:i-PrOH, 97:3, 1 ml min-1, retention times: 12.0 min and 13.6 min 
(racemic mixtures). 
 
(3S)-3-Cyclohexyl-3-hydroxy-2-oxopropyl benzoate106 
 
O
OH
O
O
Ph
100 
 
To a stirred solution of (S)-30y (0.100 g, 0.58 mmol) in 20 ml dry CH2Cl2 at rt was 
added triethylamine (177 µl, 1.27 mmol) and benzoyl chloride (147 µl, 1.27 mmol) 
under an argon atmosphere.  The reaction was heated under reflux for 6 h, and 
monitored by TLC.  The reaction mixture was poured into 30 ml CH2Cl2 and washed 
successively with 0.3 M KHSO4 (2 × 20 ml), sat. NaHCO3 (2 × 20 ml) and brine (2 × 20 
ml).  The organic layer was dried over anhydrous magnesium sulfate and was removed 
in vacuo to obtain the crude product.  The residue was further purified by silica gel 
column chromatography (EtOAc:hexane, 1:4) to afford the dibenzoate product as a 
colorless oil (0.072 g, 45 %). Rf  0.35; IR (Neat) 3420 (br, O-H), 2930, 1734 (s, ester); 
1H NMR (300 MHz; CDCl3) δ 0.64-1.83 (11H, m), 4.25 (1H, d, J 2.8), 5.00 (1H, d, J 
17.1, CHHO), 5.15 (1H, d, J 17.1, CHHO), 7.25-8.18 (5H, m); 13C NMR (150 MHz; 
 171 
CDCl3) 25.5, 25.9 (signal overlap), 26.5, 29.8, 66.7 (CH2O), 79.5 (CHOH), 128.6, 
129.1, 130.2, 133.7, 166.0 (C=O ester), 205.7 (C=O, ketone); m/z (CI) calcd [M+H]+ for 
C16H20O4 requires 277.14398, found 277.14335. HPLC conditions: Chiracel-OD 
column; mobile phase hexane:i-PrOH, 98:2, 1 m min-1, retention times: 28.5 min (S-
isomer, >99% ee) with no R-isomer detected. 
 
(2S,3’S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid 3’-cyclohexyl-3’-
hydroxy-2’-oxo-propyl ester106 
 
HO
O
O
O
CF3
Ph OMe
Ha Hb
  101 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of      
(S)-30y (0.010 g, 0.05 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. 
The product was dry loaded onto silica gel and purified using flash chromatography 
(EtOAc:hexane, 1:4) to afford 101 as a colourless oil (0.018 g, 78%), (2S,3S) >98% ee 
(from integrations of Ha and Hb 1H NMR signals of 101). Rf 0.45; [α]25D= -26.0 (c 0.2, 
CHCl3); IR (Neat) 3420 (br, O-H), 2930, 2855, 1734 (s, ester); 1H NMR (300 MHz; 
CDCl3) δ 0.89-1.76 (1H, m), 2.80 (1H, d, J 3.0, OH) 3.65 (3H, s, OCH3), 4.16 (1H, m), 
4.90 (1H, d, J 9.0, CHHO (2S,3’S)), 5.19 (1H, d, J 9.0, CHHO (2R, 3’S)) negligible (2R, 
3’S isomer detected), 7.43 (3H, m, Ph), 7.63 (2H, m, Ph); 13C NMR (125 MHz; CDCl3) 
δ 25.5, 25.9 (signal overlap), 26.4, 29.7, 41.9, 55.8 (OCH3), 67.8, 79.7 (CHOH), 127.5, 
128.5, 129.9, 131.9, 166.2 (C=O ester), 204.2 (C=O, ketone); 19F NMR (282 MHz; 
CDCl3) δ -72.2; m/z (FTMS) calcd [M+NH4]+ for C19H27F3NO5  requires 406.1836, found 
406.1831. 
 
 
 
 
 
 
 
 
 
 
 172 
 
3,4-Dimethyl-cyclohex-3-enecarbaldehyde102 
 
 
O
H
 104 
 
A zinc chloride (5.45 g, 40 mmol,) and choline chloride (2.70 g, 20 mmol) mixture was 
heated to 150 ºC and stirred for 10 min, then left to cool to 26 ºC.  2,3 Dimethyl, 1-3-
butadiene (800 µl, 12 mmol) and acrolein (800 µl, 12 mmol) was added to this ionic 
liquid and was left to stir for 2 h. The aldehyde was pipetted from the ionic liquid and 
clear colorless oil 104 was obtained (1.423 g, 84%); IR (Neat) 2923, 1720; 1H NMR 
(300 MHz; CDCl3) δ 1.54 (3H, s, CH3), 1.61 (3H, s, CH3), 1.87-2.44 (7H, m), 9.67 (1H, 
s, CHO); 13C NMR (75 MHz; CDCl3) δ 18.9 (CH3), 19.1 (CH3), 22.8, 30.1, 30.5, 46.9, 
123.4, 125.8, 204.7 (C=O); m/z (CI) calcd [MH]+ for C9H16O requires 139.11229, found 
139.11298. 
 
 
(1RS,1'RS)-1-(3’,4’-Dimethyl-cyclohe-3’-enyl)-1,3-dihydroxy-propan-2-one 
 
OH
O
OH
105 
 
To a stirred solution of Li-27 (0.33 g, 3.00 mmol) in water (60 ml) at rt, was added 104 
(0.414 g, 3.00 mmol) and N-methylmorpholine (0.33 ml, 3.00 mmol). The reaction 
mixture was stirred at rt for 48 h. The solvent was removed in vacuo and the crude 
product dry loaded onto a flash silica chromatography column (EtOAc:hexene, 1:1) to 
afford 105 as a colourless oil (0.060 g, 10%).  Rf 0.49, M.p. 150-160; IR (Neat) 3456 
(b, O-H), 2893m, 1721 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 1.40–2.08 (13H, m), 
2.93 (2H, m, OH), 4.26 (1H, m, CHOH), 4.36 (1H, br d, J 19.3, CHHOH) 4.49 (1H, dd, J 
19.3 and 4.2, CHHOH); 13C NMR (75 MHz; CDCl3) δ 18.8 (CH3), 19.1 (CH3), 23.5, 
31.5, 34.3, 38.9, 66.1 (CH2OH), 78.2 (CHOH), 125.4, 130.4, 211.6 (C=O); m/z (FAB+) 
221 (MNa+, 35%), 199 (MH+, 100); (HRFAB+) calcd for C11H19O3 (MH)+ requires 
199.13341 found 199.13381. The 2-isomer mixture of (1RS,1'R)-1-(3',4'-dimethyl-
cyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (1’R)-105 (0.06 g, 10%) was prepared 
using an identical method with (1R)-104  
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(1'R,1S)-3-(3',4'-Dimethyl-cyclo-3-enyl)-1,3-dihydroxypropan-2-one 
 
OH
O
OH
 (1'R,1S)-105 
 
The TK conversion protocol using 104 and D469T performed gave (1’R,1S)-105 (0.06 
g, 10%). [α]20D = +140 (c 0.5, CHCl3); M.p. 150-160; 1H NMR (300 MHz; CDCl3)           
δ 1.38 (2H, m), 1.59 (3H, s, CH3), 1.61 (3H, s, CH3), 1.96 (4H, m,), 2.12 (1H, m), 2.98 
(1H, m) 4.22 (1H, J 2.6, CHOH), 4.30 (1H, d, J 18.8, CHHOH) 4.48 (1H, d, J 18.8, 
CHHOH); 13C NMR (125 MHz; CDCl3) δ 18.8 (CH3), 19.1 (CH3), 23.3, 31.5, 34.3, 38.9 
(CH), 66.1 (CH2OH), 78.2 (CHOH), 125.4, 130.4, 211.6 (C=O).  The HPLC analysis 
(1'R, 1S)-105 was formed as the major isomer in 97% ee (minor isomer (1'R, 1R)-105). 
 
(1RS,1'RS)-3-(3,4-dimethylcyclohex-3-en-1-yl)-3-hydroxy-2-oxopropyl benzoate 
 
OH
O
O
O
Ph
106 
 
To a stirred solution of 105 (0.030 g, 0.10 mmol) in CH2Cl2 (3 ml) was added 
triethylamine (20 µl, 0.20 mmol) and benzoyl chloride (28 µl, 0.20 mmol). The 
reaction was then heated under reflux for 6 h, cooled and added  to CH2Cl2 (30 ml) 
and washed with 0.3 M KHSO4 (2 × 20 ml), sat. NaHCO3 (2 × 20 ml) and brine (2 × 
20 ml).  The organic layer was dried using maganesium sulfate and was evaporated 
to obtain the crude product. The residue was purified using silica gel column 
chromatography (EtOAc:hexane, 1:4) to afford the benzoate product as a colourless 
oil 106 (0.040 g, 70%). Rf 0.34; IR (Neat) 3429 (br, O-H) 2925s, 1785 (s, C=O, 
ester), 1724s (C=O), 1452m; 1H NMR (300 MHz; CDCl3) δ 1.23–2.04 (13H, m), 
3.00 (1H, br s, OH), 4.26 (1H, d, J 2.7, CHOH), 5.01 (1H, d, J 17.1, CHHOH), 5.15 
(1H, d, J 17.1, CHHOH), 7.60 (3H, m, Ar), 8.13 (2H, m, Ar); 13C NMR (75 MHz; 
CDCl3) δ 18.8 (signals superimposed), 19.2 (CH3), 22.6 (CH3), 31.6, 31.9, 34.5, 
38.4, 38.5, 66.6 (CH2C=O), 78.3 (CHOH), 78.7 (CHOH), 124.6, 128.5, 129.9, 133.6, 
165.8 (C=O ester), 205.5 (C=O, ketone); (HRFAB+) calcd for C18H23O4 (M)+ requires 
303.15963, found 303.15995.  HPLC: Chiracel-AD column; mobile phase, i-
PrOH:hexane (3:97), flow rate, 0.8 ml/min, detection, UV 214 nm. Retention times; 
28.6 min, 30.8 min, 34.0 min, 43.1 min.  
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The 2-isomer mixture of benzoic acid (3'RS,1''R)-3'-(3'',4''-dimethylcyclohex-3''-
enyl)-3'-hydroxy-2-oxo-propyl ester (1'R)-106 was prepared using an identical 
method. Chiral HPLC as above, retention times 28.6 min and 34.0 min. The D469T-
TK product (1S)-105 was also converted to the monobenzoate as described above. 
[α]20D= +7.6 (c 0.5, CHCl3). Chiral HPLC as above, retention times 28.6 min (1%), 
30.8 min (1%), 34.0 min (96.5%), 43.1 min (1.5%) to give (1S,1'R)-105 of 93% de. 
 
(2S,3'S,1''R)-3,3,3-Trifluoro-2-methoxy-2-phenylpropionic acid 3'-(3'',4''-
dimethylcyclohex-3''-enyl)-3'-hydroxy-2-oxo-propyl ester 
  
HO
O
O
O
CF3
MeO Ph
Ha Hb 107 
 
To a stirred solution of the biotransformation (1'S,1R)-105 (0.01 g, 0.05 mmol) in 
CH2Cl2 (5 ml) was added triethylamine (20 µl, 0.25 mmol) and (R)-MTPA chloride (15 
µl, 0.08 mmol) in CH2Cl2 (2 ml) and the reaction was stirred for 12 h at rt. The product 
was dry loaded onto silica gel and purified using flash chromatography (EtOAc:hexane, 
1:4) to afford 107 as a colourless oil (0.015 g, 75%), (2S,3'S) >98% ee. Rf 0.45; [α]20D= 
+7.6 (c 0.5, CHCl3); IR (Neat): 3429 (br, O-H), 2925s, 1758 (s, C=O, ester),1734 (s, 
C=O, ketone), 1170s; 1H NMR (500 MHz; CDCl3) δ 1.38 (2H, m), 1.60 (3H, s, CH3), 
1.62 (3H, s, CH3), 1.98 (4H, m), 2.12 (1H, m), 3.65 (3H, s, OMe), 4.23 (1H, m), 4.91 
(1H, d, J 17.0, CHHO (2S,3'S)), 5.18 (1H, d, J 17.0, CHHO (2S,3'S)), 7.42 (3H, m, Ph), 
7.63 (2H, m, Ph), (trace 2S,3'R isomer detected); 13C NMR (125 MHz; CDCl3) δ 18.8, 
19.1, 22.7, 31.6, 34.3, 38.6, 55.8 (OCH3), 67.7 (O=CCH2), 78.6 (CHOH), 124.5, 125.5, 
127.5, 128.5, 129.9, 131.9, 166.2 (C=O ester), 204.2 (C=O, ketone); 19F NMR (282 
MHz; CDCl3) δ -71.0; m/z (FAB+) 437 (MNa+-H, 43%), 415 (M+, 56), 307 (65), 189 
(100), (+HRFAB) calcd for C21H26O5F3 (M)+ requires 415.17322, found 415.17372. 
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2, 3-Dihydroxypropiophenone137   
     
    
O
OH
OH
   110 
 
To a stirred solution of Cs-27 (0.328 g, 3.00 mmol) in water (60 ml) at rt, was added 
benzaldehyde (363 µl, 3.00 mmol) and N-methylmorpholine (364 µl, 3.00 mmol).  The 
reaction mixture was stirred at rt for 48 h, and monitored by TLC.  The solvent was 
removed in vacuo and the crude product dry loaded onto a flash silica chromatography 
column (EtOAc: hexane, 1:1) affording 110 (0.025 g, 5%) as a colourless oil.  Rf 0.53; 
IR (Neat) 3391 (s, O-H), 1684 (C=O), 691 (Ar-H); 1H NMR (300 MHz; MeOD) δ 3.73 
(2H, dd, J 11.7 and 5.0, CHHOH), 3.88 (2H, dd, J 11.7 and 3.7, CHHOH), 5.15 (1H, m, 
HOCH), 7.51 (2H, t, J 6.0, Ar), 7.61 (1H, t, J 6.0, Ar), 8.00 (2H, d, J 6.0, Ar); 13C NMR 
(75 MHz; CDCl3) δ 64.2 (CH2), 87.2 (CHOH), 128.4, 129.2, 130.2, 137.2, 209.5 (C=O); 
m/z (ES+): 167.6 (M+, 94%), 77.7 (C6H6+, 10%), 58.9 (C2H2O2+, 25%) 
 
(3RS,4RS)-1,3,4,5-Tetrahydroxy-3-phenyl-pentan-2-one 
 
HO
OH
O
OH
OH
111 
Biotransformation side product (see 30Ar1) generated in a 50 mM TK reaction using 
D469E gave (10 mg, 6%) as an oil; [α]20D= +18.0 (c 0.5, CHCl3); IR (Neat) 3391 (s, O-
H), 1684 (C=O), 691 (Ar-H); 1H NMR (600 MHz; MeOD) δ 3.05 (1H, d, J 11.1, OH), 
3.72-3.98 (2H, m, CH2OH), 4.60 (1H, d, J 19.4, CHHOH), 4.65 (1H, d, J 19.4, CHHOH), 
4.81 (1H, m, CHOH); 13C NMR (150 MHz; MeOD) Diastereomers: δ 67.0 (CH2), 67.4 
(CH2), 68.8 (CH2), 69.1(CH2), 76.6 (CH), 76.7 (CH), 86.2, 86.8, 128.8, 128.9, 129.0, 
141.2, 214.6 (C=O), 215.4 (C=O); m/z (ES+): calcd [M+Na]+ for C11H14O5Na requires 
249.2012, found 249.2114. 
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(2R,3’R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3’-hydroxy-2’-oxo-3’-
phenyl-propyl ester  
 
HO
O
O
O
CF3
Ph OMe
Ha Hb
  115 (major isomer) 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of      
(R)-3a (0.008 g, 0.05 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. 
The product was dry loaded onto silica gel and purified using flash chromatography 
(EtOAc:hexane, 1:4) to afford 115 as a colourless oil (0.016 g, 84%), (2R,3’R) 87% ee 
(from integrations of Ha and Hb 1H NMR signals of 115). Rf 0.40; [α]25D= +30.0 (c 0.5, 
CHCl3); IR (Neat) 3420 (br, O-H), 2930, 2855, 1734 (s, ester); 1H NMR (300 MHz; 
CDCl3) δ 3.61 (3H, s, OCH3), 4.68 (1H, d, J 18.0, CHHO (2R,3’R)), 5.02 (1H, d, J 18.0, 
CHHO (2R, 3’R)) 4.84 (1H, d, J 18.0, CHHO (2S,3’R)), 4.91 (1H, d, J 18.0, CHHO 
(2S,3’R)), 5.25 (1H, s), 7.25-7.60 (8H, m, Ar), 7.59 (2H, m, Ar); 13C NMR (150 MHz; 
CDCl3) δ 55.9 (OCH3), 66.5, 78.1 (CHOH), 127.4 (signal overlap), 127.5, 128.6, 129.5, 
129.6, 130.0, 131.8, 136.7, 166.3 (C=O ester), 201.7 (C=O, ketone); 19F NMR (282 
MHz; CDCl3) δ -72.2; m/z (CI) calcd [M+H]+ for C19H18F3O5  requires 383.11063, found 
383.11154. 
 
(2R,3’S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3’-hydroxy-2’-oxo-3’-
phenyl-propyl ester  
 
HO
O
O
O
CF3
Ph OMe
Ha Hb
  115 (minor isomer) 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of      
(R)-3a (0.008 g, 0.05 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 
mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. 
The product was dry loaded onto silica gel and purified using flash chromatography 
(EtOAc:hexane, 1:4) to afford 115 as a colourless oil (0.016 g, 84%). Rf 0.40; [α]25D= 
+30.0 (c 0.5, CHCl3); IR (Neat) 3420 (br, O-H), 2930, 2855, 1734 (s, ester); 1H NMR 
(300 MHz; CDCl3) δ 3.61 (3H, s, OCH3), 4.68 (1H, d, J 18.0, CHHO (2R,3’R)), 4.84 
(1H, d, J 18.0, CHHO (2R,3’S)), 4.91 (1H, d, J 18.0, CHHO (2R,3’S)), 5.25 (1H, s), 
7.25-7.60 (8H, m, Ar), 7.59 (2H, m, Ar); 13C NMR (150 MHz; CDCl3) δ 55.9 (OCH3), 
66.5, 78.1 (CHOH), 127.4 (signal overlap), 127.5, 128.6, 129.5, 129.6, 130.0, 131.8, 
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136.7, 166.3 (C=O ester), 201.7 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2; 
m/z (CI) calcd [M+H]+ for C19H18F3O5  requires 383.11063, found 383.11154. 
 
Acetic acid 3-acetoxy-2-oxo-1-phenyl-propyl ester138 
 
O
OO
O
O
116 
To a stirred solution of 30Ar1 (0.060, 0.36 mmol) in dry CH2Cl2 (15 ml) was added a 
CH2Cl2 solution (10 ml) of DCC (0.082 g, 0.40 mmol) at 0º C under an argon 
atmosphere.  After 5 min the reaction mixture was gently warmed to rt and acetic acid 
(23 µl, 0.40 mmol) was added to reaction mixture and was left for 12 h under argon.  
The solvent was removed in vacuo and the crude product dry loaded onto a flash silica 
chromatography column (EtOAc: hexane, 1:4).  Colourless oil was isolated 116 (0.075 
g, 83 %).  Rf  0.38; IR (Neat) 3400 (br, O-H), 2950 (s, CH2), 1720 (s, C=O); 1H NMR 
(300 MHz; CDCl3) δ 2.04 (3H, s), 2.23 (3H, s), 4.62 (1H, d, J 18.0, CHH), 4.82 (1H, d,           
J 18.0, CHH), 4.61 (1H, s, OCH), 7.40 (5H, s); 13C NMR (75 MHz; CDCl3) δ 21.0 (CH3), 
21.2 (CH3), 68.2 (CH2), 78.7 (CHO), 128.5, 129.6, 132.2, 137.3, 209.9 (C=O); m/z 
(HRMS): calcd [MH]+ for C13H14O5 requires 251.0354, found 251.0923. 
The isomers were separated via HPLC conditions: chiralpak AD column, hexane:         
i-PrOH, 98:2, 1 ml min-1, retention times: 24.8 min and 28.8 min (racemic mixtures). 
 
1-Furan-2-yl-2, 3-dihydroxy-propan-1-one 
O
O
OH
OH
117 
To a stirred solution of Li-27 (0.113 g, 1.04 mmol) in water (5 ml) and THF (5 ml) at rt, 
was added furfural (83 µl, 1.00 mmol) and N-methylmorpholine (101 µl, 1.00 mmol).  
The reaction mixture was stirred at rt for 24 h, and monitored by TLC.  The solvent was 
removed in vacuo and the crude product dry loaded onto a flash silica chromatography 
column (EtOAc: hexane, 1:1) affording compound 117 (0.006 g, 4%) as a brown oil.   
Rf  0.40; IR (Neat) 3391 (s, O-H), 1708 (C=O), 694 (Ar-H); 1H NMR (300 MHz; CDCl3) 
δ 3.93 (1H, dd, J 11.8 and 4.5, CHHOH), 4.06 (1H, dd, J 11.8 and 3.3, CHHOH), 4.91 
(1H, m, CHOH), 6.60 (1H, m, Ar), 7.37 (1H, m, Ar), 7.64 (1H, m, Ar); 13C NMR (125 
 178 
MHz; CDCl3) δ 64.9 (CH2), 74.8 (CHO), 112.8, 119.5, 147.4, 150.3, 187.7 (C=O); m/z 
(CI) [M+Na]+ calcd for C7H9O4 requires 157.05008, found 157.04964. 
(2S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3-furan-2-yl-2-hydroxy-3-
oxo-propyl ester 
O
O
OH
O
O
CF3
OMePh
Ha Hb 119 
To a stirred solution of the biotransformation 117 (0.01 g, 0.05 mmol) in CH2Cl2 (1 ml) 
was added triethylamine (20 µl, 0.25 mmol) and (R)-MTPA chloride (15 µl, 0.08 mmol) 
in CH2Cl2 (1 ml) and the reaction was stirred for 12 h at rt. The product was dry loaded 
onto silica gel and purified using flash chromatography (EtOAc:hexane, 1:4) to afford 
119 as a colourless oil (0.019 g, 70%). Rf 0.40; [α]20D= +30.6 (c 0.5, CHCl3); IR (Neat): 
3429 (br, O-H), 2925s, 1750 (s, C=O, ester),1734 (s, C=O, ketone), 1170s; 1H NMR 
(600 MHz; CDCl3) δ 3.06 (0.5H, m, CHHO-), 3.30 (1H, m, CH2O-), 3.48 (0.5H, m, 
CHHO-), 3.68 (3H, s, OMe), 4.20 (1H, m, CHOH), 6.61 (1H, d, J 2.0. Ar), 7.37 (1H, m, 
Ar), 7.51 (1H, m, Ar); 13C NMR (150 MHz; CDCl3) δ 18.8, 19.1, 22.7, 31.6, 34.3, 38.6, 
55.8 (OCH3), 68.2 (O=CCH2), 77.3 (CHOH), 113.2, 126.8 (d, JCF  287, CF3), 128.9, 
129.2, 134.4, 149.5, 164.9 (C=O ester), 204.2 (C=O, ketone); 19F NMR (282 MHz; 
CDCl3) δ -71.0; m/z (+HRCl) calcd for C17H15O6F3 (M)+ requires 373.08990, found 
373.08821. 
 
4-(acetyloxy)-3-oxo-1-phenylbutan-2-yl acetate 
O
O
O
OO
121 
To a stirred solution of 30Ar4 (0.02 g, 0.11 mmol) in anhydrous pyridine (3 ml) at rt was 
added acetic anhydride (1 ml) under an argon atmosphere.  The reaction was left to stir 
at rt for 6 h, and monitored by TLC.  The volatile solvents were removed in vauo.  The 
remaining residue was dissolved in EtOAc (50 ml) and was washed with 0.3 M KHSO4 
(2 × 50 ml) and sat. NaHCO3 (2 × 50 ml).  The organic layer was dried over MgSO4 and 
the solvent removed in vacuo affording a brown oil 121 (0.029 g, 100%).  Rf 0.45;       
IR (Neat) 3400 (br, O-H), 2950 (s, CH2), 1722 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 
2.08 (3H, s), 2.18 (3H, s), 3.05 (1H, dd, J 14.3 and 8.1, PhCHH,) 3.36 (1H, dd, J 14.3 
and 5.1, PhCHH), 4.64 (1H, d, J 18.0, CHHO), 4.72 (1H, d, J 18.0, CHHO), 5.32 (1H, 
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dd, J 8.0 and 5.2, CHOH), 7.26 (5H, m), 13C NMR (125 MHz; CDCl3) δ 20.5 (CH3), 20.6 
(CH3), 36.9, 66.6 (CH2C=O), 77.3 (CHC=O), 127.3, 128.7, 129.0, 129.4, 170.1 (C=O, 
ester), 170.2 (C=O ester), 200.7 (C=O, ketone); m/z (HRMS) calcd for C14H17O5 [M+H]+ 
requires  265.10759, found 265.10797. 
3-(Benzoyloxy)-2-oxo-4-phenylbutyl benzoate 
O
O
O
OO
122 
To a stirred solution of 30Ar4 (0.01 g, 0.04 mmol) in CH2Cl2 (1 ml) was added 
triethylamine (34 µl, 0.25 mmol) and benzoyl chloride (20 µl, 0.08 mmol) the reaction 
was stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using 
flash chromatography (Hexane:EtOAc, 4:1) to afford 122 as a colourless oil (0.012 g, 
80%). Rf 0.55; IR (Neat) 3484 (br, O-H), 2931, 1722 (s, ester), 694 (Ar-H); 1H NMR 
(300 MHz; CDCl3) δ 3.28 (1H, dd, J 14.4 and 8.0, PhCHH), 3.36 (1H, dd, J 14.4 and 
4.9, PhCHH), 4.98 (1H, d, J 17.2, CHHO), 5.05 (1H, d, J 17.2, CHHO), 5.65 (1H, m, 
CHOH), 7.29 (3H, m, Ar), 7.45 (2H, t, J 7.9), 7.55 (2H, m), 8.01 (2H, d, J 8.1, Ar), 8.07 
(2H, d, J 8.1, Ar), 8.16 (2H, d, J 8.1, Ar), 8.32 (2H, d, J 8.1, Ar); 13C NMR (125 MHz; 
CDCl3) δ 37.1 (CH2Ar), 67.0 (CH2O), 77.7 (CHOH), 127.3, 128.5, 128.9, 129.0, 129.6, 
129.9, 130.0, 130.7, 133.5, 134.6, 135.5, 162.4 (C=O, ester), 166.0 (C=O ester), 205.1 
(C=O, ketone); m/z (HRMS) [MH]+ calcd for C24H20O5Na requires 411.1208, found 
411.1194. 
3-Hydroxy-2-oxo-4-phenylbutyl benzoate 
OH
O
O
O
Ph
123 
To a stirred solution of (S)- 30Ar4 (0.01 g, 0.04 mmol) in CH2Cl2 (1 ml) was added 
triethylamine (34 µl, 0.25 mmol) and benzoyl chloride (10 µl, 0.04 mmol) the reaction 
was stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using 
flash chromatography (Hexane:EtOAc, 4:1) to afford 123 as a colourless oil (0.010 g, 
91%). Rf 0.45; IR (Neat) 3400 (br, O-H), 2950 (s, CH2) 1722 (s, C=O); 1H NMR (300 
MHz; CDCl3) δ 2.97 (1H, dd, J 14.0 and 8.1, PhCHH), 3.25 (1H, dd, J 14.0 and 4.5, 
PhCHH), 4.61 (1H, dd, J 8.0 and 4.6, CHOH) 5.02 (1H, d, J 18.0, CHHO), 5.10 (1H, d, 
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J 18.0, CHHO), 7.29 (5H, m), 7.43 (3H, t, J 7.3), 7.59 (1H, m), 8.09 (1H, m); 13C NMR 
(125 MHz; CDCl3) δ 40.3, 66.7 (CH2O), 76.4 (CHOH), 127.3, 127.3, 128.6, 129.1, 
129.5, 130.0, 133.6, 136.0, 166.0 (C=O ester), 205.1 (C=O, ketone); m/z (HRMS) calcd 
for [M+H]+ for C17H15O4 requires 283.0958, found 283.0970.  
HPLC: Chiracel-AD column; mobile phase i-PrOH:hexane (3:97); flow rate, 0.8 ml     
min-1, detection, UV 214 nm. Retention times at 45.2 min (3R)-123 and 57.0 min (3S)-
123. 
 
Benzoylated TK mutants: WT-TK gave (3S,4S)-127 (10 mg, 91%), H26Y-TK gave (9 
mg, 81%) reaction, D469K-TK gave (3S,4S)-127 (11 mg, 100%) G6-TK gave (3S,4S)-
127 (11 mg, 100%) and  D469E-TK gave (3S,4S)-30Ar4 (10 mg, 91%), and D469T-TK 
gave (3S,4S)-127 (11 mg, 100%), [α]25D= -2.0 (c 0.6, CHCl3); The spectral assignments 
are the same as above. 
 
 (2S,3’S)- 3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3’-hydroxy-1,1-
dimethyl-2’-oxo-4’-phenyl-butyl ester 
 
HO
O
O
O
CF3
MeO Ph
Ha Hb 126 (major isomer) 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of 
synthesized D469E 30Ar3 (0.01 g, 0.04 mmol) in CH2Cl2 (1 ml) was added 
triethylamine (34 µl, 0.25 mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction 
was stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using 
flash chromatography (EtOAc:hexane, 1:4) to afford 126 as a colourless oil (0.015 g, 
85%), (2S,3S) 90% ee (from integrations of Ha and Hb 1H NMR signals of 126). Rf 0.40; 
[α]25D= -30.0º (c 0.3, CHCl3); IR (Neat) 3600 (br, O-H), 2932 (s,CH2) 1759 (s, C=O);    
1H NMR (300 MHz; CDCl3) δ 2.59 (1H, d, J 4.0 Hz, OH) 2.91 (1H, dd, J 14.1 and 8.6, 
PhCHH,) 3.17 (1H, dd, J 14.1 and 4.4, PhCHH) 3.66 (1H, s, OCH3), 4.50 (1H, m, 
CHOH) 4.95 (1H, d, J 17.4, CHHO (2S,3’S)), 5.06 (1H, d, J 9.5, (2S, 3’S)), 7.21-7.42 
(5H, m), 7.43 (3H, m, Ar), 7.63 (2H, m, Ar); 13C NMR (125 MHz; CDCl3) δ 40.2 (CH2Ar), 
55.8 (OCH3), 67.8 (CH2O-), 76.7 (CHOH), 127.5, 127.6, 128.5, 129.0, 129.5, 129.9, 
131.9, 135.6, 166.3 (C=O ester), 203.5 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -
72.2; m/z (HRMS) calcd [M+H]+ for C20H19F3O5 requires 395.1106, found 395.1119. 
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(2S,3’R)- 3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3’-hydroxy-1,1-
dimethyl-2’-oxo-4’-phenyl-butyl ester 
 
HO
O
O
O
CF3
MeO Ph
Ha Hb 126 (minor isomer) 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of 
synthesized D469E 30Ar3 (0.01 g, 0.04 mmol) in CH2Cl2 (1 ml) was added 
triethylamine (34 µl, 0.25 mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction 
was stirred for 12 h at rt. The product was dry loaded onto silica gel and purified using 
flash chromatography (EtOAc:hexane, 1:4) to afford 126 as a colourless oil (0.015 g, 
85%).  Rf 0.40; [α]25D= -30.0º (c 0.3, CHCl3); IR (Neat) 3600 (br, O-H), 2932 (s,CH2) 
1759 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 2.59 (1H, d, J 4.0 Hz, OH) 2.91 (1H, dd, J 
14.1 and 8.6, PhCHH,) 3.17 (1H, dd, J 14.1 and 4.4, PhCHH) 3.66 (1H, s, OCH3), 4.50 
(1H, m, CHOH), 5.16 (1H, d, J 17.4, CHHO (2S, 3’R)), 7.21-7.42 (5H, m), 7.43 (3H, m, 
Ar), 7.63 (2H, m, Ar); 13C NMR (125 MHz; CDCl3) δ 40.2 (CH2Ar), 55.8 (OCH3), 67.8 
(CH2O-), 76.7 (CHOH), 127.5, 127.6, 128.5, 129.0, 129.5, 129.9, 131.9, 135.6, 166.3 
(C=O ester), 203.5 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.2; m/z (HRMS) 
calcd [M+H]+ for C20H19F3O5 requires 395.1106, found 395.1119. 
 
(3RS,4RS)-3-Hydroxy-2-oxo-4-phenylpentyl benzoate 
 
OH
O
O
O 127 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of 
30Ar4 (0.01 g, 0.05 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 0.25 mmol) 
and benzoyl chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h at rt. The 
product was dry loaded onto silica gel and purified using flash chromatography 
(hexane:EtOAc, 4:1) to afford 127 as a colourless oil (0.012 g, 83%). Rf 0.45; IR (Neat) 
3484 (br, O-H), 2931 (s, CH2) 1722 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 1.33 (3H, d, 
J 7.1), 2.95 (1H, s, OH), 3.28 (1H, m, CHCH3), 4.49 (1H, d, J 3.8, CHOH,), 4.95 (1H, d, 
J 3.8, CHOH), 7.29-7.35 (5H, m, Ar), 7.46 (2H, t, J 7.8, Ar), 7.61 (1H, t, J 7.4, Ar); 8.08 
(2H, d, J 9.0, Ar); 13C NMR (125 MHz; CDCl3) δ 14.2 (CH3), 43.2 (CHCH3), 67.3 
(CH2O), 79.6 (CHOH), 127.3, 127.8, 128.9, 129.5, 130.0, 133.6, 142.5, 166.9 (C=O 
ester), 205.3 (C=O, ketone); m/z (HRMS) calcd for C18H17O4 [M+H]+ requires 297.1127, 
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found 297.1133; HPLC conditions: Chiracel-OD column; mobile phase, i-PrOH:hexane 
(3:97); flow rate, 0.8 ml min-1, detection UV 214 nm. Retention times at 28.6 min 
(3R,4S)-127, 30.8 min (3R,4R)-127, 34.0 min (3S,4R)-127, 43.1 min (3S,4S)-127. The 
2-isomer mixture of (3RS,4R)-3,4-dihydroxy-2-oxo-4-phenylbutyl benzoate (4R)-132 
(0.01 g, 71%) was prepared using an identical method and 127.  Retention times; 25.1 
min (major peak), 27.3 min (major peak), 30.4 min (minor peak), 45.2 min (minor peak). 
 
Benzoylated TK mutants: WT-TK gave (3S,4S)-127 (13 mg, 87%), H26Y-TK no 
reaction, D469K-TK gave (3S,4S)-127 (10 mg, 67%) G6-TK gave (3S,4S)-127 (13 mg, 
87%) and  D469E-TK gave (3S,4S)-30Ar4 (10 mg, 67%), and D469T-TK gave (3S,4S)-
127 (13 mg, 87%), [α]25D= +37.4 (c 1.4, CHCl3).  The spectral assignment same as 
above with retention times at 30.8 min (3R,4R)-127, 34.0 min (3S,4S)-127. 
 
 (2S,3’S,4’S)-3’-hydroxy-2’-oxo-4’ phenylpentyl 3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate 
 
HO
O
O
O
Ph
CF3
OMe
Ha Hb 128 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of 
(1'R,1S)-105 (0.012 g, 0.06 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 
0.25 mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h 
at rt. The product was dry loaded onto silica gel and purified using flash 
chromatography (Hexane: EtOAc, 4:1) to afford 128 as a colourless oil (0.018 g, 75%), 
(2S,3S) 91% ee (from integrations of Ha and Hb 1H NMR signals of 128). Rf 0.45; 
[α]25D= -37.2 (c 0.25, CHCl3); IR (Neat) 3471 (b, O-H), 2954s, 1759 (s, C=O, ester), 
1735s 1170 (C-F); 1H NMR (300 MHz; CDCl3) δ 2.59 (1H, d, J 4.0, OH) 2.91 (1H, dd,   
J 8.6, 14.1, PhCHH,) 3.17 (1H, dd, J 14.1 and 4.4, PhCHH) 3.66 (1H, s, OCH3), 4.50 
(1H, m, CHOH), 4.86 (1H, d, 17.3, CHHO (2S,3S)), 5.04 (1H, d, J 17.3, CHHO (2S, 
3S)), 7.21-7.42 (5H, m), 7.43 (3H, m, Ph), 7.63 (2H, m, Ph); 13C NMR (125 MHz; 
CDCl3) δ 13.8, 43.2, 55.8 (OCH3), 68.5 (CH2), 80.1 (CHOH), 127.4, 127.6, 127.8, 
128.5, 129.0, 129.9, 129.9, 131.9, 142.0, 166.2 (C=O ester), 203.7 (C=O, ketone); 19F 
NMR (282 MHz; CDCl3) δ -72.3; m/z (HRMS) calcd [M+H]+ for C21H21F3O5 requires 
433.1239, found 433.1234. 
 
 
 183 
(2S,3’R,4’S)-3’-hydroxy-2’-oxo-4’ phenylpentyl 3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate 
 
HO
O
O
O
Ph
CF3
OMe
Ha Hb 128 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of 
(1'R,1S)-105 (0.012 g, 0.06 mmol) in CH2Cl2 (1 ml) was added triethylamine (34 µl, 
0.25 mmol) and (R)-MTPA chloride (10 µl, 0.04 mmol) the reaction was stirred for 12 h 
at rt. The product was dry loaded onto silica gel and purified using flash 
chromatography (Hexane: EtOAc, 4:1) to afford 128 as a colourless oil (0.018 g, 75%). 
Rf 0.45; [α]25D= -37.2 (c 0.25, CHCl3); IR (Neat) 3471 (b, O-H), 2954s, 1759 (s, C=O, 
ester), 1735s 1170 (C-F); 1H NMR (300 MHz; CDCl3) δ 2.59 (1H, d, J 4.0, OH) 2.91 
(1H, dd, J 14.1 and 8.6, PhCHH,) 3.17 (1H, dd, J 14.1 and 4.4, PhCHH) 3.66 (1H, s, 
OCH3), 4.50 (1H, m, CHOH), 4.95 (1H, s, (2S, 3R)), 7.21-7.42 (5H, m), 7.43 (3H, m, 
Ph), 7.63 (2H, m, Ph); 13C NMR (125 MHz; CDCl3) δ 13.8, 43.2, 55.8 (OCH3), 68.5 
(CH2), 80.1 (CHOH), 127.4, 127.6, 127.8, 128.5, 129.0, 129.9, 129.9, 131.9, 142.0, 
166.2 (C=O ester), 203.7 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -72.3; m/z 
(HRMS) calcd [M+H]+ for C21H21F3O5 requires 433.1239, found 433.1234. 
(2R)-Phenylpropan-1-ol108 
OH
130 
To a cold stirred solution of LiAlH4 (0.30 g, 7.48 mmol) in anhydrous THF (10 ml) was 
added slowly 2-phenylpropionic acid (6.67 mmol, 1.00 g) under argon at 0 ºC.  The 
mixture was stirred for 60 min at 0 ºC and gently raised to rt for 2 h.  The reaction was 
cooled with an ice-water bath and quenched with sat. NaSO4 (10 ml) and poured into 
brine (10 ml).  Diethyl ether (50 ml) was added, the layers were separated and the 
aqueous layer was extracted with diethyl ether (3 × 20 ml).  The combined ethereal 
layers were washed successively with 3 M HCl (2 × 25) ml, sat. NaHCO3 (2 × 25 ml), 
and of brine (2 × 20 ml).  The organic phase was dried over magnesium sulfate 
 
and 
the solvent was removed in vacuo to obtain the aldehyde as pale colourless oil 130 
(0.753 g, 84%), [α]25D= -72.0º (c 0.4, CHCl3); IR (Neat) 3400 (br, O-H), 2950s;             
1H NMR (500 MHz; CDCl3) δ 1.28 (1H, d, J 10.0, CH3) 1.47 (1H, s, OH), 2.95 (1H, 
sextet, J 9.0, CH) 3.69 (1H, d, J 10.0, CH2), 7.23 (3H, m), 7.33 (2H, m);  13C NMR (125 
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MHz; CDCl3) δ 42.5 (CH3), 68.8 (CHCH3), 77.3 (CH2), 126.8, 127.0, 127.6, 127.9, 
128.7; m/z (HRMS) calcd [MH]+ for C9H12O requires 136.08827, found 136.08876. 
 
Cyclohexanecarboxylic acid methoxy-methyl-amide139 
 
O
N
Me
OMe
175 
 
To a stirred solution of N,O-dimethylhydroxylamine hydrochloride (0.49 g, 5.00 mmol) 
in dry CH2Cl2 (40 ml) was added N,N-diisopropylethylamine DIEA (1.93 ml, 15 mmol) at 
rt and the reaction was stirred for 5 mins.  Cyclohexanecarbonyl chloride (710 µl,          
5 mmol) was added and the mixture a was stirred at rt for 12 h.  The reaction mixture 
was poured into 30 ml CH2Cl2 and washed successively with 0.3 mol KHSO4 (2 × 20 
ml), sat. NaHCO3 (2 × 20 ml) and brine (2 × 20 ml).  The organic layer was dried over 
anhydrous magnesium sulfate and the solvent was removed in vacuo to obtain the 
pure product 175 as yellow oil (0.845, >99%). Rf 0.56; IR (KBr) 2930-2855 (s, C-H), 
1663 (s, C=O); 1H NMR (300 MHz; CDCl3) δ 1.16-1.92 (10H, m, 5 x CH2), 2.67 (1H, m, 
CHCO), 3.24 (3H, s, N-CH3), 3.68 (3H, s, OCH3); 13C NMR (75 MHz; CDCl3) δ 25.4, 
25.7 (2C signal overlap), 28.9, 39.9 (CH3N-), 61.4 (CH3O-), 172.0 (amide); m/z (CI): 
172 ([M+H]+, 100%), 111 ([M-C2H6NO], 100%), 156 ([M-CH3O), 10%). 
 
 
[1-2H]-Cyclohexancarboxyaldehyde 
 
O
D
176 
 
To a cold stirred solution of LiAlD4 (0.30 g, 7.48 mmol) in anhydrous THF (10 ml) was 
added slowly 175 (1.01 g, 6.80 mmol) under argon at 0 ºC.  The mixture was stirred for 
60 min at 0 ºC and raised to rt for 2 h.  The reaction was cooled with an ice-water bath 
and hydrolysed with sat. citric acid (10 ml) and poured into brine (10 ml).  Diethyl ether 
(50 ml) was added, the layers were separated and the aqueous layer was extracted 
with diethyl ether (3 × 20 ml).  The combined ether layers were washed successively 
with 3 M HCl (2 × 25 ml), sat. NaHCO3 (2 × 25 ml), and of brine (2 × 20 ml).  The 
organic phase was dried over magnesium sulfate
 
and the solvent was removed in 
vacuo to obtain the aldehyde as pale yellow oil 176 (0.412 g, 54%). IR (KBr) 1721     
(s, C=O); 1H NMR (300 MHz; CDCl3) δ 0.83-2.23 (11H, m); 13C NMR (75 MHz; CDCl3) 
δ 24.9, 25.1, 25.9, 49.7 (CHCO), 204.6 (C=O, t, JCD 25.0) m/z (CI): pending. 
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Tert-butyl (2S)-2-[(pyrrolidin-1-yl)carbonyl]pyrrolidine-1-carboxylate129 
N
N
OOO
187a 
To a CH2Cl2 suspension (20 ml) of (S)-Boc-proline (1.00 g, 4.00 mmol) was added  
DCC (1.05 g, 5.00 mmol) in CH2Cl2 (5 ml) at 0 ºC under an argon atmosphere and the 
reaction mixture was stirred for 15 min at that temperature. To this reaction mixture 
was added a CH2Cl2 solution (2 ml) of pyrrolidine (410 µl, 4.65 mmol) slowly at 0 ºC, 
and was increased to rt after 10 min and left stirred over 24 h.  After removal of CH2Cl2 
in vacuo, EtOAc (20 ml) was then added to the residue. After insoluble materials had 
been removed by filtration, the filtrate was washed with 1 M HCl (10 ml), saturated 
NaHCO3 solution (20 ml) and brine sequentially, then drying over anhydrous Na2SO4.  
The EtOAc was removed in vacuo, and the residue was purified by silica gel column 
chromatography, (CHCl3:MeOH, 9:1) to afford the amide 187a; yield 1.06 g (85%). 
Rf 0.45; [α]25D= -83.1 (c 0.5, EtOH); IR (Neat) 1697.5, 1658.2 (amide); 1H NMR (300 
MHz; (CDCl3) δ 1.45 (9H, s), 1.81-2.09 (5H, m), 3.41-3.75 (9H, m) 4.57 (1H, m, CH); 
13C NMR (125 MHz; CDCl3) rotamers δ 23.0, 23.3, 29.5 (CH3)3, 29.3, 30.6, 42.0, 45.7, 
46.0, 46.5, 46.8, 56.1, 56.2, 66.6, 67.5, 76.6, 153.2 (carbamate), 173.4 (amide); m/z 
(ES+) 285 (M+H+, 50%), 185 (M-Boc+, 100%). 
 
Tert-butyl (2S)-2-[(2,3-dihydro-1H-isoindol-2-yl)carbonyl]pyrrolidine-1- 
carboxylate hydrate140,130 
 
N
N
OOO
187b 
To a CH2Cl2 suspension (20 ml) of (S)-Boc-proline (1.02 g, 4.00 mmol) was added a 
CH2Cl2 (5 ml) of DCC (1.04 g, 5.00 mmol) at 0 ºC under an argon atmosphere and the 
reaction mixture was stirred for 15 min at that temperature. To this reaction mixture 
was added a CH2Cl2 solution (2 ml) of piperidine (457 µl, 4.66 mmol) slowly at 0 ºC, 
and was increased to rt after 10 min and left stirred over 24 h.  CH2Cl2 was then 
removed in vacuo, and EtOAc (20 ml) was added to the residue. After insoluble 
materials had been removed by filtration, the filtrate was washed with 1 M HCl (10 ml), 
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saturated NaHCO3 solution (20 ml) and brine sequentially, then drying over anhydrous 
Na2SO4.  The EtOAc was removed in vacuo, and the residue was purified by silica gel 
column chromatography, (CHCl3:MeOH, 9:1) to afford the amide 187b; yield 1.16 g 
(89%). Rf 0.45; [α]25D= -43.4 (c 0.5, EtOH); IR (Neat) 1697.5 (carbamate), 1658.2 
(amide); 1H NMR (300 MHz; CDCl3) rotamers; δ 1.40 (4.5H, s, CH3), 1.47 (4.5H, s, 
CH3), 1.56-2.03 (10H, m, CH2), 3.35-3.69 (6H, m, CH2), 4.53 (0.5H, dd, J 8.7 and 3.7, 
CH), 4.66 (0.5H, dd, J 8.2 and 2.2, CH); 13C NMR (125 MHz; CDCl3) rotamers δ 23.4, 
24.1, 26.5, 28.5 (CH3)3, 29.8, 30.5, 56.5 (CH), 56.9 (CH), 79.3, 154.5 (carbamate), 
171.2 (amide); m/z (ES+) 283 (M+H+, 100%), 183 (M-Boc+, 50%). 
 
Tert-butyl (2S)-2-[(morpholin-4-yl)carbonyl]pyrrolidine-1-carboxylate130 
N
N
O
OOO
187c 
To a CH2Cl2 suspension (20 ml) of (S)-Boc-proline (1.04 g, 4.00 mmol) was added a 
CH2Cl2 (5 ml) of DCC (1.05 g, 5.00 mmol) at 0 ºC under an argon atmosphere and the 
reaction mixture was stirred for 15 min at that temperature. To this reaction mixture 
was added a CH2Cl2 solution (2 ml) of morpholine (405 µl, 4.66 mmol) slowly at 0 ºC, 
and was increased to rt after 10 min and left stirred over 24 h.  After removal of CH2Cl2 
in vacuo, EtOAc (20 ml) was then added to the residue.  After insoluble materials had 
been removed by filtration, the filtrate was washed with 1 M HCl (10 ml), saturated 
NaHCO3 solution (20 ml) and brine sequentially, then drying over anhydrous Na2SO4.  
The EtOAc was removed in vacuo, and the residue was purified by silica gel column 
chromatography, (CHCl3:MeOH, 9:1) to afford the amide 187c; yield 1.10 g (83%).  
Rf 0.45; [α]25D= -83.1 (c 0.5, EtOH); IR (Neat) 1697.5, 1658.2 (amide); 1H NMR (300 
MHz; CDCl3) δ 1.45 (9H, s), 1.81-2.09 (5H, m), 3.41-3.75 (9H, m) 4.57 (1H, m, CH); 
13C NMR (125 MHz; CDCl3) rotamers δ 23.6, 24.3, 28.5 (CH3)3, 29.8, 30.6, 42.4, 45.7, 
46.0, 46.6, 46.8, 56.1, 56.7, 66.6, 67.0, 76.6, 154.0 (carbamate), 171.0 (amide); m/z 
(ES+) 285 (M+H+, 50%), 185 (M-Boc+, 100%). 
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Tert-butyl (2S)-2-[(2,3-dihydro-1H-isoindol-2-yl)carbonyl]pyrrolidine-1- 
carboxylate hydrate141 
 
N
N
OOO
187d 
To a CH2Cl2 suspension (20 ml) of (S)-Boc-proline (1.02 g, 4.00 mmol) was added a 
CH2Cl2 (5 ml) of DCC (1.03 g, 5.00 mmol) at 0 ºC under an argon atmosphere and the 
reaction mixture was stirred for 15 min at that temperature. To this reaction mixture 
was added a CH2Cl2 solution (2 ml) of isoindoline (554 µl, 4.65 mmol) slowly at 0 ºC, 
and was increased to rt after 10 min and left stirred over 24 h.  CH2Cl2 was removed in 
vacuo, and EtOAc (20 ml) was added to the residue. After insoluble materials had been 
removed by filtration, the filtrate was washed with 1 M HCl (10 ml), saturated NaHCO3 
solution (20 ml) and brine sequentially, then drying over anhydrous Na2SO4.  The 
EtOAc was removed in vacuo, and the residue was purified by silica gel column 
chromatography, (CHCl3:MeOH, 9:1) to afford the amide 187d; yield 1.32 g (90%). 
Rf 0.45; [α]25D= -103.1 (c 0.5, MeOH); IR (Neat) 1697.5, 1658.2 (amide); 1H NMR (300 
MHz; CDCl3) δ 1.24 (4.5H, s, CH3), 1.45 (4.5H, s, CH3), 1.57-1.97 (5H, m), 3.12 (2H, 
m), 3.42 (1H, m), 3.59 (1H, m), 4.09-4.84 (3H, m), 6.91 (1H, m), 7.08 (1H, m), 8.16 
(1H, m); 13C NMR (125 MHz; CDCl3) rotamers; δ 23.7, 24.2, 28.3, 28.5 (CH3)3, 29.5, 
30.4, 58.5 (CH), 58.7 (CH), 79.5, 79.6, 117.2, 123.6, 123.7, 124.5, 127.3, 127.5, 130.9, 
131.1, 142.9, 143,1, 153.7 (carbamate), 154.5 (carbamate), 170.9 (amide), 171.2 
(amide); m/z (ES+) 316 (M+H+, 100%), 216 (M-Boc+, 50%). 
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Tert-butyl(2S)-2-{[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl] 
carbonyl}pyrrolidine-1-carboxylate131 
 
N
N
O
OO
O O
187e 
To a CH2Cl2 suspension (20 ml) of (S)-Boc-proline (1.02 g, 4.00 mmol) was added a 
CH2Cl2 (5 ml) of DCC (1.03 g, 5.00 mmol) at 0 ºC under an argon atmosphere and the 
reaction mixture was stirred for 15 min at that temperature. To this reaction mixture 
was added a CH2Cl2 solution (2 ml) of 187ei (0.63 g, 4.65 mmol) slowly at 0 ºC, and 
was increased to rt after 10 min and left stirred over 24 h.  CH2Cl2 was removed in 
vacuo, and EtOAc (20 ml) was added to the residue. After insoluble materials had been 
removed by filtration, the filtrate was washed with 1 M HCl (10 ml), saturated NaHCO3 
solution (20 ml) and brine sequentially, then drying over anhydrous Na2SO4.  The 
EtOAc was removed in vacuo, and the residue was purified by silica gel column 
chromatography, (CHCl3:MeOH, 9:1) to afford the amide 187e; yield 1.15 g (76%). 
Rf 0.43; [α]25D= +42.1 (c 0.5, CHCl3); IR 1705.5, 1658.2 (amide); 1H NMR (300 MHz; 
CDCl3) δ 1.38 (4.5H, s, CH3), 1.43 (4.5H, s, CH3), 1.85-2.19 (8H, m), 3.40-3.78         
(7H, m), 4.48-4.57 (2H, m, CH); 13C NMR (125 MHz; CDCl3) rotamers; δ 23.7, 24.2, 
28.3, 28.5 (CH3)3, 29.5, 30.4, 58.5 (CH), 58.7 (CH), 79.5, 79.6, 117.2, 123.6, 123.7, 
124.5, 127.3, 127.5, 130.9, 131.1, 142.9, 143,1, 153.7 (carbamate), 154.5 (carbamate), 
170.9 (amide), 171.2 (amide); m/z (ES+) 327 (M+H+, 100%), 102 (Boc+H+, 100%). 
 
(2S)- Pyrrolidine-2-carboxylic acid methyl ester131  
N
H
O
O 187ei 
To 12 ml (0.30 mol) methanol cooled to 0 °C was added dropwise 3 ml (0.04 mol) 
thionyl chloride.  To this solution 1.5 g (0.013 mol) L-proline was added and stirred for   
1 h.  The mixture was then allowed to warm to rt and stirred for 48 h.  After evaporation 
of methanol, the crystalline product was suspended in 8 ml diethyl ether and was 
added 2.5 ml (0.018 mol) triethylamine at rt and stirred for 2 h. The white precipitate 
was filtered and washed with (2x10 ml) diethyl ether. The ethereal layers were 
combined and evaporated in vacuo to afford a pale yellow liquid 1.50 g (90%).      
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[α]25D= +19.8 (c 1.4, EtOH); IR (Neat) 13385 br, 2971, 1740, 1630; 1H NMR (300 MHz; 
CDCl3) δ 1.74 (3H, m), 2.08 (2H, m), 2.90 (0.5H, m), 3.08 (0.5H, m), 3.73 (3H, s) 3.76 
(1H, m), 4.2 (1H, s, NH); 13C NMR (125 MHz; CDCl3) δ 25.5, 30.2, 47.1, 52.1 (CH3), 
59.7 (CH); m/z (ES+) 130 (M+H+, 20%). 
 
(2S)-1-methyl-2-(pyrrolidin-1-ylmethyl)pyrrolidine130 
 
N
N
188a 
To a THF suspension (10 ml) of LiAlH4 (0.312 g, 8.22 mmol) was added a THF solution 
(10 ml) of 187a (1.02 g, 3.81 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 187a, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 188a as a colourless oil; yield 0.52 
g (81%). [α]25D= -83.1 (c 0.5, EtOH); IR (Neat) 2980s, 2950, 1422 ; 1H NMR (300 MHz; 
CDCl3) δ 1.40-2.59 (16H, m), 2.34 (3H, s, CH3-N), 2.99 (1H, m, CH); 13C NMR (125 
MHz; CDCl3) δ 22.5, 23.4, 31.0, 41.3 (CH3-N), 54.9, 57.5, 61.5, 64.9 (CHNCH3); m/z 
(HRMS) calcd for C10H20O2Na [MH]+ 1911.1208, found 191.1324. 
1-{[(2S)-1-methylpyrrolidin-2-yl]methyl}piperidine130 
 
N
N
188b 
 
To a THF suspension (10 ml) of LiAlH4 (0.310 g, 8.22 mmol) was added a THF solution 
(10 ml) of 187b (1.06 g, 3.76 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 187b, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 188b as a colourless oil; yield 0.53 
g (78%). [α]25D= -83.1 (c 0.5, EtOH); IR (Neat) 2980s, 2950s, 1722; 1H NMR (300 MHz; 
CDCl3) δ 1.22-2.51 (18H, m), 2.39 (3H, s CH3-N), 3.03 (1H, m, CH); 13C NMR (125 
MHz; CDCl3) δ 22.7, 24.5, 26.0, 31.3, 41.5 (CH3-N), 54.4, 57.7, 63.0 (-CHNCH3), 64.9; 
m/z (ES+) 183 (M+H+, 10%). 
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4-{[(2S)-1-methylpyrrolidin-2-yl]methyl}morpholine130 
 
N
N
O
188c 
To a THF suspension (10 ml) of LiAlH4 (0.314 g, 8.22 mmol) was added a THF solution 
(10 ml) of 187c (1.05 g, 3.67 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 187c, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 188c as a colourless oil; yield 0.57 
g (84%). [α]25D= -64.5 (c 0.8, EtOH); IR (Neat) 3387, 2953, 1739; 1H NMR (300 MHz; 
CDCl3) δ 1.59-2.52 (8H, m), 2.41 (3H, s CH3-N), 2.45 (4H, t, J 4.5, CH2NCH2), 3.04 
(1H, m, CH), 3.69 (4H, t, J 4.5, CH2OCH2); 13C NMR (125 MHz; CDCl3) δ 22.6, 30.8, 
41.6 (CH3-N), 54.4, 57.9, 62.5 (-CH2NCH2), 64.4 (CH2OCH2), 67.0; m/z (ES+) 185 
(M+H+, 100%). 
 [(3R)-1-{[(2S)-1-methylpyrrolidin-2-yl]methyl}pyrrolidin-3-yl]methanol amine131 
N
N
OH
188e 
To a THF suspension (10 ml) of LiAlH4 (0.312 g, 8.22 mmol) was added a THF solution 
(10 ml) of 187e (1.03 g, 3.16 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 187e, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 188e as a colourless oil; yield 0.57 
g (90%). [α]25D= -53.1 (c 0.8, EtOH); IR (Neat) 3364 (br, OH), 2951, 1738; 1H NMR 
(300 MHz; CDCl3) δ 1.62-1.88 (9H, m), 2.18-2.67 (5H, m) 2.33 (3H, s), 3.06 (1H, m, 
CH), 3.16 (1H, m, CHCH2OH), 3.33 (1H, dd, J 10.8 and 3.9), 3.54 (1H, dd, J 10.8 and 
3.1); 13C NMR (125 MHz; CDCl3) δ 22.8, 24.2, 27.7, 29.5, 41.1 (CH3-N), 56.5, 57.4, 
58.4, 63.4, 65.9 (-CHNCH3), 66.5 (-CHCH2OH); m/z (ES+) 199 (M+H+, 100%). 
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bis(decyl)({[(2S)-1-methylpyrrolidin-2-yl]methyl})amine131 
N
N
188f 
To a THF suspension (10 ml) of LiAlH4 (0.312 g, 8.22 mmol) was added a THF solution 
(10 ml) of 187f (1.02 g, 2.02 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 187f, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 188f as a colourless oil; yield    
0.60 g (81%). [α]25D= -94.5 (c 1.1, EtOH); IR (Neat) 2922, 2852, 1456; 1H NMR (300 
MHz; CDCl3) δ 1.20-2.56 (50H, m), 2.39 (3H, s, CH3-N), 3.13 (1H, m, CHNCH3);       
13C NMR (125 MHz; CDCl3) δ 22.3, 24.1, 25.0, 25.3 (signals superimposed), 26.1, 
31.3, 41.5 (CH3-N), 54.4, 57.7, 63.0 (-CHNCH3), 64.9; m/z (ES+) 395 (M+H+, 100%).  
 
(2S)-2-[(pyrrolidin-1-yl)carbonyl]pyrrolidine hydrobromide132 
 
N
H
HBr O
N
189a 
 
A mixture of 187a (1.02 g, 3.81 mmol) and 33% solution of HBr in acetic acid (3 ml) 
was stirred for 3 h. The reaction was stopped by distillation of acetic acid in vacuo and 
the crude product was purified using a silica chromatography column (CH3Cl:MeOH; 
9:1) affording compound 189a as a brown liquid; yield 0.61 g (97%). 
 [α]25D= -24.1 (c 0.3, EtOH); IR (Neat) 3380br, 2942s, 1632s; 1H NMR (300 MHz; D2O) 
δ 1.77-2.00 (7H, m), 2.42-2.52 (1H, m), 3.28-3.50 (6H, m), 4.46 (1H, t, J 7.5, CH);     
13C NMR (125 MHz; D2O) δ 24.0, 24.4, 25.7, 28.7, 47.0, 59.6 (CH), 167.7 (NHC=O); 
m/z (ES+) 169 (M+H+, 100%). 
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1-{[(2S)-pyrrolidin-2-yl]carbonyl}piperidine hydrobromide132 
 
N
H
N
HBr O 189b 
 
A mixture of 187b (1.02 g, 3.81 mmol) and 33% solution of HBr in acetic acid (3 ml) 
was stirred for 3 h. The reaction was stopped by distillation of acetic acid in vacuo and 
the crude product was purified using a silica chromatography column (CH3Cl:MeOH; 
9:1) affording compound 189b as a brown liquid; yield 0.60 g (94%); [α]25D= -63.1 (c 
1.2, EtOH); IR (Neat) 3400br, 2950s, 1722s; 1H NMR (300 MHz; D2O) δ 1.51-1.61 (6H, 
m), 1.81-2.07 (3H, m), 2.43 (1H, m), 3.34-3.54 (6H, m), 4.75 (1H, J 8.4, CH); 13C NMR 
(125 MHz; D2O) δ 24.3, 25.6, 26.2, 30.4, 44.0, 46.4, 46.9, 57.9 (CH), 168.5 (NHC=O); 
m/z (ES+) 183 (M+H+, 10%). 
 
(2S)-2-(pyrrolidin-1-ylmethyl)pyrrolidine133 
N
H
N
190a 
To a THF suspension (10 ml) of LiAlH4 (0.301 g, 8.00 mmol) was added a THF solution 
(10 ml) of 189a (0.61 g, 3.63 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 189a, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 190a as a brown oil; yield 0.52 g 
(93%). [α]25D= +8.2 (c 2.0, EtOH); IR (neat) 3250, 1460, 1400; 1H NMR (300 MHz; 
CDCl3) δ 1.25-2.04 (8H, m), 2.32-2.57 (6H, m), 2.83-3.21 (3H, m); 13C NMR (125 MHz; 
CDCl3) δ 23.5, 25.1, 30.2, 46.2, 54.6, 57.5 (CH), 62.2 (NCH2CHN), m/z (ES+) 155 
(M+H+, 60%), 154 (M+, 50%). 
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1-[(2S)-pyrrolidin-2-ylmethyl]piperidine134 
N
H
N
190b 
To a THF suspension (10 ml) of LiAlH4 (0.270 g, 7.25 mmol) was added a THF solution 
(10 ml) of 189b (0.60 g, 3.30 mmol) at 0 ºC and the temperature of the reaction mixture 
was raised to rt.  Following the complete addition of 189b, the reaction mixture was 
refluxed for 4 h.  Saturated Na2SO4 solution was added to the reaction mixture at 0 ºC 
until the evolution of H2 ceased.  After filtration of the inorganic materials, volatile 
solvent was removed in vacuo to afford the diamine 190b as a brown oil; yield 0.45 g 
(81%). [α]25D= +19.6 (c 1.2, EtOH); IR (neat) 3250, 2960, 1440, 1300; 1H NMR (300 
MHz; CDCl3) δ 1.32-2.00 (10H, m), 2.23-2.45 (8H, m), 3.63 (1H, t, J 6.0, CH); 13C NMR 
(125 MHz; CDCl3) δ 24.5, 25.0, 26.1, 30.1, 46.1, 55.1, 55.6 (CH), 65.0 (NCH2CHN), 
m/z (ES+) 169 (M+H+, 100%) 
Benzoic acid (6-methoxy-quinolin-4-yl)-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-
methyl ester125 
N
OBz
N
OMe
181 
 
To a solution of quinine 180 (2.05 g, 6.2 mmol) in anhydrous DMF (20 ml) was added 
triethylamine (863 µl, 12.4 mmol) and the reaction mixture was stirred at rt under an 
argon atmosphere for 2 h.  Then benzoyl chloride (1.0 ml, 6.8 mmol) was added 
dropwise over 15 min and the reaction mixture was stirred overnight.  After starting 
material had been consumed, brine (20 ml) was added to the reaction mixture and was 
extracted with EtOAc (100 ml). The organic layer was washed with H2O (4 x 20 ml), 
brine (50 ml) and dried over Na2SO4. The solvent was removed in vacuo to afford the 
crude oil which was purified using silica gel chromatography (CHCl3:MeOH, 9:1) to 
afford 181, as yellow crystals (1.31 g, 50%). M.p. 190-200; [α]25D = +110 (c 0.5, CHCl3); 
IR (Neat) 2941, 2855, 1711 (s, ester), 1621 (m, Ar), 1504; 1H NMR (300 MHz; CDCl3) 
δ 1.46-1.57 (2H, m), 1.69-1.73 (1H, m), 1.77 (1H, m, br), 1.97-2.04 (1H, m), 2.21 (1H, 
m), 2.47-2.52 (2H, m), 2.80-2.88 (1H, m), 3.17 (1H), 3.46-3.52 (1H, m), 3.92 (3H, s, 
OCH3), 4.97-5.05 (2H, m), 5.93-6.04 (1H, m), 6.52 (1H, d, J 8.4), 7.42 (1H, dd, J 9.0 
and 2.4), 7.68 (1H, t, J 7.5), 7.52-7.60 (4H, m), 7.91 (1H, d, J 9.3), 8.04 (2H, d, J 7.2), 
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8.67 (1H, d, J 4.5); 13C NMR (125 MHz; CDCl3) δ 24.1, 27.7, 27.9, 39.7 (OCH3), 42.6, 
55.8, 56.8, 59.5, 74.5, 101.5, 114.7, 118.7, 122.1, 127.0, 128.0, 128.7, 129.7, 131.9, 
133.6, 141.7, 143.7, 144.9, 147.5, 158.1 (ester), 165.6 (ketone), m/z (CI+) 429 (M+H+, 
100%). 
 
4-[Allyloxy-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methyl]-6-methoxy-quinoline125 
N
O
N
OMe
   182 
To a solution of quinine 180 (2.05 g, 6.2 mmol) in anhydrous DMF (20 ml) was added 
triethylamine (863 µl, 12.4 mmol) and the reaction mixture was stirred at rt under an 
argon atmosphere for 2 h. Then benzoyl chloride (1 ml, 6.8 mmol) was added dropwise 
over 15 min and the reaction mixture was stirred overnight.  After starting material had 
been consumed, brine (20 ml) was added to the reaction mixture and was extracted 
with EtOAc (100 ml).  The organic layer was washed with H2O (4 x 20 ml), brine (50 ml) 
and dried over Na2SO4. The solvent was removed in vacuo to afford the crude oil which 
was purified using silica gel chromatography, (CHCl3:MeOH, 9:1) to afford a yellow oil 
182; yield 2.52 g (93%). [α]25D = +116 (c. 0.6, CHCl3); IR (Neat) 2935, 2865, 1620, 
1590, 1508, 1240; 1H NMR (500 MHz; CDCl3) δ 1.45-1.57 (2H, m), 1.70-1.77 (3H, m), 
1.97-2.04 (1H, m), 2.22 (1H, m), 2.57-2.67 (2H, m), 3.03-3.08 (2H, m), 3.45 (1H, m), 
3.90 (3H, s, OCH3), 3.81-3.94 (2H, m), 4.85-4.92 (2H, m), 5.13-5.29 (3H, m), 5.68 (1H, 
m), 5.90 (1H, m, CHC=C), 7.30-7.35 (2H, m), 7.40 (1H, d, J 4.5), 8.00 (2H, d, J 10.2), 
8.70 (1H, d, J 5.0); 13C NMR (125 MHz; CDCl3) δ 22.1, 27.5, 28.1, 39.7 (OCH3), 43.8, 
53.1, 55.4, 56.9, 59.8, 69.7 (OCH2), 80.5 (CHOally), 102.7, 113.9 (CH=CH2), 116.8, 
118.5, 121.3, 127.0, 127.1 134.1, 141.6, 144.4, 147.3, 157.4; m/z (EI) 363 (M+, 100%). 
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4-[Allyloxy-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methyl]-6-methoxy-quinoline125 
N
OBn
N
OMe
   183 
To a solution of quinine 180 (2.00 g, 6.2 mmol) in anhydrous DMF (20 ml) was added 
triethylamine (863 µl, 12.4 mmol) and the reaction mixture was stirred at rt under an 
argon atmosphere.for 2 h. Then benzyl chloride (780 µl, 6.8 mmol) was added 
dropwise over 15 min and the reaction mixture was stirred overnight.  After starting 
material had been consumed, brine (20 ml) was added to the reaction mixture.and was 
extracted with EtOAc (100 ml).  The organic layer was washed with H2O (4 x 20 ml), 
brine (50 ml) and dried over Na2SO4. The solvent was removed in vacuo to afford the 
crude oil which was purified using silica gel chromatography, (CHCl3:MeOH, 9:1) to 
afford brown oil 183; yield 2.45 g (95%). [α]25D= +132 (c 0.90, CHCl3);  IR (Neat) 2935, 
2865, 1619, 1590, 1507, 1240; 1H NMR (500 MHz; CDCl3) δ 1.46-1.80 (5H, m), 2.23 
(1H, m), 2.58-2.68 (2H, m), 3.04-3.16 (2H, m), 3.41 (1H, m), 3.91 (3H, s, OCH3), 4.39 
(1H, d, J 12.0), 4.46 (1H, d, J 12.0), 4.89-4.97 (1H, m, CHO), 5.19 (1H, m) 5.68-5.80 
(1H, m), 5.90 (1H, m, CHC=C), 7.28-7.40 (7H, m), 7.47 (1H, d, J 4.5 Hz), 8.05 (1H, d, J 
9.0 Hz), 8.75 (1H, d, J 4.5); 13C NMR (125 MHz; CDCl3) δ 22.5, 27.5, 28.1, 39.7 
(OCH3), 43.3, 55.4, 56.9, 59.8, 70.8 (OCH2), 80.7 (CHOBn), 101.0, 113.9 (CH=CH2), 
116.9, 121.5, 127.4, 127.7, 127.9, 128.3, 131.6, 137.6, 140.9 (CH=CH2), 144.4, 144.7, 
147.3, 157.5; m/z (CI) 415 (M+H+, 100%). 
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Publications from PhD research 
‘Stereoselectivity of an ω-transaminase-mediated amination of 1,3-dihydroxy-1-
phenylpropane-2-one’.   
Smithies, K.; Smith, M.E.B.; Kaulmann, U.K.; Galman, J.L.; Ward, J.M.; Hailes, H.C. 
Tetrahedron Asymmetry. 2009, 20, 570. 
 
‘Application of a modified Mosher’s method for the determination of 
enantiomeric ratio and absolute configuration at C-3 of chiral 1,3-dihydroxy 
ketones’. 
Galman, J.L.; Hailes, H.C. Tetrahedron: Asymmetry, 2009, 20, 1828. 
 
‘Non-α-hydroxylated aldehydes with evolved transketolase enzymes’ 
Cázares, A.; Galman, J.L.; Crago, L.G.; Smith, M.E.B.; Strafford, J.; Ríos-Solís, L.; Lye, 
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‘α,α′-Dihydroxyketone formation using aromatic and heteroaromatic aldehydes 
with evolved transketolase enzymes’  
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